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ABBREVIATIONS 
Ac Acetyl or acetyl protection 
group 
AcOH Acetic acid 
ACQ 6-Aminoquinolyl-N-
hydroxysuccinimidyl 
carbamate 
AIBN 2,2’-Azobis-(2-methyl-
proponitril) 
AMQ 6-Aminoquinoline 
AX Anion exchange 
 
B Benzyl protection group 
Boc tert-Butyl oxalyl protection 
group 
CE Capillary electrophoresis 
CIP Cahn Ingold and Prelog 
ClAc Chloro acetyl protection 
group 
CSP Chiral stationary phase 
CMP Chiral mobile phase 
CX Cation exchange 
DAD Diode array detector 
DMF Dimethylformamide 
DNB 3,5-Dinitro-benzyl carbonyl 
DNS 5-Dimethylamino-naphtyl-
sulfon protection group 
DNPyr 2,4-Dinitropyridin 
DNZ 3,5-Dinitro-1-methyl-
benzyloxalyl 
F Formaldehyde protection 
group 
FITC Fluoresceine isothiocyanate 
FLD Fluorescence detector 
FMOC Fluorenyloxalyl protection 
group 
HILIC Hydrophilic interaction 
liquid chromatography 
HCl Hydrogenchloride  
LIF Laser-induced-fluorescence  
M Molar 
mm Milli meters 
MeOH Methanol 
mM Milli mol per liter 
NH4AcO Ammonia acetate 
nm Nano meters 
o.n. Over night 
OPA ortho-Phtalaldehyde 
pHa Apparent pH  
SP Stationary phase 
SO Chiral selector 
t0 void time 
(v/v) Volume per volume 
µm Micro meters 
WAX Weak anion-exchanger 
UV Ultra violet 
VIS Visible 
Z Methylphenyloxalyl 
protection group 
ZX Zwitterionic exchange
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Abbreviations of analytes 
AABA Alpha aminobutyric acid 
ACHSA 2-Amino-cyclohexyl 
carboxyl acid 
Ala Alanine 
Arg Arginine 
Asn Asparagine 
Asp Aspartic acid 
Cys Cysteine 
Cys-S-acetamide Cysteine acetamide 
Cys-S-AcOH- Cysteine acetic acid 
DNB-AA 3,5-Dinitrophenyl amino 
acid 
Gln Glutamine 
Glu Glutamic acid 
Gly Glycine 
HCys-acid Homocysteic acid 
His Histidine 
HPro Hydroxyproline 
HSer Homoserine 
Ile Isoleucine  
Isoser Isoserine 
Leu Leucine 
Lys Lysine 
Met Methionine 
Nipe Nipecotinic acid 
NVal Norvaline 
Phe Phenylalanine 
ȕ-Phe beta-Phenylalanine 
Pipe Pipecolinic acid 
Pro Proline 
Trp Tryptophane 
p-X-DL-Phe para-Halide-DL-
phenylalanine 
p-ȕ-X-DL-Phe para-ȕ-Halide-DL-
phenylalanine  
Val Valine 
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1 AIM OF THE STUDY 
The aim of this study should be the investigation of different types of fluorescence labels for amino acid 
derivatization and the enantioselective separation of these derivatives using a variety of weak anion-
exchange type chiral stationary phases. Two fluorescence tags were applied for N-terminal protection of 
amino acids, 6-aminoquinolyl-succinimid carbamate (AQC) and fluoresceine-isothiocyanate (FITC). 
The first label was a very common fluorescent tag for quantitative amino acids analysis and the other 
was frequently used as a fluorescent label for biochemical assays and labeling of cells, cell 
compartments, enzymes and amino acid residues. The comparison of separation performance of these 
two fluorescence tags should be conducted. AQC was a rather expensive derivatization reagent, of 
which the chemistry was well known and the derivatization procedure was fully optimized and easy to 
handle. Fluoresceine isothiocyanate was cheaper compared to AQC. A successful application of FITC 
for amino acid enantioseparations should demonstrate the equality of these two tags. In turn of 
enantioseparation, AQC was often used for amino acid analysis, whereas FITC is a less common tag for 
this propose. Therefore the enantioseparation of amino acids, derivatized with FITC, should be 
investigated. The fluorescence-active molecule fluoresceine was much bigger than the derivatized 
amino acids. Therefore it was expected that enantioseparations would not be as straight forward as with 
smaller N-terminal tags like DNB,- DNZ,- N-Acetyl,- Z,- etc. Fluoresceine would highly interact with 
quinine-based selectors in a non-enantioselective manner. Hence, an enantioseparation of amino acids 
carrying N-terminal the fluoresceine label would be an evidence for the high selectivity provide from a 
quinine-based chiral selector.  
The range of amino acids included all proteinogenic amino acids, as well as amino phosphonic acids, -
sulfone and -sulfonic acids and some common amino acid analogues of phenylalanine, since they were 
used as pharmaceutical drugs. Furthermore, some special separation problems should be investigated, 
such as the separation of stereoisomers of isoleucine, 4-hydroxyproline and threonine.  
Some dipeptides had been chosen as model substances to proof the applicability of these AQC-tagged 
dipeptides for the enantioselective separation on anion-exchange type quinine-based CSP. 
Glycoylphenylalanine (GlyPhe) and glycoylproline (GlyPro) and their reversed counterparts, PheGly 
and ProGly were derivatized with AQC and their enantioseparation should be investigated. 
Moreover, AQC should be applied for the separation of alanine peptides and alanine-glycine peptides, 
as well as for phenylalanine peptides. The separation of alanine enantiomers of all-D/L-peptides up to 
the hexamer, of stereoisomers of tri- and tetrapeptides and of glycine-alanine di- and tripeptides were 
investigated. The separation of phenylalanine peptides, all-D/all-L peptides up to the pentamer and the 
stereoisomers of tri- and tetrapeptides, which had a pronounced hydrophobic character, were also 
studied.  
Furthermore, the synthesis and application of new quinine-based chiral stationary phases, which 
exhibited a zwitterionic character should be conducted. Previous studies had introduced a second ion-
exchange group into the structure of the quinine selector. The combination of a strong anion- with a 
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cation-exchange group, a sulfonic acid with and a quaternary amine, in one chiral selector, the quinine 
molecule, was up to date not yet investigated. The application of these sulfobetaine-type columns 
should be examined in course of enantioseparation of acidic and zwitterionic compounds. Further, 
because this type of selector showed a lack in enantioselective discrimination ability, their application 
as HILIC columns should be explored. A set of typical HILIC compounds, acids, base, zwitterions, 
nucleosides, nucleotides and alkaloids were applied to investigate the separation performance of the 
sulfobetaine-type quinine-based columns. The retention mode should be investigated and their HILIC-
character was compared with a tert-butyl carbamate modified quinine-based column (QN/QD-AX) and 
a commercially available zwitterionic HILIC column.  
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2 INTRODUCTION 
2.1 Chirality  
Chirality (handedness) is a phenomenon occurring in the organic as in the anorganic world. The greek 
word “cheiro” means “hand” and is an acronym for the fact that a chiral molecule is not superimposable 
with its mirror image. They are called enantiomers or optical antipodes. Enantiomers have identical 
constitutions attached to a  central  C-atom, the “chiral  center”,  but  differ  in  the spatial  arrangement  of  
their binding atoms towards each other. Such an object cannot be brought in relation with one of the 
symmetry elements of the second class, such as mirror planes, center of symmetry or rotary-reflection 
axis. A pair of enantiomers has the same physico-chemical properties, if they are exposed to an achiral 
environment. They have the same density, melting- and boiling points. The optical activity is the only 
physical property in which enantiomers differ to each other. One enantiomer will rotate the plane of 
polarized light towards the right direction (+) and the other will turn it, with the same amount, to the left 
(-). Note that their chemical properties in a biological system may be diverse as one counterpart may be 
a useful drug while the other is a harmful poison, such as ?-phtalimidoglutarimid, also known as 
contergan®. Optical rotation activity is a substance specific property and is a direct method which can 
be used to distinguish to antipodes. Diastereoisomers, on the other hand, are stereoisomers, which are 
not mirror images of one another. Diastomers have different physico-chemical properties. A racemate is 
a 50/50 mixture of each enantiomer and therefore optically inactive. The mixing ratio of two 
enantiomers can be described by the enantiomeric excess (ee) (Formula 1) [1]. 
 
?? =  (?)?(?)(?)?(?) ? 100    (S)>(R) Formula 1: Enantiomeric excess 
 
2.1.1 Chirality elements 
Different kinds of chiral elements can be found in nature. The most abundant and obvious one is related 
to a single chiral atom. The tetrahedonal carbon atom is predestinated for inducing chirality. Once four 
different ligands are connected to the same carbon atom, this carbon atom becomes a “chiral center” and 
chiral nature or asymmetry is induced (Figure 1).  
 
a
d c
a
dcb
b
 
Figure 1: Chiral tetrahedonal atom and its two possible antipodes 
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Other atoms, which can function as chiral centers are Si, Ge, N, P, As, Sb and S. They also lead to a 
chiral molecule with a pyramidal structure. Furthermore, consider that nitrogen with its three different 
connecting atoms can only possess  chiral  nature,  when its  free pair  of  electrons is  regarded as  a  forth 
participant and if additional rigidity is induced by denied degrees of conformational movement in such 
an arrangement.  
When considering a molecule as chiral, it is also important to take the flexibility of this molecule into 
account. The stability of a chiral compound depends for example on the energy barrier that prevents the 
inter-conversion of the two enantiomeric forms and predefines the lifetime of one enantiomeric form. 
Other chiral elements are for example a chiral allene. The molecular rigidity of allene is here the most 
important factor for chirality. Examples are two allene-metal-ion complexes or metallocenes. If the 
interconversion by rotation is restricted, the so called atropisomers become chiral too. The chirality of 
helicenes is based on a steric crowing of condensed aromates. These chiral elements mentioned above 
possess one of the elements, a chiral center, a chiral axis, a chiral plane or a chiral helicity (Figure 2).  
 
C C C
H
R1 H
R1
CCC
H
R1H
R1
R R`
RR'
Me
Fe
R'
R
R1
R2
R2
R1
allene metal-ion-allen complex
atropisomersferrocene  
Figure 2: Chirality elements 
 
2.1.2 Nomenclature for chirality 
The accepted nomenclature for the exact and unique description of a chiral center, or more general for 
chirality  itself,  was introduced in 1966 by Cahn-Ingold and Prelog (CIP rules).  Further  details  can be 
found in the original  article  [2].  In the first  step four  ligands attached to a  chiral  center  are  numbered 
according to the CIP-rules. Checking the direction in which these ligands are numbered leads to a 
clockwise or  anti-clockwise arrangement.  In the former case the chiral  center  is  designated as  (R) for  
rectus (right) or as (S) for sinister (left). For amino acids and lower carbohydrates the Fischer 
convention (D - dexter and  L  -  laevus)  is  also  common.  Note  that  dexter means right side and laevus 
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stands for left side. Find below an example for the Fischer projections using glyceralaldehyde as a 
reference compound (Figure 3).  
 
CHO
HO H
CH2OH
CHO
OHH
CH2OH
L-glyceraldehyde D-glyceraldeyde  
Figure 3: Reference compound for the "Fischer Projection" D/L-glyceraldehyde 
 
Natural amino acids have all (S)-conformation, except glycine, which is non chiral and cysteine which 
has to be nominated as (R), according to the priority rule of CIP nomenclature. Regarding the Fischer 
projection, these natural amino acids have the L-descriptor. The majority of mono carbohydrates are 
right handed, according to the Fischer convention (D). 
2.1.3 Diversity of chirality 
Amino acids, which are the building blocks of peptides and proteins, give biomolecules such as 
enzymes the first instance of chirality. The different substructures, namely the primary, secondary, 
tertiary and quaternary structures of a protein, facilitate the 3D conformation of enzymes. This multi-
layer design of larger proteins leads to the unique ability of enzyme to molecularly recognize target 
analytes and to catalyze certain chemical reactions. A simplified model for enzyme-educt interaction is 
the “lock-key” model where an educt molecule fits into a specific binding pocket of the enzyme, which 
is thereby induced to catalyze a transformation reaction with this analyte.  
The term “chiral pool” is related to a range of naturally available small chiral substances, which exist 
mostly in high enantioselective purity and are available in large quantities at low cost [1].  
 
Widening the horizon to biomolecules, like enzymes, polysaccharides and deoxyribonucleic acids, it 
may be obvious that these classes of substances are the building material for every biological matrix. 
DNA possesses a chiral nature, due to its helicity. Enzymes, the biocatalysts, are built of chiral amino 
acids. In addition, the functionality of enzymes is based on their substructures. Besides enzymes are 
often build up as complexes, containing a number of subunits and cofactors. Frequently metal ions can 
be incorporated. Polysaccharides can exist as a complex mixture of different polysaccharides or may 
even form aggregates with other biological compounds such as proteins. The diversity of 
polysaccharides is much greater than that of proteins or DNA. Cellulose is the most abundant biological 
substance in the world. It is composed of ȕ-glucopyranoside units, which are 1,4-glycosidically bonded 
to each other. Cellulose exhibits a superstructure, where hydrogen bonds, helicity and to a certain 
degree also branching is involved in structure formation. It is well known that cellulose molecules have 
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chiral cavities which are based on this superstructure.  
The reason why an amino acid is almost exclusively produced in its L-form by each living system is 
still a non-understood phenomenon. In biological tissues of higher animals, D-amino acids are normally 
only present in trace amounts. Lately, higher levels of D-amino acids have been recognized in special 
tissues and body fluids, for example in kidney and urine, of mammals and humans. They are expected 
to be potential drug candidates and biomarkers [3]. For example, D-Ser and D-Asp are known to have 
physiological relevance for humans. D-Ser is a neuro-medulator of N-methyl-D-aspartate, a subtype of 
the glutamate receptor in the brain. D-Asp is a hormonal regulator, found in the secretion of various 
glands. Several serious diseases also brought into relation with D-amino acids, namely Alzheimer, 
schizophrenia or renal disorders [4]. It is reported that D-Pro will be excreted in larger amounts into rat 
urine, showing nephrotoxic and neurotoxic properties in rat and chicks trials [5]. The exact and accurate 
analysis of trace amounts of amino acids taken from body fluids still poses an analytical challenge. 
2.2 Impact of chirality on biological systems 
One has to recognize that the whole life is based on chirality, each biocatalyzed reaction in this world is 
stereochemically determined. Chirality is a fundamental aspect of the living world and it provides a 
huge diversity for biological systems. In a more dedicated field of application, regarding the interaction 
of a drug with a biological system, the drug induces firstly a cascade of reactions which will then lead to 
a physiological response. Since each reaction is stereoselective, the two enantiomers of a drug 
compound cannot provide the same response in biological matrices. Which enantiomer exhibits the 
desired positive effect, depends on the chemical complementary between the bioactive compound and 
the biological interaction site [1]. An example can be given by the different taste of D- and L- amino 
acids. While the D-enantiomers of asparagine, histidine, isoleucine, leucine, tryptophane and tyrosine 
have  a  sweet  taste,  the  L-enantiomers  are  tasteless  or  bitter.  Also  the  antipodes  of  terpenes,  such  as  
carvone and limonene, exhibit different odors. (R)-(–)-carvone smells like spearmint, whereas (S)-(+)-
Carvone is associated with the smell of caraway. (R)-(+)-Limonen and (S)-(–)-limonen smells like 
orange and lemon, respectively (Figure 4) [6], [7].  
 
O O
(R)-(-)-carvone (S)-(+)-carvone (R)-(+)-limonene (S)-(-)-limonene  
Figure 4: Pairs of enantiomers of carvone and limonene 
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2.2.1 The impact of chirality on pharmaceutical drug development and design 
Comparing affinities, the more affine enantiomer is called eutomer and the other one distomer. The 
eudismic ration expresses their pharmacological activity or the degree of complementarity with the 
molecule interaction site. The ratio increases with the activity of the eutomer, a relationship known as 
the “Pfeiffers rule” [8], [9].  
 
It was the contergan® disaster in the early sixties of the past century, which has depicted the necessity 
for “enantiopolishing” of bioactive drugs. The drug contergan®, also known as thalidomide, has been 
applied as a racemate. While the eutomer, (R)-(+)-thalidomide, has a sedative effect although the 
racemate has been prescribed as sleep inducing drug to pregnant women. The other enantiomer, the 
distomer (–)-thalidomide, has exhibited a teratogenic behavior. As a result, the application of the 
racemate has provided serious malformation occurring by many newborns. This tragic case has also 
highlighted the need for detailed pharmacological and pharmacokinetical studies. Since thalidomide 
undergoes a natural in vivo racemization, even the production and intake of the pure (R)-(+)-enantiomer 
may inevitably have lead to the same crucial effect in pregnant women [7], [6]. 
 
Drug regulatory authorities have issued many new guidelines and edicts, concerning the enantiomeric 
purity of chiral drugs and the characterization of the pharmacological profile of such a drug. Special 
attention is given to the so-called “isomeric ballast”. Two enantiomers have to be regarded as different 
compounds and one has to consider that the enantiomers can have very different pharmacological and 
toxicological profiles. Nowadays racemates will seldom be approved, simply because their enantiomers 
are unstable in vitro or undergo racemization in vivo, have similar pharmacokinetic, pharmacodynamic 
and toxicological properties or because their separation is technically not feasible [7], [6]. 
Nonetheless, the pharmaceutical industry still puts apparent effort into the development of 
enantiomerically pure chiral pharmaceuticals, produced either by an asymmetric synthesis or post-
purified via enantioselective clean-up steps. Rational and target oriented drug design as well as the 
investigation of stable formulations for potential new drugs are important attempts for research and drug 
development [1].  
2.3 Systematic approach to enantiomerically pure substances  
There are two approaches to get an enantiomerically pure antipode, the chiral approach and the racemic 
approach. The first is using the stereoselective (asymmetrical) synthesis, which in the best case yield an 
enantiomer with high enantiomeric excess (ee).  
 
The racemic approach is less time and cost intensive, but has to furnish the separation of stereoisomers, 
diastereomers and mostly also enantiomers in order to obtain the pure antipodes of interest in acceptable 
yield. An enantioselective step has the benefit that both enantiomers are separated in high purity, which 
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may be favorable in terms of drug research and development, concerning structure optimization. The 
separation part of the racemic approach can be split into separation techniques like enantiospecific 
crystallization and enantioselective chromatographic separation techniques using resins or membranes 
as chromatographic media. In general, liquid chromatography using a chiral stationary phase (CSP) is 
the most frequently used tool for obtaining pure enantiomers as illustrated below. It is also regarded as 
the technique of choice for the determination of enantiomeric excess of organic compounds after 
enantiopolishing from their racemic mixture (Figure 5). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Optical resolution via chromatographic separation techniques is again subdivided into the indirect and 
the direct approach. The indirect pathway normally involves the derivatization of a racemate, or a 
mixture of enantiomers, employing a suitable enantiomerically pure derivatization reagent, producing 
thereby diastereomers. Note that diastereomers do not coincide in their configurational state and exhibit 
different conformational arrangements. These substances have different physico-chemical properties 
and can be separated using an ordinary separation systems, like a common liquid chromatography 
system using a reversed phase column. Attention must be paid to chiral derivatization agent (CDA), of 
which the highest possible ee shall to be used. Otherwise the derivatization reaction itself may lead into 
the formation of a mixture of diastereomers and one or more pairs of enantiomers. Another problem can 
be the kinetic enantiomer resolution, since the formation of diastereomers will have different rates of 
reaction. Excess of derivatization reagent are applied and completion of the reaction has to be 
Direct Approach 
Chiral auxiliary agent – chiral mobile phase (CMP) 
Chiral selector immobilized on support material (CSP) 
Figure 5: Illustration of the different approaches for getting an 
enantiomerically pure substance 
 
Chiral Approach 
Asymmetric synthesis 
Racemic Approach 
Separations: 
Crystallization, Membranes, 
Chromatography 
Indirect Approach 
Chiral derivatization agent (CDA) 
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(R)-CDA-(S)-SA 
 
(R)-CDA-(R)-SA 
 
pairs of diastereomers 
pair of enantiomers     chiral    
derivatization 
reagent  
kR and kS may be not the same 
kR 
kS 
(S)-SA, (R)-SA     +     (R)-CDA  
monitored. The diastereomers should not have an equal detection response, if for example UV detection 
is used. This method is less prone to errors compared to the direct separation approach.  
 
The direct approach fulfills an enantioseparation using either a chiral auxiliary reagent, which is added 
to the mobile phase, or a chiral stationary phase (CSP), for the separation of the two antipodes. Both 
methods have in common that a transient complex of chiral selectors (SO) and chiral analytes (SA) are 
formed.  A difference in stability  and persistence of  the SO-(S)-SA and SO-(R)-SA complexes lead to 
diverging retention properties during the chromatographic separation process.  
The indirect approach uses a chiral mobile phase (CMP) and a non-chiral chromatographic system. The 
latter is a simplification of the instrumentally requirement. The SOs can be divided into ligand-
exchange metal-ion complexes, ion pairs and inclusion complexes, such as cyclodextrines, proteins, 
macrocyclic molecules, amino acids and crown-ether. Solubility in the mobile phase and availability of 
bigger amounts of these chiral auxiliary compounds are prerequisites for their routine application. The 
addition of a chiral auxiliary to the mobile phase is not applied routinely and is therefore of minor 
interest (Figure 6).  
 
 
 
 
 
Novel, tailor-made CSP are developed and examined extensively by many researchers all over the 
world. A series of different kinds of CSPs are nowadays available for enantioseparations in analytical 
scale as in preparative scale. Chiral selectors are either coated or more frequently covalently bonded 
onto a solid support material, mostly silica gel. From the macroscopic viewpoint, enantiodiscrimination 
is  based  on  symmetry  factors,  namely  that  the  steric  fit  of  one  enantiomer  is  higher  than  that  of  its  
mirror image, but also thermodynamic interaction properties come into account. Explanations for the 
chiral discrimination process are often based on empirical considerations, combining thermodynamic 
parameters and structural elements, the binding sites of SA and SO.  
 
An overview of the different types of CSPs, their applications, advantages and drawbacks is provided in 
reference [9]. Shortly, the different types of CSPs will belong to one of following categories: a) A SO-
Figure 6: The indirect approach of an enantioselective chromatography 
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SA-complex is formed mostly by attractive interactions such as hydrogen bonding, ??-interactions, 
dipole stacking, but also by hydrophobic interactions b) While primarily attractive interactions form the 
complex, inclusion complexes may also play an important role. c) The SO offers chiral cavities, where 
the solute can enter and an inclusion complex is formed. d) The analyte takes part in a diastereomeric 
metal complex formation, which resembles a chiral ligand-exchange mechanism. e) Alternatively, 
proteins or macrocyclic molecules build the chiral selector with hydrophobic and attractive interaction 
as driving forces. Enantioseparation using CSPs exhibits some important advantages, namely method 
robustness, the chiral columns are reusable and a high performance chromatographic system is standard 
equipment in any analytical laboratory. Importantly, the antipodes can be won both as purified 
substances. The upscale to preparative approaches, using chiral stationary phases, hits more the point, 
because of the possibility of the use of bulk mobile phases and automatization [6], [7], [9].  
2.4 Enantioseparation using liquid chromatography 
In the first instance, enantioseparation by liquid chromatography (LC) is related to molecular 
recognition, which describes an interaction of two or more species of chemical molecules, whereas 
chiral recognition highlights some special aspects of the more general molecular recognition. Both 
imply the formation of a transient complex in a mixture due to a selective interaction. During an 
enantioseparation via a liquid chromatographic process, one enantiomer shows different interaction with 
the stationary phase than its counterpart, which means that the interaction pattern of the pair of 
enantiomers can be different or an enantiomer can be completely discriminated from a selective 
interaction. An interaction can be attributed to structural elements of both, the chiral selector (SO) and 
the analytes (SA). The structural elements have normally some relationship in their chemical behavior. 
Mostly, the principle of structural complementary is applicable. In a LC process for enantioseparation, 
the selector and the enantiomer forms a diastereomeric non-covalent complex located at the interface of 
mobile and stationary phase. A chromatogram is an illustration of a time-averaged view of these events, 
which reflects the change of free energy according to an SO-SA complex and the free enantiomer.  
The difference in free energy of the diastereomeric adsorbate complex is indirectly a result of structural 
relationships, dynamics and solvation. To control the extent of these differences is the practical issue of 
a successful enantioseparation [10].  
2.4.1 The three point interaction model 
The three-point-interaction model describes the mechanism of chiral recognition [11]. The thesis 
postulates that at least three simultaneous interactions between the chiral selector and at least one of the 
enantiomers are necessary for a chiral recognition. Furthermore, one of these interactions has to be 
stereochemically determined, which means that the replacement of one enantiomer with another has to 
alter or diminish the interaction between selector and analyte. The three point interaction model is often 
illustrated as a tetrahedron model, where three interaction sides form a plane. Dependant of chirality of 
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the analytes and the chiral selector the interaction will takes place. Mostly, these interactions have an 
attractive nature, but this is not a requisite, repulsive steric interactions take also part in the chiral 
recognition process.  
It ought to be mentioned that considering the conformational and configurational rigidity of chiral 
analytes and chiral selectors, a chiral species with rigid conformational degrees of freedom appears with 
an arrangement of its interaction sights being strongly dependent on its configuration. This complies 
more satisfyingly with the geometrical requirements for the three point interaction model compared to a 
species with many of possible conformational states [10].  
The three point interaction is a good matching model for chiral recognition but the latter cannot be 
reduced to the three point attachment model [11], [12]. 
Another  way of  chiral  discrimination can be achieved by the use of  a  chiral  matrix or  with stationary 
phases containing chiral cavities. In the case of chiral matrixes, the enantiomers are in a chiral 
“environment” and distinction will arise from chirality itself. A chiral cavity provides different 
accessibilities  of  the  enantiomer  pairs  for  the  cavity,  which  may  be  comparable  to  a  kind  of  size  
exclusion mechanism [9].  
2.4.2 Thermodynamic aspects of enantioseparations 
The parameters, which describe the varied behavior of a pair of enantiomers, during enantioseparation, 
are the capacity and the selectivity factor. Both are thermodynamically determined and enable the 
quantification of the difference in free energy of the diastereomerical SO-SA complexes. In principle, 
the capacity factor describes the retention for an analyte in a defined set-up (Formula 2).  
 
??,? = ??,? ? ??????  Formula 2: Retention factor exemplified for the L-enantiomer 
 
 
Retention factor includes the thermodynamic contribution of enthalpic and entropic forces (Formula 3).  
 
? = ? ??
??
+ ??
?
+ ??? Formula 3: Retention factor in thermodynamic increments expressed
 
 
The selectivity factor for enantioseparation is described as the ratio of the retention factor of the later 
eluting enantiomer to its earlier eluted counterpart (Formula 4).  
 
? = ??
??
 Formula 4: Selectivity coefficient
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The equation can be also written as (Formula 5): 
 
? = ????????
?
????
?
??
 
Formula 5: Selectivity coefficient expressed as the 
ratio of the e-function of enantiospecific free energy 
?G
 
Whereas ????? is the molar free energy of adsorption. The essential difference of free energy due to 
the formation of diastereomeric adsorbates can be expressed by the below stated equation (Formula 6): 
 
?(??)? = ??? ????? = ????????
?
????
?
??
 
Formula 6: Difference of Gibbs free energy of the two 
enantiomers, expressed in term of the selectivity 
coefficient
 
 
The combination of Formula 3 and Formula 6 provides the following expression (Formula 7): 
 
??? = ????
??
+ ???
?
 Formula 7: Gibbs-Helmholtz equation
 
??H and ??S shows the difference of enthalpy and entropy in course of chromatographic separation. 
This relationship is visualized by the van’t Hoff plot (ln? vs. 1/T), with which an enthalpic or entropic 
control of enantioseparation can be distinguished. ??H/R is the slop of the linear graph and ??S/R is 
the intercept on the y-axis. The model makes the presumption that the retention of analytes is mainly 
driven by enantiospecific interactions, otherwise one has to deal with additional non-enantiospecific 
retention increments (Formula 8) [13], [10]. 
 
????,? =  ??? + ???,?   and   ???? = ???????,????????,? 
 
Formula 8: Retention factor and selectivity 
coefficient expressed as the sum of stereoselective 
(se) and non-stereoselective (ns) contributions
 
Investigations have shown that the entropy contribution to the chiral enantioseparation is frequently 
negligible. The entropic contribution is related to solvation effects and reordering of SO-SA complex 
[9].  
It should be taken into account that high absorption energies (??) can lead to higher retention times and 
as a consequence of the chromatographic process to stronger broadening of peak shapes. An operator 
has to maximize the difference in free energy ?(??), while keeping (??) at an acceptable level in order 
to maintain good chromatographic efficiencies. For an estimation of the performance of an 
enantioseparation, note that a chromatographic system with good efficiency, which furnishes tight 
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peaks, can afford small values of enantioselectivity ?(??) in order to achieve acceptable performances 
[10].  
2.5 Fluorescence labeling 
2.5.1 General considerations 
The labeling or derivatization of an analyte provides essential advantages, if the substance of interest 
lacks a suitable chromophore or fluorophore for a spectroscopical detection. Such a label or tag will also 
provide a much lower limit of detection for the labeled species compared to its native form. 
Furthermore, labeling may also change the chemical behavior of the molecule. A changed strategy of 
chromatographic separation or detection may even be beneficial. For example amino acid analysis 
(AAA), can be done using an ion-exchange chromatography, because amino acids have zwitterionic 
character. Some amino acids have a lack of chromophore and cannot be detected with a common 
UV/VIS detector. After a derivatization step, which incorporates a spectroscopically detectable tag, into 
the analyte molecule, more common reversed phase or electrophoretical separation techniques are 
applicable and most of the frequently used detectors can be applied [14]. The derivatization increases 
sensitivity and selectivity, which is especially interesting and even necessary for quantitative analysis of 
analytes from biological tissues. If the tagging reaction is highly selective, than only a group of 
substances  or  only  a  certain  type  of  functional  entities  will  be  derivatized  and  can  be  addressed  to  a  
special separation or detection strategy. Generally, there are two approaches for derivatization. “Pre-
column derivatization”, describes a derivatization step, followed by an optional purification step and a 
chromatographic separation with detection. A “post-column derivatization”, however means that after a 
chromatographic separation has taken place, the actual derivatization step is conducted in e.g. a sample 
loop, followed by the immediate detection of the derivatives. The advantage of the pre-column 
derivatization compared to the post-column derivatization is that the procedure is more flexible, 
concerning reaction time, heating steps and a chromatogram will not have a continuously higher 
baseline and band broadening. Also, dilution effects will not disrupt the chromatogram. On the other 
hand, the final procedure for a pre-column derivatization has to assure the quantitative derivatization of 
both, the standards and analytes, derived from real samples. It should be kept in mind that the 
derivatization reaction performed for a range of analytes will be highly competitive and differing 
reaction rates can be expected. Furthermore, reagent related peaks can interrupt the separation 
performance of analyte molecules [15].  
The fundamental aspects of fluorescence spectroscopy and their detection ability will not be discussed. 
For further reading, the following references may be of interest [16], [17].  
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2.5.2 Common fluorescence labels for amino acid derivatization 
Chemical structures of some common fluorescence labels are shown in Figure 7. Most tagging-reagents 
are reactive to amines, primary and ideally also to secondary. Ortho-phtalaldehyde (OPA) is one of the 
most common fluorescence reagents. It reacts only with primary amines in the presence of a thiol 
species, like mercaptoethanol and produces an isoindole derivative. The derivative can be detected with 
an excitation (ex) wavelength of 340 nm and an emission (em) wavelength of 440 nm. The reagent is 
used in excess, but since ortho-phtalaldehyde itself is not fluorescence active, it will not interfere in the 
separation of the isoindole derivative. OPA reacts at ambient temperatures and alkaline conditions with 
primary amines in several minutes, which facilitates the derivatization. Limit of quantification of OPA 
derivatives of <1 pmol are reported in literature [18].  
 
Another frequently applied tag is 9-fluorenylmethylchorformate (FMOC-Cl). It is also commonly used 
in peptide synthesis as a fluorescence active protection group. The chloroformates react in alkaline 
buffered solution with primary as well as with secondary amines. The reaction mechanism, a Sn2 based 
Schotten-Baumann reaction, is well explored. It leads to a carbamate derivative. Several side products 
are known, which are formed in turn of the derivatization. A symmetric carbonate is formed and FMOC 
reacts also with water, which produces FMOC-OH. All by-products have to be separated from the 
analyte derivative peaks. A clean-up step, employing an extraction with apolar solvent can remove most 
of  the  excess  reagent.  FMOC  methods  are  often  applied  as  fully  automatized  HPLC  amino  acid  
analysis. The excitation wavelength is 260 nm and emission wavelength 315 nm, the fluorescence 
quantum yield is 0,5. Lysine, tyrosine, histidine and cystine and tryptophane will be double derivatized 
and these derivatives have increased lipophilicity. In a reversed phase chromatography system the 
hydrophobic derivatives will have extended retention times. Because of an internal quenching effect, the 
limit of detection for the double derivatized analytes is normally higher. Lowest reported LOD is 
50 fmol for amino acid derivatives [19].  
 
Also, 7-fluoro-4-nitrobenzo-2-oxa-1,3-diazole (NBD-F) is a common fluorescence tag, which is 
reactive  to  primary  and  secondary  amino  acid.  NBD-F  reacts  within  minutes  in  an  alkaline  media.  A  
secondary amine is formed. The reaction conditions are different compared to the other here described 
procedures [20]. The excess of derivative resembles also a drawback, because a possible coelution of 
the regent peak hinders the separation of a whole series of analytes. Excitation wavelength is 470 nm 
and emission wavelength is 530 nm. The reported LOD is below 100 fmol. Recently NBD-F is often 
used for 2D-AA-analysis in a reversed phase system, coupled with an enantioseparation column in the 
second dimension for the determination of the amount of D-amino acids in biological fluids [4], [5],[3]. 
 
Dansylchlorid (DNS), 5-(dimethylamino) naphthalin-1-sulfonylchloride, is also often used. The so 
called “dansylation” is frequently conducted as a pre-column derivatization in capillary electrophoresis. 
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It exhibits a supreme UV absorption, but strong quenching effects arise in aqueous solutions. Therefore 
it is used as a model compound and much less in actual analytical applications, because of unfavorable 
by-products and quenching effects [15].  
 
A broad range of other fluorescence active labels can be found in literature, all with their applications, 
all descriptions include their field of applications as well as their advantages and drawbacks. For 
instance, naphyltene-2,3-dicarboxaldehyde (NDA) has the same reaction mechanism as OPA, but 
produces more stable derivatives [15]. Fluorescamine is a non-fluorescent label, which reacts with 
primary and secondary amines to yield highly fluorescent derivatives. It is used for the labeling of 
proteins and amino acids prior to quantitative analysis as well as for the chiral separation of single 
amino acids [21].  
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Figure 7: Common fluorescence labels 
 
2.6 AccQ – Fluorescence Tag 
The AQC tag (AQC  6-Aminoquinolyl-N-Hydroxysuccinimidyl Carbamate) is a fluorescence active, 
and  amine  reactive  urea  derivative  that  was  introduced  by  Cohen  et  al.  [22].  The  active  N-
hydroxysuccinimide ester is very reactive with nucleophiles like primary and secondary amines under 
alkaline conditions and the reaction led within several seconds to mixed urea derivatives (Figure 8).  
The excess amount of AQC is quickly hydrolyzed to 6-aminoquinoline (AMQ), the N-hydroxy 
succinimide and carbon dioxide in the aqueous buffer solution with pH 8 following [23]. Within several 
days the symmetric bis-quinolyl urea will be generated, because AMQ is a weak nucleophile and can 
react with still existing AQC. This symmetric urea is not soluble in the derivatization mixture and 
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precipitates. Due to te derivatization, the amino acid derivatives show a blue shift in the emissions 
spectra. Typically, the excitation wavelength applied is 250 nm and the emission wavelength of the 
derivative is about 395 nm. In comparison the 6-aminoquinoline is also excited at 250 nm, but its 
emission maxima is shifted to 520 nm. UV detection is also applicable with excitation coefficients 
typically exceeding 22,000 [24]. Dependencies of fluorescence intensities towards water content and pH 
in solution are yet known [22].  
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Figure 8: Reaction pathway of 6-Aminoquinolyl-N-Hydroxysuccinimidyl Carbamate 
 
The urea derivatives are stable, for at least one week. The major application field is amino acid analysis 
(AAA) [25], [26], [27]. Also for the analysis of biogenic amines in blood, body fluids and food are 
procedures reported in literature [28], [29]. However, standard operating procedures (SOPs) for AAA 
are well established but several uncertainties can be found in literature. Due to an internal fluorescence 
quenching effect induced by the indole ring of tryptophane and the AQC quinoline group, of the AccQ-
tag, this amino acid can barely detected via fluorescence detection, UV detection can be successfully 
applied [30], [24]. Besides lysine also other diamino species like ornithine or thiol-containing amino 
acids such as cystine will be double derivatized. The phenolic hydroxyl group of tyrosine forms an 
unstable and transient intermediate, which is thermally destroyed within ten minutes at 55°C, in the 
course of the derivatization procedure. Under alkaline conditions, cysteine will be oxidized to the dimer 
species. Derivatization of free cysteine or cysteamine forms also the bis-derivative via a thioamide 
linkage [31]. Alcohols react very slowly with AQC, as has been proven by analyzing a solution of AQC 
in methanol, but there is yet no evidence that the hydroxyl groups of serine or threonine are also 
derivatized. Chromatographic conditions for the separation of all twenty proteinogenic amino acids are 
well established [28], [25] and mostly contain only slight modifications from the original procedure 
described by Cohen et al. [22]. Using mild acidic conditions, between pH 4,95 and 5,75 for the mobile 
phase, the excess of derivatization reagent AMQ elutes prior to most of the analyzed amino acids, 
except of acidic compounds such as cysteic acid. The tuning of the mobile phase pH, allows the 
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modification of elution strength and elution order. This affects, especially the polar amino acids, in a 
strong manner. Employing a high performance liquid chromatographic system with a quaternary pump 
combined aqueous eluents with different pH values, allows a supreme resolution optimization for all 
twenty amino acids within one chromatographic run [25]. Generally, the pH dependencies of the AQC-
amino acid derivatives are a drawback, leading to a reduced stability against mobile phase uncertainties 
of the method. 
2.7 FITC – Fluoresceine isothiocyanate 
The common fluorophore fluoresceine can be linked via a thiourea linkage to nucleophiles such as 
primary amines (Figure 9). Fluoresceine is mostly used in biochemistry for labeling of cells, cell active 
substances like anti bodies, proteins and intra cellular compartments. In the field of amino acid analysis, 
fluoresceine isothiocyanate is only used in a few cases. It was determined that the derivatization 
efficiency reaches a maximum, when the reaction time is set to twenty hours or longer in a mixture of 
20 mM borate buffer pH 9,8  with 10 % acetonitrile [32]. Applications using fluorescence emission are 
conducted by laser-induced-fluorescence (LIF) at an excitation maximum of about 395 nm and an 
emission maximum near 520 nm. Separation of 21 derivatized amino acids during one run employing 
capillary electrophoresis (CE) with different types of back ground buffers has been performed [33]. 
Enantioseparations of twenty racemic amino acids were successfully applied using a mixture of ȕ-
cyclodextrine and sodium taurochlorate as chiral selectors [34].  
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Figure 9: Reaction pathway of fluoresceine isothiocyanate with primary amines 
 
2.8 Strategies for the analysis of cysteine 
Cysteine is one of the twenty proteinogenic amino acids. In biological matrices this amino acid is 
mostly present as the dimer cystine. For quantitative analysis of cysteine different approaches can be 
found in the literature. The analysis and quantification of native cysteine is mostly not practicable, 
because of the formation of the dimer cystine, especially on air and in neutral to alkaline conditions. 
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Therefore a number of derivatization procedures for the reactive thiol group were introduced. In many 
AAA, using the before mentioned AQC-label,  this  amino acid is  analyzed as  the cystine species  [28].  
This approach is based on the assumption that just one species of cysteine, the dimer, is present in the 
sample. A proposal, which will not always hit the goal [24]. The derivatization with halide alkyls, such 
as iodo acetamide or iodo acetic acid, is often recommended. Samples, containing a biological matrix, 
have to be reduced with 2-mercaptoethanol [35] or tris-(2-carboxyethyl)-phosphine (TCEP) [36] [37] or 
other phosphines [38] to get the monomer cysteine in first instance. After reduction of dithiols, 
derivatization with a number of reagents is investigated in the literature. Iodo acetate and iodo 
acetamide are the most frequently used derivatization reagents [35], both lead to an acid stable 
derivative and therefore are suitable for an acid hydrolysis in the case of an AAA of a biological matrix. 
4-vinylpyridine is another good known derivatization reagents [28, 39] [40]. Another approach is the 
derivatization of cysteine with 3,3´-dithiopropionic acid, where a mixed disulfide results due to the 
reaction. Frequently, cysteine and methionine are oxidized during a performic acid hydrolysis to cysteic 
acid and methionsulfone, respectively and quantification is conducted afterwards [41, 42] (Figure 10).  
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Figure 10: Derivatization strategies for the analysis of cysteine 
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However, the determination of cysteine is still an unsolved problem for quantification and for 
enantioselective analysis. 
 
2.9 Investigation of the chiral separation of peptides and peptide 
stereoisomers 
The enantioseparation of peptides via liquid chromatography is not as straight forward as it is regarding 
to amino acids. Especially the growing number of stereoisomers due to the growing number of amino 
acids in a peptide chain renders them often to be hardly separable. Dipeptides containing glycine, 
especially if glycine is N-terminal located, are often badly enantioseparated. The task of peptide 
stereoisomers separation is often present in peptide synthesis.  
An investigation of retention mechanism and chiral discrimination process of a quinine-based chiral 
selector has also been investigated [43], [44] and [45]. For all-D/L-alanine peptides, up to the hexamer, 
the chiral discrimination is found to decrease with growing chain length. The overall retention is also 
decreased with the addition of each amino acid. A glycine effect was found. An achiral bridge at the C-
terminus affects the chiral recognition process more strongly than an achiral bridge at the N-terminus of 
di- or tripeptides. A glycine in the peptide chain back bone gives the molecule more conformational 
degrees of freedom and more SO-SA complexes can be formed. This variety in complex formation 
leads to a reduced or diminished enantiodiscrimination [46].  
2.9.1 Amino acid racemization  
A racemization of an amino acid can be performed in an acidic milieu and on addition of an aldehyde 
species, according to the protocols of [47], [48]. These references showed excellent yields up to >90 % 
in case of an amino acid, but no investigation were found due to di- or oligopeptides. The reaction 
mechanism was proposed in the article from Yamada et al. [47] (Scheme 1).  
 
A N-terminal located acidic hydrogen atom can be racemized during the formation of a Schiff base. 
Further articles like [49] have given evidence that during an acidic treatment under influence of high 
temperature over a longer period of time, peptides are able to form diketopiperazine-like intermediates 
and hence the inverted peptides and/or an inversion of the stereochemistry may appear. If the formation 
of a diketopiperazine species is involved during the racemization, then the inverted dipeptide with 
randomized stereochemistry had to be expected (Figure 11). 
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Figure 11: Possible drawbacks of a racemization of dipeptides: a) formation of a diketopiperazine b) ring opening of the 
amide bonds of a diketopiperazine leads to the original dipeptide or to the inverted dipeptide c) ring opening of the 
diketopiperazine and randomization of the stereochemistry of the two chiral carbon atoms leads to eight stereoisomers 
in case of a dipeptide with two chiral centers. 
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2.10 Quinine-based chiral stationary phase 
Quinine  was  first  time  available  as  a  pure  substance  in  1820.  It  was  retrieved  from  the  bark  of  the  
medicinal plant, cinchona. Quinine, cinchona and quinidine were known for their fever reducing 
properties. In fact, the chiral nature of the alkaloid quinine was first recognized by Louis Pasteur, who 
postulated that quinine and quinidine were left- and right handed compounds. Today they are known as 
stereoisomers. Pasteur had used the chiral nature of quinine for the racemization of tartaric acid and he 
enabled thereby the stereoselective crystallization of racemic tartaric acid with quinine, the first 
enantioseparation ever mentioned in human history. He also made one crucial and fascination 
postulation, namely that the living world itself and all biomolecules had to be asymmetric in their 
nature. Pasteur was with his great mind, ahead of his time [50].  
2.10.1 The quinine molecule as chiral selector 
More recently, the chiral nature of quinine was used for enantioseparation purposes. The separation of 
racemic arylalkylcarbinole and binaphtole derivatives were achieved with quinine-based CSP [51] using 
the normal phase mode of aqueous-free apolar mobile phases. The immobilization of the chiral selector 
via the radical starter mediated addition of the olefinic double bond on a mercaptopropyl support was of 
great importance, because the hydroxyl group on C9 position was free for interaction with the analytes 
anitpodes and free for further chemical modifications. For the chiral recognition the stereogenic centers 
at position C8/9 were known to be of highest importance. The hydroxyl group at C9, in the 
neighborhood of these chiral stereocenters, turned soon into the focus of interest for simple chemical 
modification and its influence on chiral recognition. The introduction of an acetyl group indicated a 
stronger reduction in enantioseparation compared to the native quinine [52]. The authors proposed a 
model for the chiral recognition mechanism of quinine-based CSPs, where enantiodiscrimination would 
progress  via  the  formation  of  a  diastereomeric  transition  state  of  SO  and  SA  molecule.  They  
emphasized that a single attractive interaction, namely a hydrogen bonding of the hydroxyl group on the 
selector and hydrogen bond acceptor site on the analyte, combined with a differing steric fit of the two 
antipodes, would ensure an enantioselective separation.  
Lindner et al. had introduced a tert-butyl carbamate group (Figure 12), located at the C9 position of 
quinine, which enabled  the separation of racemic acidic compounds in normal phase mode but also in 
hydro-organic or polar-organic mobile phase mode [53]. This new type of CSP is classified as weak 
anion-exchanger type chiral stationary phase (WAX-CSP).  
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Figure 12: tert-Butyl-carbamate-quinine selector (1S, 3R, 4S, 8S, 9R) (left) and possible non covalent interactions 
between the chiral selector and a 3,5-Dinitrobenzyl-derivative (right) [53]. 
 
The tertiary amine of the quinuclidine group is protonated at pH 4-7 and therefore available for long 
range coulomb interactions with deprotonated acidic analytes. The retention is predominantly controlled 
over an ion-pairing process. The ion-pairing reinforce the formation of a specific association of SA and 
SO. The chiral recognition mechanism has been the topic of detailed studies [54]. The binding pocket is 
restricted of the quinoline, the carbamate and the quinuclidine group which span the stereogenic centers 
of C8/9 of the quinine molecule. If the acid functionality of a SA is blocked, e.g. because of acetylation, 
the chiral recognition is diminished. In order to observe chiral separation on quinine-based CSPs, the 
SA should possess acid groups like carboxylic, sulfonic, phosphoric and phosphonic acid. The acidic 
group has not to be attached directly to the stereogenic center, but better enantioseparation are achieved 
if the stereogenic center is located in alpha, beta or gamma-position to the acidic functional group. For 
SAs, having more than one acidic group, reduced enantioselectivity is often observed. The presence of 
two equally strong interaction sites, such as ??- or acidic interaction, may lead to a competitive effect, 
which disturbs a directed orientation of the SA into the binding pocket of the SO. SO-SA complexes 
with varied stability are formed and the chiral discrimination mechanism will be reduced because of that 
[53].  
Quinine and quinidine are so called “pseudo-enantiomers” because of inverted stereochemistry 
according  to  the  stereocenters  of  C8  and  C9,  but  in  fact  they  are  diastereomers.  The  chiral  
discrimination process has been studied in detail for N-(3,5-dinitrophenyl-)-leucine as SA and the tert-
butyl-carbamoyl-quinine as SO. The presence of a ??-interaction site is not a condition of chiral 
discrimination, but it stabilizes the transient state complex. It seems that a ?-acidic aromatic moiety, like 
DNB- interacts much stronger with the corresponding binding site on the SO, the ?-basic quinolyl ring. 
For an optimal fit of the ??-interaction site, the type of linkage e.g. carbamoyle or aroyle, its flexibility 
and the relative distance to the stereogenic center is of great importance. Bulky side chains of amino 
??-interaction 
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acids increase the chiral discrimination, whereas a modification at or near the stereogenic center with 
bulky substituents leads to its reduction. Generally, higher lipophilicity and steric bulkiness of the 
amino acid side chain leads not only to a higher retention of the later eluting antipode, but also to 
increased enantioselectivity. A space filling substituent at amino acid side chain stabilizes also the SO-
SA complex. The X-ray structure of a most favorable SO-SA complex and the importance of the 
orientation of the stereocenters concerning the C8/9 position, have been investigated by Maier et al. 
[54].  
2.10.2 Liquid chromatography using a chiral anion-exchange type quinine-based column 
A typical ion-exchange behavior of the quinine-based columns is observed. The influence of mobile 
phase parameters on elution time and chiral recognition is well known. Elution of carboxylic acid is 
controlled by adjusting the pH value of the mobile phase, according to the WAX type of quinine-based 
CSPs. Strong dependencies of retention and enantioselectivity will arise if the pH value is altered from 
acidic to basic. The best results are obtainable in a pH range of 5-6, more generally pH should be 
adjusted near the pKa of the analyte for partially ionization. Parameters, like the pKa of the analyte, 
counterion and the selector (quinuclidine group), pH of the mobile phase accounts for overall retention. 
A hydrophobic retention increment, which does not take part in the chiral discrimination process, 
exhibits stronger contribution when the pH is decreased. The buffer type and concentration used is also 
of high importance. The buffer concentration affect the enantioselectivity in a minor extend, but the 
retention is decreased in the following order, citrate, phosphate, acetate and formate buffers.  
 
For the enantioseparation of amino acids or in general, zwitterionic SAs on quinine-based CSPs, N-
terminal protection for the amine group is a necessity. In summary, for primary amino acids the DNB, 
B,  Ac,  Clac,  F,  Fmoc,  Z,  Boc,  DNS,  DNP,  DNPyr,  DBD and  NBD protection  groups  are  suitable  to  
receive an enantiodiscrimination[53] [4]. Secondary amino acids, like proline, are only separated as 
DNP, DNPyr, and DBD derivatives [53]. The influence of the N-protection group has been explored by 
systematic alteration of type of protection group and of the type of the linkage. The N-protection group 
is also an important interaction site for chiral discrimination. The relative orientation, and therefore the 
fit of the SO-SA complex, is influenced by its functionality, shape and conformational arrangement of 
functional groups. A hydrogen bond interaction between the carbamate moiety of the SO and the 
corresponding functional group on the analyte, based on the linkage type, is of predominant importance. 
The variation of linkage enables the study of different chiral recognition mechanism and their driving 
forces. Furthermore, the elution order can be changed on a quinine-based CSP by changing the 
protection group. Other manipulations at the amine side, for example N-methylation, lead mostly to a 
complete loss of enantiorecognition and enantioseparation.  
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2.11 Quinine-based zwitterionic-exchanger chiral stationary phases 
Standard quinine-based CSPs, CSP 1 and 2 (Table 2 and Figure 12), exhibit a weak anion-exchange 
(WAX) behavior. Thus the applicability of this type of CSP is limited to chiral acids. To expand the 
range of applicable chiral analytes on the quinine-based CSP, modification of this low-molecular mass 
selector (SO) are done to introduce a second ion-exchange motif. By combining a strong cation-
exchanger site with the WAX moiety of quinine, a zwitterionic species is generated. The application 
scope of these zwitterionic ion-exchanger-type CSPs has been reported by Hoffmann et al. [55], [56] 
and [57]. Typically the spectrum of these type of CSPs can be expanded to Į- and ȕ- amino acids and to 
peptides. In principle, such a zwitterionic-type CSP can perform an anion-exchange-mode (AX), a 
cation-exchange-mode (CX) as well as a zwitterionic-exchange-mode (ZX) separation. Investigations 
by Hoffmann et al. give evidence for synergistic effects between the two oppositely charged groups 
during the molecular recognition process, especially for zwitterionic analytes [55]. In both cases, the 
CX and AX mode, one site is responsible for the ion-exchange mechanism, whereas the other existing 
ionic site can act as an intramolecular-counterion (IMCI), and therefore takes part in the ion-exchange 
equilibrium and is also responsible for analyte retardation. In ZX the oppositely charged site are not 
only involved in a simultaneous ion-pairing process, but can also act as an IMCI [57]. Several different 
CX sites have been introduced into a quinine-based CSP and have been thoroughly investigated ( Figure 
13).  
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 Figure 13: Quinine-based zwitterionic-type CSP 
 
Due to the closeness of molecule position C9 of the quinine structure to the two stereogenic center and 
the anion exchange side, modifications are often implemented on this position. Further modifications 
have also been constructed on the 6’- and the 3R-position.  
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2.12 HILIC – Hydrophilic interaction liquid chromatography 
The hydrophilic interaction liquid chromatography (HILIC) separation mode means the use of a hydro-
organic mobile phase and a very polar stationary phase. The latter one can be bare silica or silica based 
separation materials, modified for example with amines, amides, zwitterionic or polyoles e.g. saccharide 
groups. HILIC is assigned to aqueous normal phase liquid chromatography (NPLC). It is a 
complementary separation technique to the NP mode, which uses silica and water free highly apolar 
mobile phases and HILIC is often orthogonal to the reversed phase liquid chromatography (RPLC). It is 
applied for the separation of highly polar or charged analytes, such as nucleosides, nucleotides, amino 
acids, peptides, proteins, oligosaccharides, carbohydrates, pharmaceutical drugs and neurotransmitters. 
RPLC, the most frequently applied separation mode, lacks for sufficient retention of highly polar 
analytes, whereas HILIC exhibits its benefits in the separation of polar compounds [58].  
 
In HILIC, the mobile phase consists of an organic solvent, mostly acetonitrile (MeCN) that is mixed 
with pure water or an aqueous buffer. As a rule of thumb, retention increases with decreasing content of 
aqueous additive and with increasing polarity of the (hydrophilic) stationary phases. The retention 
mechanism in HILIC is more complex than in RP mode. Hydrogen bonding and dipole-dipole 
interactions may be responsible for the retention of polar compounds, but a partitioning between an 
aqueous rich layer on the silica surface and the organic rich mobile phase may also be involved [59].  
Mobile phase normally consists of acetonitrile where water or buffer up to 5-40 % is added. Mostly 
volatile buffers such as ammonium formate or ammonium acetate are used. In an aqueous-organic 
mobile phase, which has to contain at least 0,5-1 % water, a water-rich adsorbed diffuse multi layer will 
be formed on the polar surface of the stationary phase. A liquid-liquid partition takes place between the 
water rich layer and the organic-modifier rich bulk mobile phase. The elution strength of the mobile 
phase increases with the polarity of the bulk organic solvent, for example in the order of 
methanol>ethanol>isopropanol>acetonitrile. A proton-donor/acceptor interaction also contributes to the 
retention behavior. The buffer type and composition influences the retention and selectivity in HILIC 
separations, especially when charged analytes and charged moieties on the stationary phase are involved 
[60].  
 
There  is  a  big  variation  of  available  HILIC  stationary  phases  regarding  their  chemical  structure  
compared to the common n-alkyl chain based RP columns. Widely accepted HILIC columns have an 
amine,- amide or a diol functional groups bound to a silica support and are mostly used for the 
separation of carbohydrates, proteins and oligosaccharides. Newer HILIC columns are  assembled with 
a polymeric structure of poly(succinimide) derivative or with a sulfoalkylbetaine functional group, 
immobilized on silica gel [58]. Other available separation materials consist of cyanoalkyl, polyethylene 
glyco-, cyclodextrine, pentafluorophenylpropyl, polyvinylalcohol or polypeptides modified silica 
support. Generally these bonded stationary phases show higher retention for acidic compounds, which 
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results from a combination of a partition and sometimes an ion-exchange mechanism if a basic moiety 
is involved [61].  
 
 
Tailing of peaks are more common in HILIC than in RP separation. Another advantage of HILIC is the 
compatibility with common coupling techniques like mass spectrometry employing soft ionization, like 
electro spray ionization (ESI) or charged aerosol detection (CAD). The combination HILIC-ESI-MS has 
a promising future in the analytical chemistry field [61]. 
A HILIC retention increment for the tert-butyl carbamate modified quinine-based CSPs was proposed 
in literature [62],[63].  
2.12.1 Zwitterionic-HILIC stationary phases 
Chromatographic stationary phases with zwitterionic functional groups are introduced for ion-exchange 
purposes. In HILIC, a zwitterionic type stationary phase (SP) allows the simultaneous separation of 
anionic and cationic compounds in a single analytical run. The first zwitterionic HILIC stationary 
phases were of the sulfoalkylbetaine type. These sulfobetaines adsorb strongly water on its surface and 
hydrogen-bonding and dipole-dipole interactions are of primary importance, the electrostatic 
interactions  affect  the  separation  to  a  smaller  extent  [61].  Typical  analytes  for  zwitterionic  HILIC  
phases are glucosinolate, aminoglucosides, peptides and glycopeptides, as well as purines, pyrimidine 
bases and nucleosides.  
Mostly, this column type consists of a sulfobetaine or a phosphorylcholine species which contains a 
quaternary amine and a negatively charged sulfonic or phosphonic group (Figure 14). Ion-exchange 
interactions are believed to play a marginal role in the performance of zwitterionic HILIC columns. 
Amine based columns exhibit stronger ion-exchange characteristics. The two oppositely charged groups 
are believed to shield each other off from their environment, which is called intra molecular counter ion 
effect (IMCI). It is known that sulfobetaine adsorbs water strongly on its surface. Partitioning of the 
analyte between the aqueous layer and the bulk phase will account for retention, but electrostatic 
interactions will affect the separation of analytes, which carry either a positive or a negative net charge 
[61].  
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Figure 14: ZIC-HILIC stationary phase SeQuant® and KS-polyMPC [60] 
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2.12.2 Mixed RP/HILIC mechanism on polar columns in an aqueous-organic mobile 
phase 
In both modes, RP and HILIC, a polar interaction with the silica support or a lipophilic interaction with 
hydrophobic structure elements, respectively, will contribute to the entire retention behavior. Depending 
on the percentage of organic solvent applied, a mixed retention mechanism will occur during a HILIC 
separation. This mixed mode mechanism is controlled by RP interactions at highly aqueous mobile 
phase compositions and become more HILIC type with growing content of organic solvent. In such a 
case, a plot with logarithmic retention factor log(k) versusĳ of water content will show a characteristic 
U-shape. The minimum of retention states a transition state of the RP or HILIC mechanism and can be 
illustrated with such a plot [64], [60]. The mixed mode interaction offers the possibility for separation 
with better efficiency and improved selectivity. However, the latter also induces a challenge, because 
peak broadening appears quiet often under HILIC conditions and the prediction of elution order is not 
so straight forward with mixed mode HILIC separations compared to reversed phase chromatography 
[65].  
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3 EXPERIMENTAL 
3.1 Chemicals 
The source of used chemicals is given in this chapter. The chemical purity is provided in the brackets, 
where unknown means that the information of the purity was not available, due to the missing 
information of the provider or of an in-house production. 
 
The AccQ® Tag Ultra Derivatization Kit was purchased from Waters Corporation (Milford, USA), 
using 6-aminoquinoline succinimide carbamate (AQC) as fluorescence label. 
 
The following chemicals were purchased from Sigma (Vienna, Austria): 
Acetic acid (?99,8 %), ammonium acetate (?98 %), ammonium formate (?98 %), formic acid (?97 %), 
ammonium hydroxid solution 25 % (w/w) 1,3-propansulton solid (98 %), iodoacetamide (98 %), 
iodoacetate (98 %), glycine (99 %), DL-Ala (99 %) L-Ala (99 %), DL-Ile (98 %), L-Ile (99 %), DL/L-
Leu (99), DL/L-Tyr (99 %), DL/L-Val (98,5 %), DL-Thr (98 %), L-Thr (99,5 %), DL-Trp (99 %), L-
Trp (99,5 %), L-Phe (99 %), p-F-DL-Phe (98 %), DL-cysteine (98 %), L-cysteine (99 %), DL-cystine 
(99 %), DL/L-His (98 %), DL-Lys (unknown), L-Lys (98 %), DL/L-Met (99 %), L-Arg (99,5 %), alpha 
amino butyric acid (99 %), DL-allo-Ile (99 %), DL-pipecolinic acid (97 %.), L-pipecolinic acid (98 %), 
L-Gln (99,5), D-Gln (98 %), DL/L-nipecotinic acid (98 %), cis-aminocyclohexylcarboxylic acid (98 %), 
4-Cl-DL-Phe (98 %), 2-F-DL-Phe (98 %), DL/L-Asp (99 %), DL-Asn (98 %), L-Asn (99 %), DL/L-Ser 
(98 %), DL-allo-Thr (99 %), L-allo-Thr (90 %) trans-D/L-4-hydroxyproline (98/99 %), cis-D/L-
hydroxyproline (unknown), beta-DL/L-Phe (99 %), DL-isoser (98), DL-homoser (99 %), DL/L-3,4-
Dihydroxyphenylalanine (99 %), N-methyl-DL-Leu (98 %), N-methyl-DL-Val (99 %), DL-dichlorprop 
(95 %), 2-amino-cyclohexylsulfonic acid (unknown), DL/L-methioninsulfone (unknown), DL-
phoshporleucin (96 %), triethylamine (98 %), (-)-adenosine (99 %), adenine (99 %), 2 -´
desoxyadenosine (99 %), cytosine (99 %), R-(-)-phenylephrine (99 %), 4-OH-phenyl-acetic acid 
(98 %), nicotinic acid (99 %), alpha methyl tryptophane (98 %), (-)-thiamine (99 %), DL-flurbiprofene 
(98 %), ibuprofene (99 %) and theobromine (99 %) theophylline (99 %). 
 
DL-homocysteic acid (unknown purity) was purchased from Vespa Biochemicals (unknown supplier). 
 
Amino acids and peptides purchased from Bachem (Bubendorf, Switzerland):  
D-Pro (99 %), D-Phe (99 %), DL-Pro (98 %), DL-Arg (99 %), D-allo-Ile (95 %), DL/L-Gly-Pro (99 %), 
DL/L-GlyGlyPro (96 %), Gly-DL-Phe (97 %), Gly-D-Phe (98 %), DL/L-Phe (97 %), LLL-Phe3 
(unknown), DD/LL/LD/DL Phe2 (unknown), all-D/L-Phe4/5/6/7/8 (unknown), DL-Pro-Gly (99 %), 
DD/LL-Ala2 (99 %), L-Ala-Gly-Gly (91,9 %), DL-Ala-Gly-Gly (95 %), Gly-D-Ala (unknown), DL-
Ala-DL-Ala (unknown), All-D/L-Ala5/6 (98 %). 
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Peptides purchased from AnaSpec Inc. (Fremont, USA): 
All possible stereoisomers of PhePhePhe tripeptides (85 %), all-D/L-alanine hepta- and octapeptides 
(85 %).  
 
Amino acids and peptides purchased from Pi-Chem (Graz, Austria): 
All possible combinations of stereoisomers of D/L-phenylalanine tetrapeptides (90 %) and all possible 
stereoisomers of alanine tripeptides and tetrapeptides (90 %)  
 
Amino acids purchased from Loba Chem. (Fischamed, Austria):  
DL-p-Br-Phe (unknown), DL-cystine (95 %). 
 
Ortho-phosphoric acid 85 % (wt), was purchased from Fisher Scientific (Loughborough, UK). 
 
Methanol (HPLC grade), acetonitrile (HPLC grade), dichloromethane (technical) and methanol 
(technical) were from VWR (Vienna, Austria) purchased. 
 
2-Butanone (98 %) was from ABCR (Karlsruhe, Germany) purchased. 
 
Salicylaldehyde 98 %, TLC Silica gel 60 F254 and TLC Silica gel amino modified 60 F254, mercapto 
propyl modified silica gel 60, particle size 5µm and porosity 120 Å were from Merck (Darmstadt, 
Germany). 
 
Chemicals from other unknown sources: 
DL-Ala2, Gly-DL-Ala, LL-Ala2, Gly-L-Ala, Gly-DL/L-Ala-Gly, Gly-DL-Ala-Gly, Gly-L-Ala-Gly (in-
house production), TCEP (in-house production). 
 
High recovery vials, 1,5 ml crimp top, 12x32 mm were purchased from Sigma-Aldrich, Vienna, 
Austria. 
Thermo magnetical stirrer was purchased from IKA GmbH (Darmstadt, Germany).  
Thermomixer compact was purchased from Eppendorf (Hamburg, Germany). 
Satorius micro balance M3P was purchased from Satorius (Göttingen, Germany). 
Thermo incubator MP Series was purchased from Binder (Tuttlingen, Germany). 
Micro balance Mettler AB 104 was purchased from Mettler Toledo (Vienna, Austria). 
Mercapto propyl modified silica gel, 5 µm particle size and porosity 120 Å, was produced in-house. The 
coverage of thiol groups is about 650 µmol per gram silica gel [54] [66].  
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Thin layer chromatography was performed on silica gel pressing plates 60 F254 from Merk (Darmstadt, 
Germany). 
 
Table 1 summarizes analytical HPLC columns which were used in this study. 
 
Table 1: Denomination of applied analytical columns in contrast to this study 
Short name Full name, column dimensions, particle and pore size 
RP C18 Phenomenox Gemini C18 150 x 3,0 mm, 3µm 
zwitterionic-HILIC Macherey-Nagel, Nucleodur® 100-3 HILIC, 150 x 4,6 mm, 5µm 
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3.2 Analytes 
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Figure 15: Structures of native proteinogenic amino acids used in this study  
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Figure 16: Stereoisomers of threonine and cysteine/cystine derivatization products 
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Figure 18: Amino phosphonic and sulfone acids 
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Figure 19: Test substances 
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Figure 20: N-Terminal protection groups which were used in this study. 
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Figure 22: Set of representative HILIC compounds  
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3.3 Synthesis part 
3.3.1 Synthesis of a quinine-based sulfobetaine modified chiral selector  
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Scheme 2: Reaction pathway for the synthesis of CSP 3; conditions: a) 1,3- propylsultone in 2-butanone, reflux 8 h, 
recrystallisation using 2-butanone and methanol provides SO 2a, side products are 2b and 2c, b) MeOH/2-butanone 1:1 
reflux 8 h, radical starter AIBN 
 
Scheme 2 shows the synthesis of selector 2 and the immobilized selector on mercapto propyl modified 
silica gel. 7,13 g (21 mmol) of commercially available free base of quinine 1 was dissolved in 80 ml 2-
butanone and 2,1-fold mole excess of 1,3-propylsultone (44 mmol) was added. The mixture was 
refluxed under nitrogen over night, providing a white to yellow solid. The mixture was allowed to cool 
down to room temperature. After TLC check using 60 TLC plates and in dichloromethane/methanol 3:1 
with 1-3 % (v/v) acetic acid as mobile phase, three different species were identified as side products 
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from the alkylation reaction, of which one was produced in bigger amounts compared to the others. The 
flask was stored in the freezer over night during which further precipitation occurred. The solid was 
filtered off, using a filter frit with porosity 4 and was washed three times with 30 ml of 2-butanone. The 
educt was almost completely washed away, since the product was soluble in 2-butanone. A 
crystallization in 2-butanone gave a precipitate, containing three produced quinine derivatives. The 
three products were supposed to be the two possible mono-alkylated and the di-alkylated quinine 
species. A recrystallization was carried out. Selector 2 was isolated during recrystallization with 
methanol and 2-butanone. Thereby the solid was dissolved in a small amount of boiling methanol and 2-
butanone was added dropwise. As soon as precipitation occurred, the addition of 2-butanone was 
stopped. The solution was allowed to cool to room temperature and it was allowed to age over night. 
The solid was filtered off and yielded selector 2 in acceptable purity, with a yield of 2,3 g (23 %). Other 
substances, which occurred, were thougth to be the quinine derivative, alkylated on the quinoline ring 
and the quinine derivative alkylated on both nitrogen atoms. Due to great differences in the nature of 
these amphoteric substances, recrystallization could be applied to separate these side products from 
selector 2.  
Elementary analysis: C= 10,84 %, H= 1,90 %, N= 0,85 %, S= 2,44 % (%w, averaged) 
1H-NMR [MeOD]: į= 8,73 (d, 1H), 7,94 (d, 1H), 7,80 (d, 1H), 7,44 (d, 1H), 7,3 (d,1H), 6,4 (s, 1H), 5,7 
(m, 1H), 5,15 (d, 1H), 5,00 (d, 1H), 4,37 (m, 1H), 4,05 (s, 3H), 4,01 (m, 1H), 3,9 (m, 1H), 3,76 (m, 2H), 
3,53 (m, 2H), 3,05 (m, 2H), 2,86 (s, 1H), 2,46 (m, 2H), 2,27 (m, 1H), 2,19 (m, 1H), 2,09 (m, 1H), 2,01 
(m, 1H), 1,36 (m, 1H) 
13C-NMR [MeOD]: į= 160 (CarH), 148 (CarH), 146 (CarH), 144 (CarH), 138 (CH), 131 (CarH), 127 
(CarH), 123 (CarH), 121 (CarH), 117 (=CH2), 101 (CarH), 68 (CH), 66 (CH2O), 62 (CH2), 61 (CH2), 57 
(OCH3), 55 (CH2), 49 (CH2SO3-), 39 (CH), 27,7 (CH), 26 (CH2), 22 (CH2), 20 (CH2) 
 
3.3.1.1 Immobilization of selector 2 on mercapto propyl modified silica gel – chiral stationary 
phase 3 (CSP 3) 
The general immobilization procedure was described in [67] and is well established. For the 
immobilization onto mercapto modified silica gel, a radical mediated addition reaction was used, where 
the vinyl group of the quinine moiety reacts with a surface bound thiol group to give the corresponding 
thio-ether linkage. To a slurry of 3,49 g of silanol-endcapped, mercapto propyl modified silica gel, 
selector 2 (1,7 mmol), dissolved in 50 ml of a mixture of H2O/water 1:1, was added. Because of the 
“problematic” zwitterionic nature of 2, a loading of selector on the silica gel of 500 µmol/g silica gel 
was  aspired.  First  the  selector  was  coated  on  the  silica  gel.  The  coating  was  done  for  a  better  
distribution and accessibility of the zwitterionic selector two the pores of the mercapto propyl modified 
silica gel. A methanol/water mixture was added and the liquid was ultra sonicated. Then the solvent was 
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evaporated under reduced pressure and dried in the vacuum oven at 60°C. Immobilization was carried 
out in a methanol/2-butanone mixture (40 ml) and radical starter 2,2’-Azobis-(2-methyl-proponitril) 
(AIBN) (70 mg) was added. The mixture was stirred with a mechanical stirrer and was allowed to reflux 
under nitrogen over night. Then the silica gel was filtered off, using a filter frit with a porosity of 4, 
washed with water, methanol and dichloromethane several times and dried under vacuum at 60°C.  
Elementary analysis indicated an immobilization of 318 µmol/g selector per gram silica gel. The 
immobilization yield, concerning the coverage of available thiol groups on the mercapto propyl 
modified silica gel was 49 %.  
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3.3.2 Synthesis of a tert-butyl-quinine-based sulfobetaine modified chiral selector 
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Scheme 3: Synthesis pathway of CSP 4 and CSP 5, c) tert-butyl-carbamoylated-quinine and propylsulton in 2-butanone, 
reflux over night, d) MeOH/2-butanone, AIBN reflux over night, e) methanolic hydrochloric acid in methanol f) tert-
butyl-carbamoylated-quinine and propylsultone in chloroform, reflux o.n., g) MeOH/2-butanone and AIBN reflux o.n. 
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Scheme 3 shows the synthesis of CSP 4. Quinine was already modified at the hydroxyl group in 
position C9 following the procedure from reference [54]. Because of the more apolar character of tert-
butyl-carbamoylated quinine (tBuCQN) compared to quinine, 10,5g (24,8 mmol) of 3 were easily 
dissolved in 80 ml 2-butanone and afterwards 2,1 mole equivalents of propylsultone (50 mmol) were 
added. The mixture was refluxed over night. Precipitation occurred again in context of the alkylation. 
The mixture was allowed to cool down to room temperature and the solid was filtered off using a glass 
filter frit with porosity 4. The solid was washed with 2-butanone at 5°C. After TLC check using 
dichloromethane/methanol 3:1 with 1-3 % (v/v) acetic acid, it could be observed that three different 
sulfobetaine species were generated 4, 6, 7, as it was expected for the alkylation reaction. In comparison 
to the equivalent reaction of native quinine, the yield of the products was quite different. It was 
proposed that the more apolar tBuCQN was easier dissolved in 2-butanone and because of that 
zwitterionic species did not precipitate to the same extend as observed for quinine during the alkylation 
reaction. Furthermore, the combination of an excess of alkylation reagent and better soluble 
intermediates, the double alkylated species was preferentially formed.  
Recrystallization was performed as earlier described for selector 2, but without yielding selector 4 in 
acceptable purity, since co-precipitation of the other alkylated products occurred. A column separation 
was performed, using silica gel, to yield the product of interest in acceptable purity. The zwitterionic 
character of alkylated quinine was inhibited by the addition of acetic acid to the mobile phase. The 
elution strength was increased with increasing amounts of acid added. A step gradient was applied 
beginning with the addition of 1 % (v/v) acetic acid and was raised to 5 % (v/v) in the mobile phase. 
The solid was dissolved in small volumes of dichloromethane/methanol mixture 20:1 and was applied 
onto the silica gel bed (about 200 g). A step gradient was necessary for the generation of an efficient 
zone separation of the three containing substances. Elution and proper separation of three different 
alkylated species was done with mixtures of dichloromethane/methanol (20:1 to 5:1) with addition of 
acetic acid as mentioned before. Selector 4 was identified as the second of four eluting quinine-based 
substances (Yield: 3,6 g or 26,7 %).  
Another fraction, the third of four, was also collected and structure analysis revealed that this compound 
conformed to the structure of selector 6  (Error! Reference source not found.) (Yield: 1,22 g, 9 %). It 
was found that during the drying at 60°C in the vacuum, a chemical alteration occurred with this 
compound. Selector 6 was found to be thermo labile.  
Elementary analysis: C= 12,54 %, H= 2,04 %, N= 0,89 %, S= 2,73 % (%w, averaged) 
1H-NMR [D2O]: į= 8,80 (d, 1H), 8,32 (s, 1H), 8,07 (d, 1H), 7,87 (d, 1H), 7,65 (d, 1H), 7,3 (d, 1H), 6,95 
(s, 1H), 5,58 (m, 1H) 5,0 (d, 1H), 4,97 (d, 1H), 4,01 (s, 3H), 3,82 (m 5H), 3,62 (m, 1H); 3,38 (m, 1H), 
3,04 (m, 2H), 2,87 (m, 1H), 2,34 (m, 2H), 2,23 (m, 2H), 2,10 (m, 1H), 2,01 (m, 1H), 1,63 (m, 1H), 1,2 
(s, 9H)  
13C-NMR  [D2O]:  į=  160  (CarH), 153 (COON), 146 (CarH), 146 (CarH), 143 (Car), 138 (Car), 137 (-
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CH=), 127 (CarH), 126 (Car), 125 (CarH), 123 (CarH), 120 (CarH), 117 (=CH2), 102 (CarH), 68 (CH), 66 
(CHO), 61 (CH2), 60 (CH2), 57 (OCH3), 53 (CH2N), 51 (C), 47 (CH2SO3), 37 (CH), 28 (CH3), 26 (CH), 
25 (CH2), 22 (CH2), 19 (CH2). 
 
3.3.2.1 Immobilization of selector 4 on mercapto propyl modified silica gel – chiral stationary 
phase 4 (CSP 4) 
Immobilization procedure for selector 4 was  the  same  as  for  CSP  3  (chapter  3.3.1.1).  Elementary  
analysis indicated selector coverage of 202 µmol/g selector per gram of modified silica gel or an 
immobilization yield of 32 %.  
 
3.3.3 Synthesis of a tert-butyl-quinine-based sulfobetaine modified chiral selector – 
another approach for the synthesis of selector 6 
An alternative approach for the synthesis of selector 6 was investigated, because this compound was 
produced only in minor amount compared to selector 4 and the double alkylated quinine derivative 
(Scheme 3). The mono hydrochloric salt of tert-butyl carbamoyl quinine 5 was produced by adding 1,1 
mole equivalents of methanolic hydrochloric acid to 8,35 g (19,4 mmol) of compound 3 in water free 
methanol. The solvent was evaporated and the mono-chloric salt 5 was obtained. Then 1,1 mole 
equivalents of propylsultone was used for the alkylation reaction, which was repeated several times 
using different solvents, e.g. dichloromethane, chloroform and methanol. In chloroform a mono-
alkylated species was generated in larger quantity compared to the corresponding reaction using 2-
butanone. For clean-up, column chromatography with silica gel was performed. The reaction mixture 
was evaporated and dissolved in a small volume of a mixture of methanol/water 1:1, before it was 
coated onto silica gel.  The flash column was filled with 120 g pure silica gel  and the selector,  coated 
onto silica gel, was added on the top. Elution was performed with mixtures of 
dichloromethane/methanol from 20:1 to 5:1 with varying amounts of acetic acid ranging from 0,1 to 
3 % (v/v). Fractions of selector 6 were collected as the third of four separated substances. The solvent 
was evaporated, but acetic acid remained in high amount, because of its higher vapor pressure compared 
to organic solvents. The sticky solution was dried under vacuum. After some days white crystals were 
generated. Due to the risk of hydrolysis of the carbamate linkage at these solution in pure acetic acid, a 
precipitation by addition of 2-butanone was done. The precipitate 6 was filtered off, was washed with 2-
butanone and dried under vacuum (Yield 1,75 g, 16,7 %).  
Elementary analysis: C= 9,35 %, H= 1,71 %, N= 0,79 %, S= 2,10 % (%w, averaged) 
1H-NMR [D2O]: į= 9,11 (d, 1H), 8,48 (d, 1H), 8,08 (d, 1H), 7,94 (d( 1H), 7,70 (d, 1H), 6,76 (s, 1H), 
5,72 (m, 1H), 5,12 (m (1H), 5,04 (d, 1H), 4,16 (t, 1H) 4,07 (s, 3H), 3,81 (m, 1H), 3,78 (m, 1H), 3,64 (m, 
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2H), 3,50 (m, 1H), 3,35 (m, 1H), 2,95 (m, 2H), 2,81 (s, 1H), 2,47 (m, 2H), 2,21 (m, 1H) 2,03 (m, 1H), 
1,93 (m, 3H). 1,20 (s, 9H).  
13C-NMR [D2O]: į= 161 (Car), 152 (CarH), 144 (Car), 146 (Car), 138 (-CH=), 137 (CarH), 134 (Car), 136 
(CarH), 123 (CarH), 119 (CarH), 116 (=CH2), 103(CarH), 70 (CH), 66 (CHOR), 64 (CH2), 60 (CH2), 60 
(CH2), 57 (OCH3), 57 (CH2), 47 (CH2SO3), 36 (CH), 28 (CH3), 27 (CH2), 25 (CH2), 24 (CH2).  
 
3.3.3.1 Immobilization of selector 6 on mercapto propyl modified silica gel – chiral stationary 
phase 5 (CSP 5) 
The first immobilization approach was carried out as described for CSP 3 or 4. Mercapto propyl 
modified silica gel (3 g) was taken into a round beaker and 1,5 mmol of selector 6 was added. The 
selector was dissolved with methanol and the solution was ultra sonicated. The solvent was evaporated 
under reduced pressure and the coated silica gel was dried. The immobilization was performed in a 
mixture of methanol/2-butanone 1:1. Radical starter AIBN was added (70 mg) and the solution was 
stirred with a mechanical stirrer under reflux over night. The silica gel was filtered off and washed 
several times with methanol, dichloromethane and 2-butanone. Elementary analysis showed 
unsatisfactory loading of selector 6 onto the silica gel where the selector loading was 67 µmol/g selector 
per gram silica gel. It was assumed that the difficult zwitterionic character of the selector had caused a 
worse behavior and disabled a good immobilization. 
In a second approach the selector 6 was added in a higher excess into the immobilization reaction 
(3 mmol) and 3,4 g of mercapto modified silica gel was used. Radical starter was also added in a higher 
amount (350 mg). The reaction slurry was mixed in 120 ml of MeOH/2-butanone 1:1 with a mechanical 
stirrer and it was allowed to reflux for ten hours under nitrogen atmosphere. After that the selector 6 
modified  silica  gel  was  filtrated  off  and  washed  according  to  the  procedure  described  for  CSP  4.  
Elementary analysis was done, giving a calculated selector coverage of 188 µmol/g selector per gram of 
silica gel and an immobilization yield of 29 %.  
Table 2 gives an overview of CSPs used for enantioseparation analysis during this master thesis.  
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Table 2: Denomination of investigated CSP columns together with their dimension and selector coverage 
CSP code 
CSP short 
name 
CSP full name 
column 
dimensions, 
particle and 
pore size 
Selector coverage 
[µmol SO/g Silica 
gel] 
CSP 1 QN-AX tert-butyl-carbamoyl-quinine-based chiral stationary phase 
150 x 4 ID 
5 µm, 120 Å 380 
CSP 2 QD-AX tert-butyl-carbamoyl-quinidine-based chiral stationary phase 
150 x 4 ID 
5 µm, 120 Å 380 
CSP 3 QN-SB-V2 N-1-propylsulfonic acid modified quinine-based chiral stationary phase 
150 x 4 ID 
5 µm, 120 Å 318 
CSP 4 tBuCQN-SB-V2 
N-1-propylsulfonic acid, tert-butyl-
carbamoyl modified quinine-based 
chiral stationary phase 
150 x 4 ID 
5 µm, 120 Å 202 
CSP 5 tBuCQN-SB-V3 
N-1’-propylsulfonic acid, tert-butyl-
carbamoyl modified quinine-based 
chiral stationary phase 
150 x 4 ID 
5 µm, 120 Å 188 
CSP 6 lcQN-AX Low coverage tert-butyl-carbamoyl-quinine-based chiral stationary phase 
150 x 4 ID 
5 µm, 120 Å 142 
 
3.3.4 Racemization of dipeptides 
3.3.4.1 Pretest with phenylalanine 
The  procedure  for  the  racemization  of  amino  acids  via  the  formation  of  a  Schiff-base   was  tested  by  
racemization of L-phenylalanine [48]. An aliquot of 6,1 mmol of L-Phe and 615 mmol (100 fold 
excess) of acetic acid, HPLC grade, were taken into a round bottom flask. It was necessary to heat the 
mixture up to 40°C to dissolve phenylalanine in acetic acid. Then 20 % mole equivalents of 
salicylaldehyde were added and the mixture was refluxed for two hours. The acetic acid was then 
evaporated under reduced pressure, providing a yellow to orange sticky solid. About 40 ml water was 
added and the mixture was heated under stirring to 40°C to dissolve the solid. A spatula tip of charcoal 
was added and the slurry was stirred at room temperature. The charcoal and all other insoluble contents 
were filtered off, using a folded filter and the filtrate was evaporated under reduced pressure. 30 ml of 
methanol was added and the white crystalline precipitate was separated using a glass filter frit (porosity 
4) and was dried under vacuum (yield 900 mg or 90 %).  
The racemization efficiency was investigated using enantioseparation chromatography. The solid was 
derivatized with AQC and injected into a HPLC run using CSP 2 and method 1. As a result, a pair of 
enantiomeric peaks, with equal peak area, was obtained. 
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3.3.4.2 Racemization of dipeptides  
Reaction mechanism was considered to be exemplified in Scheme 1. 
For racemization of L-Phe-Gly, 5,3 mmol of dipeptides was added to fifteen-fold molar excess of acetic 
acid (76 mmol). The peptide was easily dissolved in the organic acid and 0 % mole equivalents of 
salicylaldehyde (2,1 mmol) was added. The mixture was refluxed for two hours before it was 
evaporated under reduced pressure to dryness. After addition of 40 ml water and a spatula tip of 
charcoal, the liquid was stirred for 30 min at room temperature. Then the adsorbent was filtered off and 
the filtrate was evaporated under reduced pressure. By adding methanol, precipitation occurred and the 
solid  was  isolated  with  a  glass  filter  frit  (porosity  4).  The  racemization  yielded  467  mg  or  39  % of  a  
white solid. The same reaction was carried out for Gly-D-Phe using 2,6 mmol of the peptide (Yield 
370 mg or 77 %). It was a contrasting test, because the N-terminally located glycine might not be 
racemized if  the racemization was conducted using a  Schiff  base intermediate  (Scheme 1).  If  just  this  
mechanism was involved in the racemization, the Gly-D-Phe should not been altered. Otherwise, by the 
formation of a diketopiperazine, an inverse dipeptide and/or a changed stereochemistry should be 
observed. 
3.4 Derivatization procedures 
3.4.1 Derivatization procedure for amino acids using AQC 
For derivatization of amino acids common protocols as described in reference [68] were conducted.  
AQC was purchased from Waters Corporation, Millford, USA. The kit contained a screw vial with solid 
AQC,  water  free  acetonitrile  and  vial  of  20  mM  borate  buffer  pH  8,8.  Three  milligrams  of  AQC  tag  
were dissolved in one milliliter of acetonitrile. The solution had to be heated to 55 °C for ten minutes to 
complete the solubilisation process. The solution was protected from light and was stored tightly 
wrapped with parafilm® in a desiccator. The solution could be used for more than one week. A partial 
hydrolysis of the tag was recognized, but due to an excess of used derivatization reagent to analyte, an 
influence on derivatization efficiency could not be observed.  
Amino acid standard solutions were prepared with a concentration of 2,5 mM in 0,1 M HCl. Further 
dilutions were done in bidistilled water. For a typical derivatization 80 µl of borate buffer was added to 
HPLC vial with 100 µl glass insert or a high recovery vial. From the diluted amino acid solution ten 
micro liters were added and the solution was immediately mixed. Then ten micro liters of derivatization 
reagent were added and the solution was mixed immediately. Afterwards the vial was heated at 55°C for 
ten minutes prior to analysis. The formation of the symmetric bis-urea derivative had led to a 
precipitation in the derivatization solution after several days. This solid was removed by centrifugation 
of the mixture and liquid phase was used.  
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3.4.2 Derivatization procedure for amino acids using FITC 
Several protocols for the derivatization of free amino acids with fluoresceine-isothiocyanate were taken 
into account [33], [32] [69]. The last mentioned protocol [69] yielded a good derivatization of amino 
acids, concerning the reaction time and temperature. Therefore the derivatization was carried out in an 
alkaline milieu, a 20 mM borate puffer pH 9,8, adjusted with 10 % (w/v) NaOH. 100 µl of the borate 
buffer was added in a light protected reaction tube. From amino acid standard solutions, of about 
50 mM, an aliquot was added. FITC was prepared as a 10 mM solution in dry dimethylformamide 
(DMF)  and  10  µl  were  added  to  the  reaction  tube.  The  amino  acid  was  added  in  a  slightly  excess  to  
FITC for each derivatization reaction. The solution was mixed and stored in a thermoshaker at 60°C in 
the dark for two hours. It was investigated that a pH >9 was necessary to obtain proper derivatization 
yields as well as a temperature of 60°C during a reaction time of about 2 hours. Other protocols, which 
had performed the derivatization in the dark over night, had been found to be faulty. The AA-FITC 
derivatives could be stored in the freezer for at least one weak, if only a qualitative analysis was to be 
conducted. Absorption maximum was found at 235 nm, other absorption maxima were 250 nm and 
460 nm. Fluorescence detection was done with an excitation wavelength of 460 nm and an emission 
wavelength of 520 nm. 
3.4.3 Reduction of cystine and derivatization with iodo acetamide, iodo acetate and 4-
vinylpyridine 
A cystine solution with a concentration of 16 mM was prepared in 0,1 M HCl. Iodo acetamide and iodo 
acetate solutions were freshly prepared in acetonitrile with a concentration of 50 mM. The reduction of 
cystine was carried out by the addition of a reduction agent. A TCEP solution with 50 mM in water was 
prepared freshly before every use. The reduction was done with 50,- 100 and 200 fold molar excess of 
TCEP relative to disulfides in an aqueous media. The reaction was allowed to proceed in the dark at 
room temperature for two hours. Then the derivatization with the iodo species and afterwards the 
derivatization with AQC were conducted in the same solution.  
To an aliquote of diluted amino acid solution with TCEP, a 10-fold molar excess of the iodo species 
was added and the reaction was allowed to proceed in the dark for two hours. The AQC derivatization 
was done according to the above mentioned protocol (capture 3.4.1). The cysteine derivatives were 
stable for at least one week in the freezer. The 4-vinylderivative was produced in-house.  
3.5 Analysis protocols 
3.5.1.1 General conditions and aspects for the enantioselective separations 
Standard parameters for the enantioseparation were a flow rate of 1 ml/min and a column temperature 
of 25°C. Isocratic elution mode was performed. For each column the void volume was determined by an 
injection of 10 % (v/v) acetone in mobile phase and detection at 280 nm. A sequence of analytical runs 
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included one or more blank runs followed by a series of analyte injections, a blank run and/or a column 
washing run. A reagent blank was always included after each longer sequence in order to identify 
reagent  related  peaks  in  the  chromatogram.  Samples  were  kept  in  the  autosampler  plate,  which  was  
temperature controlled to 5 °C or were stored in the freezer.  
Mobile phases were degassed in a sonification bath prior use. Identification of enantiomer peaks were 
achieved by injection of a racemic mixture and a single injection of one of the enantiomers. 
Furthermore, the peak areas of the racemic mixture had to be equal. With the application of quinine 
instead of quinidine-type CSPs, the elution order of most of the used analytes were reversed. This 
provided another hint to the enantiomeric character of an observed peak pair.  
Newly synthesized columns were washed with 1 % (v/v) acetic acid in MeOH, until the baseline of both 
detectors, DAD and FLD was constant. The columns were stored in methanol. 
3.5.2 Methods 
3.5.2.1 Method 1 
Standard method 1 was used for chiral separations, mainly for AQC-derivatives. tert-Butyl carbamate 
modified quinine/quinidine based chiral stationary phases were used. The column temperature was 
controlled to 25 °C. The mobile phase was MeOH/AcOH/NH4AcO 98/2/0,5 % (v/v/w). The flow rate 
was 1 ml/min. Detection was carried out with a diode array detector at an absorption wavelength of 
248 nm and with a fluorescence detector at an excitation wavelength of 248 nm and an emission 
wavelength of 395 nm.  
3.5.2.2 Method 2 
Method 2 was used for enantioseparations, mainly for the separation of alanine peptides and 
stereoisomers. tert-Butyl carbamate modified quinine/quinidine based chiral stationary phases were 
used. The column was tempered to 25 °C. The mobile phase was MeOH/H2O 80/20 20 mM NH4AcO 
and pHa 6,0 adjusted with acetic acid. The flow rate was 1 ml/min, if not. Detection was carried out with 
a diode array detector at an absorption wavelength of 248 nm and with a fluorescence detector at an 
excitation wavelength of 248 nm and an emission wavelength of 395 nm. 
3.5.2.3 Method 3 
Method 3 was set up as method 2, besides the mobile phase. MeOH/H2O 80/20 200 mM NH4AcO and 
pHa 6,0 adjusted with acetic acid, was used. Method 3 was used for the enantioseparations of 
phenylalanine peptides, therefore the flow rate of 0,5 ml/min was applied  
3.5.2.4 Method 4 
Method 4 used a reversed phase system for the separation of AQC tagged amino acids. An Agilent 
HPLC 1200 Series, with quaternary pump, degasser, column oven, diode array detector and a 
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fluorescent detector was applied. Phenomenox Gemini 150x3,00 mm 3µ 110 Å RP C18 column was 
used. Mobile phase and elution gradient were based on reference [28], but were modified. Eluent A was 
an aqueous buffer, 100 mM NaAcO, 0,1 % (v/v) triethylamine and pH 5,0, adjusted with acetic acid. 
Eluent B was a mixture of acetonitrile/water 60/40. The gradient was [t (min)/%A] 0/100, 0,5/98, 18/93, 
19/90, 29,5/67, 38/67, 39/0, 43/0, 43,5/100 and 50/100 all linear segments. The flow rate was set to 
0,8 ml/min and the column temperature was 40°C. Detection was carried out with a diode array detector 
at an absorption wavelength of 248 nm and with a fluorescence detector at an excitation wavelength of 
248 nm and an emission wavelength of 395 nm. 
3.5.2.5 Method 5 
Method 5 was equal to method 4, besides the type of buffer. For the investigations using a mass 
analyzer with electrospray ionisation, a volatile buffer was used. Eluent AMS was an aqueous buffer, 
100 mM NH4AcO, 0,1 % (v/v) triethylamine and pH 5,0, adjusted with acetic acid. 
3.5.2.6 Method 6 
Method 6 was used for the enantioseparations of fluoresceine-labeled amino acids. tert-Butyl carbamate 
modified quinine/quinidine based chiral stationary phases were used. The mobile phase was a mixture 
of MeOH/ACN 80/20, 150 mM FA, 75 mM NH4AcO.  Flow  rate  of  1  ml/min  was  applied  and  the  
column temperature was 25 °C. Detection was carried out using a diode array detector at the absorption 
maximum of 235 nm.  
3.5.2.7 Method 7 
Method 5 was used for separations in the HILIC mode. The mobile phase was a mixture of ACN/H2O 
90/10 with 10 mM NH4AcO, buffer pH 5,0 or 8,0 was adjusted with acetic acid or ammonia hydroxide. 
Column  temperature  was  maintained  at  25  °C  and  a  flow  rate  of  1  ml/min  was  applied.  Different  
columns were applied using method 5 e.g. CSP 2, CSP 3, CSP 4, CSP 5 and Nucleodur® 100-3. The 
detection was carried out using a diode array detector. The highest absorption maximum of an 
individual analyte of one of following wavelength, 215, 248, 280 and 360 nm was taken into account.  
3.5.3 Screening for chiral enantiodiscrimination of the synthesized sulfobetaine-type 
quinine and tert-butyl carbamate modified quinine-based chiral stationary phases 
The study of the chiral recognition and enantiomer discrimination ability of the synthesized 
sulfobetaine-type quinine-based selectors was conducted as follows: First the standard mobile phase, 
MeOH/AcOH/NH4AcO  98/2/0,5  %  (v/v/w)  was  used  for  the  separation  of  a  small  set  of  typical  test  
substances, DNB-DL-Leu, DL-Ac-Phe and DL-Z-Phe. AQC-derivatives of representative amino acids 
were also tested. Then the mobile phase was altered and the test set was extended. The mobile phases of 
choice were MeOH/AcOH/NH4AcO 99/1/0,25 % (v/v/w), 20 mM AcOH in MeOH, 20 mM TEA in 
MeOH, 50 mM Na2HPO4  buffer, where pH 2,0  was adjusted with H3PO4 and the mobile phase was a 
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mixture of MeOH/buffer 50/50. A hydro-organic mobile phase with MeOH/H2O 80/20 20 mM 
NH4AcO pHa 6,0, adjusted with acetic acid, was also tested.  
3.5.4 Application of the synthesized sulfobetaine-type quinine and tert-butyl-carbamate-
quinine-based stationary phases in the hydrophilic interaction liquid 
chromatography mode 
Each  of  the  three  columns,  CSP  3,  CSP  4  and  CSP  5  were  used  for  the  separation  of  a  set  of  typical  
HILIC compounds ( Figure 22) using a mobile phase, containing ACN/buffer 90/10, where the buffer 
contained 100 mM NH4AcO. The pH was adjusted with acetic acid to 5,0 and 8,0. For another study the 
apparent pH value in the hydro-organic phase was adjusted to 5,0. The samples were dissolved and 
diluted with a mixture of ACN/H2O 90/10.  
For the investigation of the retention mechanism exhibited by the synthesized HILIC columns, some 
representative analytes were tested using CSP 3. A series of test analytes were injected and different 
mobile phase compositions were used for elution. Mobile phase A was a mixture of ACN/aqueous 
buffer 5/95, containing 10 mM NH4AcO and mobile phase B was 95/5 ACN/ aqueous buffer containing 
10 mM NH4AcO. The pH of the buffer was adjusted to 5,0 with acetic acid. The thereby obtained data 
were processed in a plot of log(k) vs.ĳ H2O. A trendline was fitted to the distribution of data points. 
Note, that an U-shape of the trendline would imply a mixed retention mechanism.  
3.6 Instrumentation and methodologies 
3.6.1 Instrumentation 
Chromatographic analyses were mainly done with an Agilent 1200 Series HPLC system (Agilent 
Technologies Waldbronn, Germany). The HPLC was equipped with a quaternary pump, as well as with 
an autosampler, degasser and a column oven. Detection of fluorescence active compounds was 
accomplished with a fluorescence detector (Type G131GA). Non-fluorescence active analytes were 
detected using a DAD (Type G1321A).  
Data analysis was carried out with Chemstation software for LC 3D system, from Agilent Technologies.  
 
Mass spectrometric analyses were performed on a quadrupole-Qtrap mass spectrometer, MDS Sciex 
4000 QTrap, from Applied Biosystems (Foster City, USA) connected with an Agilent 1200 Series 
HPLC or an Ion-trap MS 1100 Series LC/MSD Trap SL from Agilent (Santa Clara, USA) connected 
with a HPLC 1100 Series from Agilent. Mass spectrometric analyses were performed in direct infusion, 
or after chromatographic separation in scan- or product-ion mode. After identification of the molecular 
ion mass, fragmentation analysis was performed. The analyses were also done in scan mode using 
positive or negative ionization. Also MSn investigations were done. The AQC-amino acid derivatives 
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were in some cases identified with mass spectrometric analysis, using a RP phase method 5. 
 
Elementary composition of the potentially interesting stationary phases were determined with a CHNS-
O element analyzer (Carlo Erba) and the selector coverage on silica gel was calculated from mass 
percent of nitrogen detected (w-% N).  
 
NMR spectra, 1H- and 13C-NMR, were recorded at room temperature with a Bruker DEX400 and 
DRX600 spectrometer. The spectra were recorded in different totally deuterated solvents, mostly CCl3D 
or CD3OD and for the zwitterionic sulfobetaine-quinine derivatives D2O and CD3COOD were used. The 
solvent signals were also used as reference signal. NMR data analysis was done with SpinWork® 
software (version 3).  
 
IR spectra were measured with a Bruker Tensor 27, Diamond ATR FTIR. Spectras were normalized and 
data analysis were done with OPUS® 2,4 software. 
3.7 Chromatographic parameters 
3.7.1 Retention factor k 
The retention factor k is a standardized value, containing the retention time tR1 and the void time tRo of 
the chromatographic system (Formula 9).  
 
? = ??? ????
???
 Formula 9: Retention factor 
 
3.7.2 Selectivity Įij 
Selectivity is described as the quotient of the retention factors of two peaks, related to each other. It 
describes the separation performance and selectivity of two analyte peaks for one chromatographic 
system. In the concept of enantioseparation, enantioselectivity is defined by Formula 10.  
 
??? = ???? Formula 10: Enantioselectivity coefficient 
 
Enantioselectivity is a parameter for the difference in selectivity expressed for a pair of enantiomers 
retained in the same chromatographic run. Alpha values above 1,0, means that one enantiomer is 
stronger retained than the other. High values indicate a different affinity of the selectand for the chiral 
selector and provide baseline separation. 
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3.7.3 Resolution RS 
The resolution is one of the most significant parameter describing the separation performance and 
efficiency of two peaks. A resolution above 1,5 indicates a baseline separation. The Rs-value depends 
on the plate number, the retention factor and the selectivity. Many different formulas are known. The 
best known one is presented in Formula 11:  
 
?? = ??4 ? ?? + 1 ? ? ? 1?  Formula 11: Chromatographic resolution 
 
It shall be mentioned that resolution values presented in this work are calculated values from the 
Agilent Chemstation software. In preparative chromatography of enantiomers, high resolution is 
desirable, since it increase the loadability and therefore the productivity of a column.  
3.7.4 Plate number N 
The plate numbers for a single analyte peak describes the efficiency of a chromatographic column in a 
quantitative way. It describes the number of equilibration zones of the analyte between the mobile and 
the stationary phase. In context of chiral separation it also describes the quality of the column packing 
and the selector coverage. Different formulas are known from literature. A general one is presented in 
Formula  12.  There  tR1 means the retention time of the peak and wFWHM is the peak width at half 
maximum.  Note,  that  all  plate  numbers  in  this  work  are  calculated  by  the  Agilent  Chemstation  
Software. 
 
? = 5,54 ? ? ???
?????
 Formula 12: Plate number 
 
3.7.5 Selectivity coefficients s2 
The influence of a chromatographic parameter on the separation selectivity, e.g. pH, can be 
demonstrated with a selectivity plot. The natural logarithm of the retention factors, obtained from a 
chromatogram of two different applied parameters, has to be calculated. A linear plot of the ln(k) values 
is fitted to a linear relationship and the square of the correlation coefficient R2 can be calculated. The 
selectivity coefficient can be found by the use of Formula 13.  
 
?? = 1??? Formula 13: Selectivity coefficient 
 
A  s2 value of zero indicates that the two applied parameters (mobile phase, columns, or different 
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packing) do not exhibit any selectivity difference. A s2 value of one means the two compared 
parameters are totally uncorrelated or orthogonal and an alteration of one of both leads to a change in 
selectivity.  
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4 RESULTS AND DISCUSSION 
4.1 General aspects concerning the analytes and labels 
6-Aminoquinoline succinimide carbamate (AQC) is a fluorescence tag often used for the sensitive 
determination of amino acids. Primarily the tag was introduced as an amino acid label for quantitative 
approaches in natural biological matrices. Especially for the determination of trace amounts of amino 
acids, in presence of bulk quantities of matrix or the other antipode, fluorescence detection had shown 
to be most suitable for detection and quantification [70], [71]. Furthermore, the possibility of a N-
terminal derivatization of amino acids via an urea linkage was not investigated, concerning the 
enantioselective separations of N-derivatized analytes using a tert-butyl carbamate modified quinine-
based chiral stationary phase. It should be conducted how far this new linkage group would influence 
the enantioseparation. Most important was the enantioseparation of proteinogenic amino acids, followed 
by a number of non-proteinogenic amino acids, with commercial, health or pharmaceutical relevance. 
Because of good enantioseparation results for amino acids N-derivatized with AQC, a number of 
dipeptides and mixtures of stereoisomers were investigated according to their separation abilities on 
quinine-based CSPs. A series of alanine as well as phenylalanine peptides up to the hexamer was also 
derivatized and chromatographed. The approach should be further investigated and it was thought to 
yield a deeper insight into the chiral recognition process. A comparison with later done experiments 
with peptides should be also conducted. Fluoresceine isothiocyante (FITC) was linked with amino acids 
via a thiourea bridge. FITC, a relatively large molecule compared to the rather small proteinogenic 
amino acids, should be successfully applied using a WAX-type quinine-based chiral stationary phase. 
Enantioseparations of amino acids labeled with fluorescein were already investigated [72]. Therefore 
the behavior of this structural linkage-analogue, compared to the urea bridge of AQC-derivatives, was 
studied.  
A set of HILIC suitable compounds, highly polar and/or charged substances, were chosen for the 
investigation of the performance of the generated sulfobetaine-type CSPs regarding their applicability in 
the HILIC mode. 
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4.2 Investigation of AQC-tagged proteinogenic amino acids using reversed 
phase HPLC 
4.2.1 Separation of a mix of AQC-tagged proteinogenic amino acids via reversed phase 
HPLC 
The derivatization procedure for AQC derivatization was conducted according to literature [28]. 
Concerning the choice of HPLC vials for the derivatization, it was found that the recommended high 
recovery vials, had no significant advantages compared to ordinary scrimp HPLC vials with 150 µl 
glass inserts. The reproducibility as the peak areas were found to be equal for both types of HPLC vials.  
 
A reversed phase method was conducted for following reasons. First, the derivatization had to be 
monitored, concerning the optimization of the derivatization procedure and for investigation of 
unexpected occurring species in term of the derivatization. Secondly, a mixture of proteinogenic amino 
acids were derivatized and separated in one chromatographic run. Method 4 was used for the 
investigations. Some unexpected reagent related peaks were found in each chromatogram. The retention 
time dependency on buffer pH for 6-aminoquinoline and all AQC amino acids derivatives was observed 
[73].  
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Figure 23: Scheme of an AQC-amino acid derivative 
 
An exact adjustment of pH value was necessary to keep the variation of the retention time as low as 
possible. A pH >5,0 leads to an increase of retention and to a peak overlapping with acidic amino acids. 
The NH3-related peak elutes under the mentioned conditions in chapter 3.5.2.4 at about 22,8 min, which 
means an overlapping with the His-AQC derivative. A striking problem was the overlapping of reagent 
peaks with analyte derivatives (Figure 24), eluting at 33,1 min, 34,1 min, 40,78 min and 40,88 min. As 
it could be seen in Table 14, the system peaks will overlap with Lys, Ile and Leu. Another fact was the 
different sensitivity of the fluorescence detection. As described in [22], fluorescence quenching had 
increased with increasing water content of the mobile phase. Derivatized amino acids with two 
chromophores could underlie a quenching effect, namely cystine, Phe and Trp. Phe as Lys were less 
influenced from this effect, Trp was not detectable by fluorescence detection but exhibited strong UV 
absorption and could be analyzed via UV detection. For cystine it was found that the LL/DD-cystine 
exhibited less fluorescence quenching than the DL-meso-cystine, which may originate from the 
difference in conformation of these molecule variants. The three stereoisomers were partially separated 
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in two peaks and a mono-substituted species was found rarely in small quantities in the chromatogram. 
The species could be identified with mass spectrometry investigations. The parameters were the same as 
for the dipeptide racemization analysis (3.3.4 Racemization of dipeptides). A chromatogram illustrating 
the separation of nineteen amino acids, without Trp is shown Figure 24. Ser and Gln coeluted as well as 
Thr and Arg. His was not present in the mixture.  
 
 
 
 
 
Figure 24: Chromatogram of a separation of nineteen ACQ-tagged amino acids. Tryptophan was not included because 
of a fluorescence quenching effect. Detection was carried out with an FLD excitation wavelength of 248 nm and an 
emission wavelength of 395 nm. The separation conditions, column and gradient were used as described in method 4.  
 
4.2.2 Cysteine/Cystine derivatization 
The cysteine/cystine problem was an issue of this master thesis. A reduction of cystine with tris-(2-
carboxyethyl)-phosphine (TCEP) and a derivatization with iodo acetate and iodo acetamide was 
investigated prior derivatization with the AQC label. The reduction and derivatization of 
cysteine/cystine was performed according to the protocol from reference [74]. The retention behavior 
was investigated on both, a reversed phase column, to find a suitable Cys-derivative for later acidic 
hydrolysis of biological matrixes and for an enantioseparation of DL-Cys-derivatives with a quinine-
based chiral stationary phase.  
 
Surprisingly, the reduction of a cystine standard with TCEP and derivatization with AQC had led to a 
new peak in the chromatogram (Figure 26). The new peak had a different emission maximum than 
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AMQ (Figure 27). The emission maxima were at 395 nm and 520 nm, respectively. Mass spectrometric 
investigations revealed a molecular mass of 187 g/mol, using method 5. For that reason the new 
appearing peak was related to a carbamic acid derivative of AMQ (Figure 25), which was proposed to 
be an unstable intermediate during an acid or base catalyzed degradation of 6-aminoquinolyl-
succinimidyl carbamate in aqueous solutions, as referred in literature [23]. It was supposed that in 
presence of TCEP the carbamic acid was more stable and could be detected in the time frame of 
derivatization and subsequent RP analysis. This finding stood in contrast to reports in literature [75], 
where the authors proposed a TCEP-AQC educt, which should be responsible for the new appearing 
peak.  
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Figure 25: Hydrolysis of AQC in buffered aqueous solutions leading to the unstable carbamic acid derivative according 
to reference [23] 
 
 
 
Figure 26: Overlay of chromatograms from reagent blanks. One just contained AQC (blue) and the other 10 nmol AQC 
and 100 nmol TCEP (red). AMQ exhibites different emission spectrum to AQC and its peak is not shown here. The 
investigation was carried out using method 4. 
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Figure 27: Overlay of the reagent blank with TCEP and AQC, L-cysteine with AQC derivatized and DL-cystine 
reduced with 100 molar excess of TCEP and derivatized with AQC. The investigation was carried out using a RP 
system and method 4. 
 
The retention behaviour of cysteine-S-acetate and cysteine-S-acetamide were investigated during the 
reversed phase run. The additional acid functional group of cysteine-S-acetic acid had led to a strongly 
reduced retention, leading to retention times before AMQ. In such an aqueous media the quenching was 
remarkably strong. A lower sensitivity for this compound could be disadvantageous for further 
investigations. The acetamide derivative had a retention time of 24,6 min and coeluted with other amino 
acids such as Thr and Arg, which resembles an undesirable retention behaviour for the cysteine-
acetamide derivative. The cysteine-vinylpyridine derivative had a retention time of 31,5 min, which 
would be preferable, because it would elute in a retention window between the AQC derivatives of Met 
and Ile. Stability problems occurred in term of the vinylpyridine derivatization and this mode of 
derivatization had to be dismissed.  
 
On a quinine-based CSP the retardation of the cysteine-S-acetate was very strong, using CSP 1 
enantioselectivity was 1,55 and Rs was 5,03, but the retention factor for the first and the second eluting 
enantiomer were 33,14 and 51,33, respectively. When CSP 6 was applied, a low-coverage-QN-AX 
column with a selector coverage of 142 µmol/gram silica gel, enantioselectivity was 1,6 and Rs was 
4,08 and additionally the retention factors were acceptable, 6,54 and 10,58, respectively for the first and 
the second eluting antipode. Cys-S-acetate had higher retention than homocysteic acid, which had as 
second  acid  moiety  a  sulfonic  acid.  In  comparison  of  these  two  bi-acidic  AQC  derivatives,  it  was  
expected, that the stronger the acid, the stronger the retention on an anion-exchange type CSP. The pKa 
value of cysteine is 1,92 and of the sulfonic acid functionality it is1,3. The acetamide moiety has an pKa 
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value in the range of 3,12 to 4,76, according to the pka values of iodo acetate and acetic acid, 
respectively. It could be stated, that the expected behaviour was not observed instead, the bi-carboxylic 
acid derivative Cys-S-acetate had a stronger retention than homocysteic acid. 
The elution of cysteine-S-acetamide was achieved in an acceptable time scale with k2 of  3,96.  It  was 
separated with an alpha >1,5 and a resolution between 4 and 5 using either CSP 1 or CSP 2 (Figure 28).  
 
 
 
 
 
Figure 28: Chromatograms of the enantioseparations of cysteine derivatives. Cys-acetamide matched all requirements 
of good enantioselectivity and resolution within a short time. The cys-acetate derivatives had an expanded retention on 
less strong retained than the cys-S-acetate species. Method 1 was applied.  
 
4.3 Racemization of dipeptides 
A  racemization  of  an  amino  acid  could  be  conducted  via  the  formation  of  a  Schiff  base  and  the  
racemization of an acidic proton located at the N-terminal end [47]. The racemization was illustrated in 
Scheme 1. 
The procedure was established by the racemization of phenylalanine and then the racemization of 
GlyPhe and PheGly was carried out. The products were derivatized with AQC and the racemization 
progress was controlled via liquid chromatography runs on CSP 1 using method 2. For the racemates of 
PheGly, a peak pair of enantiomers was found and the contrasting test with Gly-D-Phe yielded one 
peak, namely the unchanged educt compound. The retention times of DL-PheGly were different, 
compared to the peak pair of Gly-DL-Phe (Figure 29). 
A diketopiperazine would not show retention on an anion-exchange type CSP and furthermore the AQC 
derivatization was not suitable for an amide bond. For that reason, the racemized DL-PheGly and the 
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Gly-D-Phe were analyzed using a reversed phase system, where the diketopiperazine was expected to 
show retention, whereas a zwitterionic dipeptide would be eluted very quickly. The analysis was 
performed using a RP column (Table 1). Isocratic elution with mobile phase ACN/10 mM NH4AcO 
20/80 aqueous buffer, where the buffer pH 5,0 was adjusted with acetic acid was conducted. Detection 
was carried out at 248, 280 and 360 nm with a diode array detector. The chromatograms did not show 
any peaks, which could be related to diketopiperazine species.  
The DL-PheGly racemate and the L-PheGly enantiomer were also analyzed with mass spectrometry. 
Both were derivatized with AQC and were also injected in their native form into a HPLC-RP C18-
system using a modified gradient of literature [28] (method 6). The mass analyzer was a MDS Sciex 
4000 QTrap, from Applied Biosystems, parameters were: scan range 180-550 m/z, ESI negative mode, 
maximal accumulation time of 300 ms, nebulizer 60 psi, dry gas 11 ml/min, dry temperature 350°C, 
with an auto MS2 mode for ion trap fragmentation. Signals with mass 391 m/z and 221 m/z were found 
for the AQC-derivative and the native dipeptide, respectively. The mass peak for a diketopiperazine, 
204 m/z, was not observed.  
 
The racemization of the N-terminal chiral amino acid was tested and the inversion of the dipeptide was 
not observed. The stereochemistry was solely changed for N-terminal located stereocenters containing 
an acidic proton and a C-terminal located stereocenter was not influenced by the racemization 
procedure. A diketopiperazine species was not observed, neither in an enantioselective nor in a reversed 
phase analysis using both an UV and a mass spectrometric detection. These investigations provided 
evidence, that the N-terminal racemization of dipeptides followed the reaction mechanism as illustrated 
in Scheme 1 [47] and did not lead to a formation of diketopiperazines (Figure 11), with an eventual 
inversion of the dipeptide or an inversion of the stereochemistry.  
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Figure 29: Overlay of chromatograms of AQC derivatives of Gly-DL-Phe and DL-Phe-Gly dipeptides. A QD-AX 
column was used with a hydro-organic mobile phase. The investigation was carried out using method 2.* unknown 
AQC reagent related peaks 
 
FTIR investigation was conducted. It was thought that the amide bond of dipeptide would be different 
to an amide bond of a diketopiperazine in their IR spectrum. Absorption band for an amide bond in 
solid state, for N-mono-substituted amides, was expected at 1690-1640 and 1550-1510 cm-1. Exaclty the 
same absorption bands at 1659 cm-1 and at 1515 cm-1 were found, in both, the racemized DL-PheGly 
and the untreated Gly-DL-Phe samples. A diketopiperazine formation would cause altered absorption 
bands. The finding of equal absorption bands indicated the presence of the same amide bond species in 
both mentioned samples and was a further confirmation of a successful racemization [16].  
4.4 Enantioseparations of fluorescence tagged amino acid-derivatives using 
tert-butyl carbamate modified quinine/quinidine alkaloid-type chiral 
stationary phases 
In this chapter, the evaluated data for all separations regarding N-terminal labeled amino acids are 
presented. The chromatographic parameters, such as retention factor k, enantioselectivity ĮRS and 
resolution Rs will be discussed. Mainly, the separation of AQC-tagged amino acids and peptides were 
presented. Further, another fluorescence-label for N-terminal derivatization of amino acids, namely 
fluoresceine isothiocyanate (FITC), was used for the derivatization of proteinogenic amino acids. The 
two fluorescence tags were compared, according to their enantioselectivity and separation performance. 
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4.4.1 General considerations 
Enantioseparation of racemic mixtures of amino acids, derivatized with AQC were performed via 
quinine/quinidine alkaloid-type chiral stationary phase (CSP 1 and 2). Identification of the (S/R)-
enantiomers was done by comparison of the peak areas of a racemate, which should be equal. 
Furthermore, an injection of a pure enantiomer accomplished the identification of the single enantiomer 
by comparing retention times. The combination of a quinine and quinidine based CSP reversed the 
enantiomer elution order and furnished another identification possibility for the two enantiomer peaks.  
In many cases it was found that a mobile phase, consisting of methanol with 2 % (v/v) AcOH and 0,5 % 
(w/v) NH4AcO, provided good enantioseparations for the large set of analytes with different chemical 
properties. For this reason it was chosen as standard mobile phase for investigations using quinine-
based CSPs in the polar-organic phase mode (method 1). Further standard conditions were a flow rate of 
1 ml/min and column temperature was 25 °C. Detection of analytes were performed with diode array 
detector (DAD) at the absorption maxima of the AQC-amino acid derivatives of 248 nm and with 
fluorescence detector (FLD) at an excitation maximum at 248 nm and an emission maximum of 
395 nm. It was recognized that a reduction in flow rate had led to a better resolution of the enantiomers 
or stereoisomers, but provided stronger peak broadening. Synthesis and preparation of the tert-butyl-
carbamoyl modified quinine and quinidine based CSP’s were performed according to in-house protocol 
[54]. Further column descriptions were provided in Table 2.  
Generally, due to the weak anion-exchanger character of CSP 1 and 2, analytes with an additional acid 
functional group showed higher retention times, whereas basic or neutral molecules were less retained. 
According to that, amino acids with a second acid functional group in the side chain will undergo much 
stronger retention compared to its mono acid counterpart.  
Derivatization was done according to the procedure described in chapter 3.4.1. 
4.4.2 Evaluation of the separation performance of AQC-tagged amino acids on tert-
butyl carbamate quinine/quinidine-based chiral stationary phases 
4.4.2.1 Proteinogenic amino acids 
The separation data of proteinogenic amino acids were summarized in Table 10, Table 11 and Table 12. 
The separations were done under the same conditions on CSP 1 and CSP 2 using method 1. The 
enantioselectivity values from the two columns were presented in Figure 30. Comparison of the alpha 
values from the separation of AQC tagged proteinogenic amino acids was performed for QN-AX and 
QD-AX CSPs. Alpha values, higher than 1,5, were aspired to yield good chromatographic performance 
for the enantioseparation on both columns. It was found that above the critical alpha value of 1,5, the 
QD-AX column exhibited better alpha values, compared to QN-AX. Aspartic acid and glutamic acid 
showed unsatisfactory separations on both columns. Aspartic acid was partially separated only by QD-
AX with no separation observed on QN-AX. The elution order of aspartic acid was different than to all 
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other proteinogenic amino acids, expect proline. Using a QN-AX column the L-enantiomer of aspartic 
acid eluted firstly. Other Ȗ-carboxylic acid amino acids, like homocysteic acid exhibited also a reversed 
elution order. Cysteic acid, which had a beta carboxylic acid moiety and glutamic acid, with their acid 
functionality on the į-position, did not exhibit such an effect concerning a changed elution order. It is 
known, that a second acid functionality led to a reduced enantiodiscrimination due to more SA-SO 
complexes could be formed. Concerning aspartic acid, two nearly equal carboxylic acid moieties will 
interact with the selector and the overall enantiodiscrimination was diminished. Homocysteic acid had 
one sulfonic acid moiety and therefore the SO-SA complexes differed in their nature. Enantioselectivity 
was 1,6 and resolution 5,06 for homocysteic acid. A second acid functionality at the Ȗ-position led to a 
diminished enantiodiscrimination, but the effect depended on the acidity of the additional acid moiety. 
 
For some amino acids, such as threonine, asparagine and tryptophane, the QN-AX exhibited higher 
alpha values than QD-AX.  
 
 
Figure 30: Alpha values of the separation of proteinogenic amino acids derivatized with AQC 
 
Figure 31 showed the resolution values of the separation of proteinogenic amino acid derivatized with 
AQC. Predominately, the QD-AX CSP exhibited better resolution values and higher plate numbers. 
Exceptions were threonine, asparagine, tyrosine and tryptophane. However, for threonine, asparagine, 
tyrosine and tryptophane, the resolution was significantly higher on the QN-AX than on the QD-AX 
column.  
The measurements with the QD-AX CSP was done on an Agilent 1100 Series HPLC with a multi 
wavelength detector and the QN-AX separations on an Agilent 1200 Series HPLC with DAD and FLD. 
Table 3 illustrated the investigation, concerning the significant different resolution values and plate 
numbers, which were obtained for the separation on QD/QN-AX. Three analytes were injected on an 
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Agilent 1200 Series HPLC using the same chromatographic parameters, except the columns. Once the 
QD-AX was used and afterwards the QN-AX. Generally, QN-AX exhibited a lower performance than 
QD-AX. The application of two different HPLC systems did not affect the resolution or the plate 
numbers. The difference had to be based on the applied columns. The procedure for selector synthesis, 
immobilization and column packing were well established [66], [51]. The column packing process 
might be less prone for errors.  
 
Table 3: Investigation of resolution and plate numbers for QN- and QD-AX column. Three amino acids were 
derivatized with AQC and injected on an Agilent 1200 Series HPLC. The mobile phase was MeOH/AcOH/NH4AcO 
98/2/0,5 % (v/v/w). 
 DL-Ser DL-Pro DL-Ile 
 QN-AX QD-AX QN-AX QD-AX QN-AX QD-AX 
Rs 5.73 6.41 2.77 6.69 7.88 9.95 
N1 2639 4039 2802 4217 2409 3496 
N2 2910 4372 2960 4316 2924 4296 
 
 
 
Figure 31: Resolution of the separation of proteinogenic amino acids derivatized with AQC 
 
4.4.2.2 Comparison of polar-organic and hydro-organic mobile phase for the separation of AQC-
amino acid derivatives 
A comparison of separation performance for two common mobile phase compositions, namely polar-
organic and the hydro-organic was established for QN-AX CSP. The result for the enantioseparation of 
a set of proteinogenic amino acids, derivatized with AQC and separated with a hydro-organic mobile 
phase were summarized in Table 13 and the result for polar-organic mode were listed in Table 10. 
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Figure 32: Comparison of chromatographic parameters of AQC-amino acid derivatives with two different mobile phase 
compositions. The hydro-organic mobile phase, MeOH/H2O 80/20 containing 20 mM NH4AcO and pHa was set to 6,0, 
was applied.  
 
As shown in Figure 32, the k2, alpha and resolution values were plotted. Obviously, the retention of the 
derivatives was much shorter when the polar-organic phase mode was applied, because different buffer 
types and buffer salt concentrations were used. The polar organic buffer consisted of 350 mM acetic 
acid and 65 mM of the corresponding base (method 1), whereas the hydro-organic mobile phase used 
20 mM NH4AcO with pHa 6,00, adjusted with acetic acid (method 2). The enantioselectivity was 
approximately same for both mobile phase compositions, with moderately better alpha values for the 
hydro-organic mode. However, Phe, Tyr and Trp were not enantioseparated with the hydro-organic 
mobile phase. The resolution was stronger influenced by the hydro-organic mobile phase and was in all 
observed cases better than observed for the polar-organic mode. For example, Pro had an alpha of 1,35, 
if polar-organic mobile phase was used, but with hydro-organic mobile phase alpha was raised up to 
1,94. On the other side, the retention was increased with the hydro-organic mobile phase (Figure 33). 
This negative effect was illustrated in Figure 34 for the valine derivative. The separation performance of 
valine enantiomers was sufficient in polar organic mode, allowing enantioseparations within ten 
minutes. In comparison, the hydro-organic mobile phase exhibited rather same enantioselectivity and an 
unnecessarily high resolution. The run time was 23 minutes, compared with seven minutes for the polar 
organic mode. It was found that in general an optimized mobile phase depended on the side chain of 
amino acids, which account mainly for the chromatographic behavior of their AQC derivatives. Further, 
the hydro-organic mobile phase could be applied using a higher buffer concentration to yield shorter 
retention times.  
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Figure 33: Comparison of chromatograms of AQC-Pro derivatives. First chromatogram shows the separation using 
method 1. The second chromatogram shows the separation applying method 2. 
 
 
 
 
Figure 34: Comparison of chromatograms of AQC-Val derivatives. First chromatogram shows the separation using 
method 1. The second chromatogram shows the separation applying method 2. 
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4.4.3 Separation of AQC derivatives for non-proteinogenic amino acids 
It was decided to investigate the separation performance of an extended set of amino acids, derivatized 
with the AQC-tag.  
4.4.3.1 Stereoisomers of 4-Hydroxyproline  
4-Hydroxyproline could exist as four stereoisomers. The most common stereoisomer in biological 
tissues is the 2S, 4R-trans-4-L-hydroxyproline. Hydroxyproline is often found in collagen, as an 
important structure element. This amino acid is generated during a posttranslational modification of the 
genetically coded proline.  
In comparison, the two columns (CSP 1 and CSP 2) exhibited the same low performance for the 
hydroxyproline derivatives, when standard conditions were applied (Table 4). It was found that the 
separation of all four stereoisomers was much better if the flow rate was reduced from 1 ml/min, which 
is a standard value, to 0,4 ml/min. The retention factor and enantioselectivity values were not influenced 
by reducing the flow rate, but the resolution was increased (Figure 36). It should be mentioned that the 
elution order of proline and hydroxyproline was changed. From the enantioseparation of AQC-tagged 
proteinogenic amino acids on QD-AX it was known that the L-enantiomers eluted first, except for 
proline and aspartic acid. The latter was only partially separated and exhibited extraordinary long 
retention times. D-Proline was the first eluting enantiomer, when QD-AX column was used. For this 
secondary amino acid, it was thought that the construction of the urea derivative had an influence on the 
interaction of the selector with the amino acid derivative. For 4-hydroxyproline it was found that the 
elution order was reversed as well.  
 
N
H
N O
N COOH N
H
N O
N COOH
HO
AQC-proline derivative AQC-4-hydroxyproline derivative  
Figure 35: Structure of secondary amino acids, proline and 4-hydroxyproline, derivatized with AQC 
 
Figure 35 shows the structure of the AQC derivatives of secondary amino acids. As illustrated the urea 
derivative led to a tertiary amine functionality. In contrast to primary amino acids, the AQC derivatives 
of secondary amino acids might not interact with the selector using a hydrogen bonding of the 
carbamate and the alpha amine moieties of the amino acid. The urea linkage bridge exhibited a second 
amine, which might be capable for hydrogen bonding. Especially for secondary amino acids, the 
characteristic of the urea linkage bridge come into account for the formation of the SO-SA complex. A 
hydrogen bonding was a requirement of the multiple point interaction of a chiral molecule with the 
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quinine selector [53]. It was thought that the different participating moieties of the AQC derivatives of 
secondary or primary amino acid accounted for the reversed elution order.  
 
Table 4: Separation data for four stereoisomers of hydroxyproline, derivatized with AQC-tag and separated on 
QN/QD-AX column applying method 1.  
Analytes  to t1 t2 k1 k2 alpha Rs e.o. 
trans-4-D or trans-4-L- 
Hydroxyproline (2R,  4S and 
2S, 4R) 
QN-
AX 1.40 4.03 4.59 1.88 2.28 1.21 0.94 L 
cis-4-D or cis-4-L- 
Hydroxyproline (2R, 4R allo 
and 2S,  4S) 
QN-
AX 1.40 4.45 5.10 2.18 2.64 1.21 1.10 L 
trans-4-D or trans-4-L- 
Hydroxyproline (2R,  4S und 
2S, 4R) 
QD-
AX 1.50 4.37 5.78 1.91 2.85 1.49 2.34 D 
cis-4-D or cis-4-L- 
Hydroxyproline (2R, 4R allo 
and 2S, 4S) 
QD-
AX 1.50 5.20 6.30 2.47 3.20 1.30 1.59 D 
 
 
 
Figure 36: Comparison of separation performance of two pairs of 4-hydroxyproline enantiomers on QN/QD-AX 
applying two different flow rates, standard mobile phase condition with flow rate 1 ml/min and reduced flow rate 
0,4 ml/min** 
 
All four stereoisomers were well separated on both columns, CSP 1 and CSP 2, by applying the 
standard polar-organic, as well as the hydro-organic mobile phase composition (Table 17). In direct 
comparison, the latter provided slightly better performance according to enantioselectivity and 
resolution. Two hydro-organic mobile phases were applied and varied in their buffer concentration. The 
chromatographic parameters were the same, except that for one method a flow rate of 0,5 ml/min were 
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used. Better enantioselectivity and resolution was obtained for the hydro-organic mobile phase with 
higher buffer concentration of 200 mM NH4AcO. When applying the flow rate of 0,5 ml/min, the best 
separation  performance  was  achieved  for  the  four  stereoisomers.  It  could  be  stated  that  for  the  
separation of 4-hydroxyproline stereoisomers the optimal mobile phase composition was MeOH/H2O 
80/20, 200 mM NH4AcO pHa 6,0 and a flow rate of 0,5 ml/min.  
4.4.3.2 Stereoisomers of Threonine 
For the amino acid threonine, in total eight stereoisomers can be found, D/L-threonine, D/L-allo-
threonine, DL-isoserine and D/L-homoserine. Threonine contains two stereogenic carbon atoms, L-Thr 
has 2S, 3R, D-Thr 2R, 3S, and the D/L-allo-Thr species have 2S, 3S, and 2R, 3R configuration, 
respectively. Homoserine can often be found in drugs as a mimetic compound to threonine. It is also 
produced during the enzymatic digestion of L-methionine. Homoserine has also been used for several 
syntheses of amino acid related compounds. Isoserine has been added to the set, because it can be used 
for the same purposes as homoserine. Isoserine is a precursor compound in organic synthesis, known as 
a bioactive substance important for the proliferation of yeast and plants [6].  
The results for the separation of each of the single racemic mixture could be seen in Table 5. Obviously, 
under standard conditions, all eight stereoisomers were not separated neatly. The L-enantiomers of 
threonine and homoserine were expected to coelute and L-isoserine eluted very close to them. The 
resolution was better for the QD-AX column. It should be mentioned, that the four stereoisomers of DL-
threonine and DL-allo-threonine were separated using method 1 (Figure 38). The elution order was L-
Thr<L-allo-Thr<D-allo-Thr<D-Thr and the enantioselectivity values were1,21; 1,78 and 1,27, 
respectively to the 2nd/1st, 3 rd/2nd and 4th/3rd pair of stereoisomers. Resolution values were 1,34; 4,13 and 
2,52 for the same order as mentioned before.  
Isoserine had the highest retention factors in this series of related compounds (Table 5). This amino acid 
had a ?-hydroxy functionality, which means that a –I-effect might acidify the carboxylic acid moiety. 
The stronger the acid functionality is, the stronger the ion-exchange interaction and therefore the 
stronger the SO-SA complex. The retention was generally higher but also the enantiodiscrimination for 
the two enantiomers was therefore raised. The structure of isoserine is illustrated in Figure 16 and 
provided an explanation for the better enantioseparation performance of this amino acid compared to 
the other structure analogues.  
Isoserine was excluded for the investigation of the separation of threonine analogues, because only the 
racemate was available and therefore the peak identification was impossible in a mixture of eight 
compounds.  For  this  reason  a  mixture  of  all  six  remaining  enantiomers  was  separated  with  a  slower  
flow rate of 0,4 ml/min. Chromatographic parameters were listed in Table 6. Again, the L-enantiomers 
of homoserine and threonine coeluted. All other enantiomers were separated with an alpha >1,5 and 
resolution in the range of 3,94 and 8,98. Figure 37 showed a chromatogram of this separation study. 
Under the applied conditions, the L-antipodes of homoserine and threonine coeluted.  
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Table 5: Stereoisomers of threonine and their separations parameters of each single racemic mixture using method 1 
for both QN/QD-AX.  
 QN-AX QD-AX 
Analytes t1 t2 k1 k2 alpha Rs t1 t2 k1 k2 alpha Rs 
DL-Thr 3.95 8.19 1.82 4.85 2.66 8.88 3.99 7.26 1.66 3.84 2.31 8.89 
DL-allo-Thr 4.40 6.74 2.14 3.81 1.78 5.33 4.30 6.64 1.87 3.43 1.84 6.58 
DL-Isoser 8.17 15.10 4.84 9.79 2.02 5.82 3.99 7.26 1.66 3.84 2.31 8.89 
DL-Homoser 4.00 5.52 2.14 2.94 1.37 3.94 4.30 6.64 1.87 3.43 1.84 6.58 
 
 
Table 6: Chromatographic parameters for a mixture of homoserine, threonine and allo-threonine are presented. QD-
AX column applied under method 1.  
Analyte to k1-3 k4-6 
?3/1,2 
?4/3 
?5/4 
?6/5 
Rs 1,2/3  
Rs 3/4 
Rs 4/5 
Rs 5/6 
N 1-3 N 4-5 e.o. 
DL-Homoser 3.54 1.81 2.85 1.13 1.30 1.61 4.24 5990 7801 L-Hser=L-
Thr<L-allo-
Thr<D-
Hser<D-allo-
Thr<D-Thr 
DL-Thr 3.54 1.81 4.09 1.39 1.11 5.20 1.81 \ 7855 
DL-allo-Thr 3.54 2.04 3.70 \ \ \ \ 6820 7612 
 
 
 
 
Figure 37: Chromatogram of an injection of a mixture of all six enantiomers of threonine analogues using a QD-AX 
column and method 2.  
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Figure 38: Separation of a mix of DL-threonine and DL-allo-threonine using a QN-AX column and method 1.  
 
4.4.3.3 Phenylalanine/Proline-Glycine-Dipeptides 
The enantioseparation and detection of chiral peptides were known as a challenging field in 
enantioseparation science. Several small peptides exhibited biological activity and especially in 
synthesis small peptides were common precursor compounds. On this account, the separation of 
dipeptides with a suitable sensitive detection was useful in this field of chemistry. Glycine moieties 
were often introduced during a derivatization as linkage groups [76-78]. Dipeptides, containing one 
glycine moiety, were optically active. It was known that the introduction of a glycine often hindered an 
otherwise easily achievable enantioseparation [43, 45].  
For the investigation of the separation performance of specific dipeptides, derivatized with AQC, a 
study was conducted using CSP 1 and 2 and two different mobile phases were tested. The Gly-Phe 
species was always worse separated than the Phe-Gly species and QD-AX exhibited better separation 
performance than QN-AX. Resolution was increased by decreasing the flow rate. For example Gly-DL-
Pro had a Rs of 0,74, 1,07 and 2,05 at a flow rate of 1,0; 0,4 and 0,25 ml/min, respectively (Table 7). It 
should be mentioned that the achieved separation performance was not supreme (method 1), but beat 
most of the published data, mentioned in the references above. Especially, the Gly-Pro species was 
often excluded of such investigations, because bad separation was expected. The present study used 
another mobile phase composition in hydro-organic mode with a different acid to base ratio (method 2). 
This mobile phase composition was known to yield good separation, especially for di- and higher 
peptides [43, 45]. The relatively low resolution of Gly-DL-Pro (Table 7) was possibly caused by the 
formation of rotamers. Rotamers were converted into each other by simple rotation of C-C bonds. It was 
known that glycine containing peptides were predestinated for rotames, because the peptide back bone 
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became more volatile. Rotamers also produced broader peaks in a chromatogram, because many 
different conformational intermediate states were possible. The formation of rotamers would provide an 
explanation of the reduced enantioselectivity and decreased resolution of glycine containing dipeptides.  
As listed in Table 8, in most cases the resolution was increased with hydro-organic (method 2 or 
method 3), compared to the polar-organic mobile phase using method 1. The alpha values were worse 
for DL-Phe-Gly, but became better for Gly-DL-Phe. For Gly-DL-Pro, the hydro-organic mobile phase 
seemed to be the better choice, according to the mobile phase. Comparing the data of Gly-Gly-DL-Pro 
and Gly-DL-Pro, it was obvious that the introduction of another glycine moiety strongly hindered an 
enantioseparation. A different picture was observed when comparing the Ala-Gly peptides. Gly-DL-Ala 
and DL-Ala-Gly had rather the same k-values, but quiet different alpha and resolution values. Another 
glycine moiety on the N-terminal or the C-terminal end, respectively, resulted in reduced separation of 
the enantiomers (Table 8).  
 
Table 7: Chromatographic parameters for the separation of AQC derivatized Phe/Pro-Glycine dipeptides using CSP 1 
and 2 and method 1. 
QN-AX polar-organic mode  QD-AX polar-organic mode   
Analyte k1 k2 alpha Rs Analyte k1 k2 alpha Rs 
Gly-DL-Phe 2.91 3.44 1.18 1.60 Gly-DL-Phe 1.36 2.06 1.51 2.26 
Gly-DL-Pro 2.17 2.68 1.23 0.74 Gly-DL-Pro** 2.54 3.62 1.42 2.05 
Gly-DL-Pro * 2.24 2.64 1.18 1.07 DL-Phe-Gly 2.19 3.35 1.53 4.44 
DL-Phe-Gly 1.95 3.18 1.63 4.26 
     
*flow rate 0.4 ml/min   
**flow rate 0.25 ml/min   
polar-organic mobile phase: MeOH/AcOH/NH4AcO 98/2/0,5 % (v/v/w) 
 
Table 8: Separation parameters of special dipeptides, derivatized with AQC and separated on a QD-AX column using 
method 2. 
Analytes k1 k2 alpha Rs 
Gly-DL-Phe 8.99 13.56 1.51 6.26 
DL-Phe-Gly 10.83 12.53 1.16 2.32 
Gly-DL-Pro 6.66 8.63 1.30 1.17 
Gly-Gly-DL-Pro* 5.60 5.70 1.02 0.32 
Gly-DL-Ala 6.31 7.07 1.12 1.68 
DL-Ala-Gly 5.71 7.55 1.32 4.11 
DL-Ala-Gly-Gly 4.67 4.67 1.00 \ 
Gly-Gly-DL-Ala 4.29 4.73 1.10 1.12 
* flow rate 0.4 ml/min     
hydro organic mobile phase: MeOH/H2O 80/20, 20 mM NH4AcO adjusted to pHa 6.00 with acetic acid 
RESULTS AND DISCUSSION 
75 
4.4.3.4 Stereoisomers of Isoleucine 
Isoleucine contained two stereogenic carbon atoms and therefore four stereoisomers. An 
enantioseparation was easy to perform for each of the racemic mixtures, D/L-Ile and the D/L-allo-Ile. A 
mixture of all four stereoisomers could not be separated when using method 1 or method 2. It should be 
mentioned  that  the  QN-AX phase  was  able  to  separate  at  least  the  L-enantiomers,  whereas  with  QD-
AX, both, the D- and L-enantiomers coeluted (Figure 39). The separation data were summarized in 
Table 15 and Table 16. 
 
 
Figure 39: Chromatogram of four stereoisomers of isoleucine, separated on QN-AX (blue) and QD-AX (red) using  
method 1. * reagent related peak 
 
For further investigation, the other type of mobile phase, the hydro-organic ones, with varied buffer 
concentration were tested (Table 17). Summarizing, a separation protocol for all four stereoisomers of 
isoleucine could not be established using tert-butyl carbamate modified quinine/quinidine chiral 
stationary phases. Three types of mobile phase and various chromatographic parameters were tested. 
The enantiodiscrimination of the first two eluting enantiomers was too small for proper peak separation. 
The later eluting enantiomers were partially separated on QN-AX column and were not separated on 
QD-AX column. 
4.4.3.5 Other investigated enantioseparations of AQC-tagged amino acids and general aspects of 
the investigation 
The separation parameters for all investigated amino acids, except the proteinogenic ones, were 
collected in Table 16 and Table 17. Concerning the elution order, normally, the D-enantiomer eluted 
first when a tert-butyl carbamate modified quinine-based CSP was applied. For secondary amino acids, 
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such as proline, 4-hydroxyproline but also for beta-phenylalanine, the AQC derivatization led to a 
reversed elution order. Amino acids containing a Ȗ-carboxylic acid moiety, exhibited also a reversed 
elution order.  
Due to the weak anion-exchanger type of QN/QD-AX columns, amino acids with a second acid moiety 
were much stronger retained than the mono acidic amino acids. Some bi-acidic analytes were tested, for 
example cysteic acid, methioninsulfone, some phosphor amino acids, such as phospholeucine and 
cysteine-S-acetic acid. As a rule of thumb, the higher the acidity of the second acid moiety the stronger 
might be the overall retention of both enantiomers. The enantiodiscrimination was also enhanced, due to 
a stronger SO-SA complex formation, expect of aspartic acid. A good enantioseparation of acids could 
often be achieved, when a so called “low coverage” column (CSP 6) with less immobilized selector, 
was applied. The separations on a low coverage column provided no significant loss in 
enantioselectivity or resolution, but were established in shorter run times.  
The amino acid cysteine often exists as the dimer, cystine, especially in biological context. Cystine was 
double derivatized with AQC and because of strong ??-interactions with the selector, the elution time 
was also high. Cystine provided three stereoisomers with DD/LL-cystine as enantiomers and the DL-
cystine as a meso-species. The ratios of the peaks were expected to be 1:2:1.  
No quenching effect [30] was observed in a polar-organic mobile phase, but was observed when a 
reversed phase run in hydro/acetonitrile was performed. Two common derivatization strategies for the 
thiol group of cysteine, with iodo acetamide and iodo acetic acid were conducted and their 
enantioseparation performance was investigated. It was observed that the acetamide modification 
offered a much better chromatographic behavior on a WAX-type CSP than the acetic acid derivative, 
because the latter was extraordinarily strong retained. Nevertheless, both analytes were separated with 
comparable performance.  
Phenylalanine analogues, such as 3,4-dihydroxy-DL-phenylalanine and several bromo,- chloro- or fluoro-
derivatives were successfully derivatized with AQC. The chromatographic parameters were illustrated 
in Figure 40. It was found that the two beta-Phe species had the highest enantioselectivity and the best 
resolution in this series of analytes. Especially, beta-DL-Phe had the lowest retention, but exhibited the 
best enantioseparation. The enhanced retention of the halogen species could be related to a higher ?-
acidity of the phenyl ring. It was known that a ?-acid exhibited stronger retention on a quinine-based 
CSP, according to a ?-acid and ?-base interaction with the selector [54].  
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Figure 40: Phenylalanine analogous and their chromatographic parameters 
 
Aminophosphonic acids were also successfully derivatized with AQC and enantioseparations were 
performed. The derivatization strategy was not suitable for secondary amino acids, such as pipecolinic 
acid, nipecotinic acid and 3-carboxy pyridinic acid. N-Methyl leucine could be derivatized with AQC, 
but an enantiodiscrimination was not capable using a quinine-based CSP. The reason for this 
miscarriage was not further investigated.  
4.5 Separation of AQC-labeled oligopeptides via tert-butyl carbamate 
modified quinine/quinidine based chiral stationary phases 
4.5.1 Separation of alanine peptides 
The collected separation data for the enantioseparation of AQC-tagged alanine peptides were 
summarized in Table 18, Table 19, Table 20 and Table 21. The investigation of alanine peptides, 
namely all-D and all-L enantiomers up to the heptamer, was expected to provide a deeper insight into 
the chiral reorganization mechanism of the SA-SO interaction. Furthermore, the derivatization with 
AQC, with an urea linkage, might expand previous investigations for alanine peptides on a quinine-
based  WAX-type  CSP  [43,  45,  46].  Different  types  of  protection  groups  were  applied  in  the  before  
mentioned studies. Separation of alanine peptides, tri- and tetrapeptides and their stereoisomers as well 
as di- and tripeptides containing one or more glycine moieties were investigated. The collected 
separation data for the AQC-tagged alanine peptides was provided in Table 18 and Table 20. The polar-
organic mobile phase was not found to be suitable for the separation of alanine peptides. Previous 
studies had achieved better results with hydro-organic mobile phase, consisting of MeOH/H2O 80/20 
with 20 mM NH4AcO pHa 6,00 (method 2). 
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As a trend in the change in retention, enantioselectivity and resolution of the stereochemically pure 
peptide series from alanine up to its heptamer, it was found that the enantioselectivity was negligibly 
influenced by the growing peptide chain. Alanine and DD/LL-alanine showed an alpha >1,5, but 
beginning with the tripeptides and up to the heptamer, the alpha value was slightly lower than 1,3. 
Resolution and retention showed a different behavior, both were decreased with increasing peptide 
chain length (Figure 41). Note that retention and resolution was again quiet equal for the tripeptide up to 
the hexamer.  
 
 
Figure 41: Comparison of separation parameters of an enantiomerically pure alanine peptide series using method 2. * 
flow rate was decreased to 0,4 ml/min 
 
All sixteen stereoisomers of alanine tripeptides were derivatized with AQC and their chromatographic 
behavior was explored by applying two different flow rates of 1 ml/min and 0,4 ml/min (Figure 42). 
The  results  provided  a  mixed  picture.  The  retention,  expressed  as  k2 value of the later eluting 
enantiomer, was quiet the same for all tripeptides. A low enantioselectivity <1,5, with low variation was 
found for the whole peptide series. The resolution underwent significant changes, because some 
enantiomer  pairs  were  not  separated  at  all.  For  the  LDL/DLD-  and  the  LLD/DDL-Ala3 pairs,  the  Rs  
values were enhanced when the flow rate was decreased. The LDD/DLL-Ala3 pair showed the reversed 
behavior and the Rs value was decreased when the flow rate was reduced. 
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Figure 42: Stereoisomers of alanine tripeptides and their separation parameters 
 
The investigation of Ala/Gly peptides served to provide a better insight regarding the influence of a 
non-stereogenic glycine moiety into close proximity of the stereogenic center. As illustrated in Figure 
43, the performance of alanine and DD/LL-alanine was almost the same. The stereoisomers of the 
dipeptides, DL/LD-Ala2 showed slightly lower values. All four stereoisomers could be separated if QD-
AX column was applied, which produced better separations than QN-AX. QD-AX exhibited an elution 
order of DD<LD<DL<LL, in contrast the QN-AX had the elution order of DD<LD<LL<DL. A change 
in the elution order, by varying the N-protection group or by applying different mobile phase 
compositions were reported in literature [79]. Based on the “pseudo-enantiomeric” character of 
QN/QD-AX and keeping all other parameters constant, it could actually be expected that the elution 
order should be reversed. In case of the AQC-tagged alanine dipeptides, the elution order on QN/QD-
AX was a surprising phenomenon.  
Generally, for glycine/alanine peptides the resolution and enantioselectivity were decreased, especially 
when glycine was N-terminally located, compared to the alanine peptides. The tripeptides with two 
glycine moieties were hardly ever separated and exhibited reduced retention, compared to the alanine 
peptides. It did not matter, whether the two glycines were located on the N- or C- terminal end. The 
results for glycine up to the tripeptide, pointed out that the retention time decreased with increasing 
length of the peptide chain. The AlaGlyGly/GlyGlyAla tripeptides had nearly the same retention time as 
the GlyGlyGly species.  The retention time was the same as  observed for  the DDD/LLL-peptides,  but  
chiral recognition was totally diminished. The slightly higher retention of alanine and alanine 
dipeptides, compared to glycine and glycine dipeptides, could be explained with an additional 
hydrophobic retention increment, based on the alanine side chain. The additional interaction had led to a 
higher molecular interaction of alanine with the SO, compared to glycine. 
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Figure 43: Comparison of chromatographic parameters of Ala/Gly peptides measured on a QD-AX column applying 
method 2.** flow rate was 0,4 ml/min 
 
4.5.2  Separation of phenylalanine peptides 
The separation of phenylalanine peptides, N-derivatized with the AQC tag, was investigated on 
QN/QD-AX columns. The hydrophobic character of the phenylalanine peptides led to their reduced 
solubility in a certain solvent mixture. Generally, a small amount of peptide was dissolved in a mixture 
of acetonitrile/water 40/60, better solubility were achieved with an solution containing 10 % (v/v) 
acetonitrile in 20 mM aqueous borate buffer, with pH 9,8 adjusted with 15 % (w/v) natrium hydroxide 
solution. The derivatization was carried out as described in chapter 3.4.1. It should be mentioned that 
the phenylalanine derivatives seemed less soluble in the derivatization mixture than alanine peptides or 
amino acids. A precipitate was often noticeable soon after derivatization of the phenylalanine peptides. 
For the enantioseparation of phenylalanine peptides, it was expected that retention times should be 
increased relatively to the alanine peptides. On that account, a suitable mobile phase composition and 
optimized chromatographic parameters had to be obtained in order to yield the aspired chiral separation 
of these peptides. The measurements were performed in a hydro-organic mobile phase using method 3. 
It was found that the buffer concentration had to be ten times higher to reach acceptable retention times, 
compared to the mobile phase, which was used for the alanine peptide separation. The adjustment of the 
flow rate was an important parameter, because at 1 ml/min nearly no enantioseparation was observed. 
Therefore, it was decided to keep the flow rate constant at 0,5 ml/min for all phenylalanine 
investigations.  
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Table 22, Table 23, Table 24 and Table 25 represented the calculated separation data for the separation 
of AQC-tagged phenylalanine peptides. The series of all-D/all-L phenylalanine peptides from the amino 
acid up to the pentamer was derivatized and the chromatographic parameters were illustrated in Figure 
44. The retention time, expressed as k2 value, was increased with growing peptide chain length on a 
QD-AX CSP. This effect was more distinct on QD than on QN and stood in high contrast to the results 
obtained for the alanine peptides, where retention was decreased with growing chain length. 
Enantioselectivity was better on QD and the variation range was 2, 00 to 2, 24. For the QN, alpha was 
generally lower and varied from 1,41 to 1,91. Enantioselectivity of phenylalanine peptides were better 
than for alanine peptides, for which the range of enantioselectivity was between 1,29 and 1,59. On both 
columns the resolution exhibited a trend towards lower values when the chain length was increased.  
 
 
Figure 44: Comparison of chromatographic parameters of the phenylalanine peptide chain series derivatized with 
AQC. Separation was done with a QD-AX column using method 3. 
 
The separation study for the phenylalanine tripeptides produced a mixed picture (Table 9). The elution 
order of these peptides was influenced by stereochemistry of the C-terminal moiety. For the observed 
QD-AX column, the first eluting enantiomer had in all cases a L-phenylalanine at the C-terminus. The 
enantioseparation decreased in the series of DDD/LLL>DLL/LLD>DLD/LDL>DDL/LDD. The 
DDL/LLD-Phe pair were be separated, for the DLD/LDL-Phe pair a partial separation was observed, 
and the DLL/LDD-Phe pair was fully enantioseparated with an alpha of 1,73. The mixed tripeptides had 
lower retention times and their resolution was decreased or diminished compared to the 
stereochemically pure DDD/LLL-tripeptide.  
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Table 9: Comparison of chromatographic parameters of AQC-tagged tripeptides of phenylalanine. They were 
separated on a QD-AX column using method 3. 
Analytes 
 
to t1 t2 k1 k2 alpha Rs N1 N2 e.o. 
DDD/LLL-Phe3 
Q
D
-A
X
 
3.10 12.13 21.33 2.91 5.88 2.02 8.79 4222 4020 LLL 
DLL/LDD-Phe3 3.10 12.77 19.91 3.12 5.42 1.74 6.94 4002 4074 DLL 
DDL/LLD-Phe3 3.10 12.66 12.66 3.08 3.08 1.00 \ 3445 3445 n.a. 
DLD/LDL-Phe3 3.10 11.23 12.60 2.62 3.06 1.17 1.87 4294 4142 LDL 
DDD/LLL-Phe3 
Q
N
-A
X
 
2.80 10.10 14.26 2.61 4.09 1.57 4.30 2538 2561 DDD 
DLL/LDD-Phe3 2.80 10.51 13.34 2.75 3.76 1.37 3.18 2887 2899 DLL 
DDL/LLD-Phe3 2.80 10.21 10.21 2.65 2.65 1.00 \ 2645 2945 n.a. 
DLD/LDL-Phe3 2.80 9.25 10.19 2.30 2.64 1.15 1.31 2947 2933 DLD 
n.a. not applicable           
 
The series of phenylalanine tetrapeptides showed a more plausible result. In Figure 45, the 
chromatographic parameters were juxtaposed. The enantioselectivity and resolution values were best for 
the all-D/all-L enantiomers and the retention was also the highest, followed by the DDLL/LLDD and 
the DLLL/LDDD-species, which exhibited nearly the same chromatographic behavior. The 
DLDD/LDLL-pair was only slightly worse separated and could be positioned in the before mentioned 
group of well separated phenylalanine tetrapeptides. This group fulfilled the same criteria, namely at 
least two stereochemically equivalent phenylalanines at the C-terminus. If this criteria was not matched, 
as for the DDDL/LLLD,- DDLD/LLDL,- DLLD/LDDL,- and DLDL/LDLD-pairs, enantioselectivity as 
well as resolution was almost diminished. The same behavior was obtained applying the QN-AX CSP. 
This effect was observed due to a generally better enantioselectivity for the phenylalanine peptides 
compared to the alanine peptides. Additionally, the phenylalanine peptides were available in all forms 
of diastereomers, which completed the set of obtainable data. The same effect was also observed by 
studying the tripeptides series of phenylalanines (Table 9), but in a less clarified way. These results 
explained bad enantioseparation performance of phenylalanine dipeptides stereoisomers on QD-AX. No 
separation  could  be  achieved  on  QN-AX.  The  DL/LD-pair  was  in  both  cases  inadequately  separated  
(Table 25 and Table 23).  
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Figure 45: Chromatographic parameters compared of a series of phenylalanine tetrapeptides derivatized with AQC 
and separated with QD-AX 
 
4.6 Evaluation of the separation performance of FITC-tagged amino acids 
on tert-butyl carbamate modified quinine/quinidine-based chiral 
separation columns 
4.6.1 Optimization study for the enantioseparation of FTIC-labeled amino acids 
The fluoresceine-label was frequently used to tag proteins, peptides and amino acids in biochemical 
assays, involving biological matrices, cells and cell compartments. Enantioseparations of racemic 
mixtures of amino acids, derivatized with FITC, were performed in this investigation and 
quinine/quinidine alkaloid-type chiral stationary phases were used (CSP 1 and 2). Identification of the 
(S/R)-enantiomer was performed by comparison of the peak areas of a racemic mixture, which were 
expected to be equal. Furthermore, the injection of a pure enantiomer allowed the identification of 
single enantiomers by comparison of the retention times. The reversal of the elution order on quinine 
and quinidine based CSPs provided a further identification possibility for the enantiomer peaks. Several 
mobile phase mixtures were tested to find optimized separation conditions. The obtained resolution, Į 
and k2 values were juxtaposed in Table 27 and Table 28. 
First investigations aimed to find appropriate separation conditions, especially a suitable mobile phase 
providing acceptable run times and enantioselectivity. As shown in Figure 9, a successful 
enantioseparation of FITC-derivatives would challenge with two requirements. The fluoresceine label 
was a quiet huge molecule with a strong apolar and aromatic nature. Compared with the proteinogenic 
amino acids, the label would prevail the chemical properties of the whole derivative. The label has also 
a carboxylic function group and according to the enantioseparation on a WAX-type CSP, a strong 
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retention was expected. Method 1, used for the enantioseparations of AQC labels amino acids, did not 
match good chromatographic behavior, because of extra-ordinary extended retention times on a “normal 
loaded” quinine-based CSP (CSP 1). Hereby, normal loaded meant a coverage of >380 µmol selector 
per gram of silica gel. For the investigation of an adequate mobile phase, a so-called “low coverage” 
QN-AX column (CSP 6)  was used,  which had a  loading of  142 µmol per  gram silica gel.  It  was well  
known that a lower coverage of selector would lead to reduced retention times, but need not lead to 
lower enantioselectivity or resolution. The following mobile phase compositions were tested to find an 
optimized separation conditions, such as, retention time, enantioselectivity and resolution of the FITC-
derivatives. The overlapping of analytes peaks with reagent related peaks was an important factor 
during the optimization process.  
 
? a) MeOH 2 % (v/v) AcOH, 0,5 % (w/v) NH4AcO 
? b) MeOH 100 mM FA, 50 mM NH4AcO 
? c) MeOH/ACN 80/20, 100 mM FA, 50 mM NH4AcO 
? d) MeOH/ACN 70/30, 200 mM FA, 100 mM NH4AcO 
? e) MeOH/ACN 80/20, 150 mM FA, 75 mM NH4AcO 
 
The optimized mobile phase conditions for investigation of all FITC-AA derivatives on 
quinine/quinidine-base CSP 1 and 2 were MeOH/ACN 80/20, 150 mM FA, 75 mM NH4AcO. In 
average, the chromatographic performance was regarded best for this mobile phase composition. Other 
parameters were applied according method 6. 
 
Comparison of retention, expressed as k2-value from the later eluting enantiomers is illustrated in Figure 
46.  For  the  mobile  phase  composition  a)  to  c)  a  low coverage  QN-AX column was  used.  The  lower  
coverage of about 142 µmol/g selector, influenced the enantioselectivity to a minor degree, but the 
retention was reduced compared to CSPs of “normal” loadings. For the standard mobile phase a), 
retention was the highest. The change of the buffer type, from AcOH/NH4AcO (350/65 mM) to formic 
acid/NH4formate (100/50 mM), reduced retention. These results stood in agreement with later 
investigations regarding the elution strength of different type of acids and base additives to the mobile 
phase [56]. An added amount of 20 % (v/v) of acetonitrile to the mobile phase composition of b) 
increased the elution strength. It is known that acetonitrile inhibits the ??-interactions and could be 
used as a retention time reducing additive [79]. After changing from a low coverage column to a 
column with normal selector coverage, the mobile phase composition e) was used. Compared to d), both 
mobile phases matched the requirements.  
Aspartic acid as well as the more apolar amino acids like tryptophane was highly retained. Especially 
asparagine was unexpected to exhibit such high retention. Enantioselectivity was not influenced and 
was little changed for all analytes, when one of the five mobile phase compositions were used. Bigger 
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variability was obtained for lysine and aspartic acid, the first one was the least retained and the latter 
was the strongest retained. Asp could not been separated with any of the five tested mobile phases.  
 
 
Figure 46: k2-values of a set of amino acids, derivatized with FITC, for five different mobile phases. Data for the elution 
strength of the first three mobile phases, MeOH/AcOH/NH4AcO 98/2/0,5 % (v/v/w), MeOH 100 mM FA, 50 mM NH4 
formate and MeOH/ ACN 80/20 100 mM FA, 50 mM NH4 formate were done using a low coverage QN-AX column 
(loading of about 142 µmol/g silica gel). QN-AX was used with mobile phase consisting of MeOH/ACN 80/20 150 mM 
FA, 75 mM NH4formate and QD-AX was applied, when mobile phase composition MeOH/ACN 70/30 200 mM FA, 100 
mM NH4formate was used.  
 
The investigated resolution for a set of ten amino acids, derivatized with FITC and separated on 
different tert-butyl carbamate modified quinine-based CSPs with five different mobile phase 
compositions were illustrated in Figure 47. For alanine and leucine, mobile phase e) produced best 
resolution, whereas for valine and histidine the resolution was quiet unchanged. Proline was badly 
resolved and the alpha values were <1,5 for all five testes mobile phases. Asparagine, serine and 
tryptophane were best resolved with b) and had the worse resolution with d). Lysine and aspartic acid 
were not resolved with any of the tested mobile phases. 
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Figure 47: Resolution of a set of amino acids, derivatized with FITC, for five different mobile phases. Data for the 
resolution of separated enantiomer peaks of the first three mobile phases, MeOH/AcOH/NH4AcO 98/2/0,5 % (v/v/w), 
MeOH 100 mM FA, 50 mM NH4formate and MeOH/ ACN 80/20 100 mM FA, 50 mM NH4formate were done using a 
low coverage QN-AX column (loading of about 142 µmol/g silica gel). QN-AX was used with mobile phase consisting of 
MeOH/ACN 80/20 150 mM FA, 75 mM NH4formate and QD-AX was applied when mobile phase composition was 
MeOH/ACN 70/30 200 mM FA, 100 mM NH4formate. 
 
4.6.2 Enantioseparation of twenty proteinogenic amino acids labeled with FITC 
Twenty proteinogenic amino acids were derivatized with FITC and enantioseparation was performed 
using the optimized chromatographic separation conditions as stated in chapter 4.6.1 (Table 27 and 
Table 28). Lysine had the first eluting pair of enantiomers and was badly separated. This diamino acid 
was surely monosubstituted and therefore the basic substance was eluted early using an anion-exchange 
type CPS. Proline was separated with an alpha of 1,13 and a resolution of 1,38, which was significantly 
below the average of the whole set of amino acids.  
 
Comparison of enantioselectivity of the separations of proteinogenic amino acids, derivatized with the 
two investigated N-derivatization labels, AQC and FITC, is given in Figure 48. Generally, AQC-tagged 
amino acids exhibited higher enantioselectivity with the used QN-AX CSP. Aspartic acid was not 
separated employing both labels. Alanine, proline, glutamic acid and glutamine AQC derivatives were 
separated with an alpha below 1,5. Lysine, arginine, histidine, and cysteine were separated tightly above 
this critical alpha value, if AQC was used as label. Better enantioseparation for FITC-amino acid 
derivatives were only generated for alanine, glutamic acid and glutamine.  
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Figure 48: Comparison of enantioselectivity of N-derivatized proteinogenic amino acids, with AQC and FITC, both 
fluorescence active labels. AQC amino acid separations were done using method 1. FITC-AA analyses were done using 
method 6. QN-AX column was applied. 
 
Resolution values for the enantioseparation of amino acids, derivatized with AQC or FITC, were given 
in Figure 49. Summarized, the FITC-amino acid derivatives were slightly better resolved than the AQC-
tagged derivatives. Proline, lysine, phenylalanine, and tyrosine were better resolved with the AQC-tag.  
 
 
Figure 49: Comparison of resolution of N-derivatized proteinogenic amino acids, with AQC and FITC, both 
fluorescence active labels. AQC amino acid separations were done using method 1. FITC-AA analyses were done using 
method 6. QN-AX column was applied. 
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4.7 Evaluation of the sulfobetaine-type chiral stationary phases (CSP) 
4.7.1 Screening for chiral recognition of sulfobetaine-quinine-based CSPs 
The synthesis of quinine-based-zwitterionic CSPs was conducted as described in literature [80]. The 
combination of a strong acid and a weak base in one selector molecule was already investigated by 
Hoffmann et al. [56]. In previous studies, the introduction of a second charged moiety was carried out 
with a carbamate linkage at C9, the vinyl group at C3, or on the C6’ position of the quinoline ring. 
Modifications at the two amino groups were done by a simple alkylation reaction. The addition of an 
acid functional group, connected to the nitrogen atoms, present near the chiral recognition center at 
C8/C9, were not investigated. A sulfobetaine moiety could easily be created, when a sultone species 
was used. Sultones were known as alkylating reagent and provided a modified quinine-type selector in a 
one step synthesis approach (Figure 50).  
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Figure 50: Illustration of the quinine selector and its modification possibilities for the alkylation reaction with a sultone 
 
Summarized, all three sulfobetaine-type CSPs exhibited little to no enantiodiscrimination ability. A 
partial separation into two peaks was observed for the AQC derivatives of lysine, aspartic acid, 
cysteine, cystine, tyrosine and tryptophane. Some DNB derivatives were only partially separated on 
CSP 5. Note that CSP 5 delivered more often a partial enantioseparation than CSP 4 (Scheme 3). It also 
showed a minor difference in the retention behaviour compared to the QN/QD-AX columns. The 
retention of all analytes was reduced on the other sulfobetaine columns, CSP 3 and CSP 4. CSP 5 was 
able to separate DNB-Leu and AQC-cystine and AQC-Asp (Table 29).  
 
The missing enantioseparation is not only based on the absence of chiral recognition, but is possibly 
influenced by the loss of enantiodiscrimination ability of the selector. In most cases, the two 
enantiomers showed exactly the same retention and therefore were not separated. In comparison to CSP 
1 or 2, a difference in retention time was obvious. The sulfobetaine-type CSP showed a lower retention 
of the analytes. Another drawback could be based on the type of chemical functionalities combined in 
the selector. The combination of a strong acid, the sulfonic acid moiety and a quaternary amine, which 
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was altered to a strong base, was not yet investigated. In different studies, a strong (SCX) or weak 
(WCX) cation exchange moiety was introduced via the C9, or the C6´-position of the quinine molecule. 
These modifications were fully tested and were found to be applicable in AX, CX and ZX mode for 
separation of basic, acidic and zwitterionic compounds [56], [55]. In this study the zwitterionic CSPs 
were only used in an AX mode for the separation of acidic and zwitterionic analytes. An intermolecular 
counter  ion (IMCI) effect  was investigated in earlier  studies  [57].  The IMCI effect  meant  a  shortened 
retention time for acidic analytes and reduced ion-exchange capacity due to intermolecular charge 
compensation. In the case of sulfobetaine, the two moieties were connected with a four atom-bond 
bridge. For CSP 3 and 4, the quinuclidine ring was altered from a weak to a strong AX site. It is well 
known that the attractive anion-exchange moieties were essential for the chiral recognition process, 
because of its closeness to the stereogenic centres at C8/C9 of the quinine structure [54]. It was 
supposed that the IMCI and the modification at the quinuclidine ring wiped away the 
enantiodiscrimination ability of the quinine-based selector, because of a counter ion effect, a strong 
repulsive force of the sulfonic acid group and the modification to a quaternary base.  
If the two opposite charged intramolecular ions would shield each other, an ion pairing process would 
be prevented. The addition of a strong base or acid to the mobile phase would overwhelm this 
intermolecular process. A phosphate buffer with pH 2,0 was tested, but did not provide the aimed 
results. 
4.7.2 Screening for separation performance in the HILIC mode of the sulfobetaine-type 
stationary phases 
As it was mentioned in previous publications, a HILIC retention increment for the tert-butyl carbamate 
modified quinine-based CSPs, was expected [63].The sulfobetaine-based CPSs were studied, in course 
of their applicability for hydrophilic interaction chromatography (HILIC), because of the strongly more 
polar character of the sulfobetaine modified quinine-based columns, compared to the tert-butyl 
carbamate modified CSPs. 
A screening study was set up, using method 7. A representative set of hydrophilic compounds 
containing fourteen analytes, acidic and basic compounds, purines and nucleosides were used for the 
investigation ( Figure 22). The influence of mobile phase composition and pH was investigated. Special 
parameters for HILIC were recorded and compared, e.g. the peak shape, efficiency and selectivity to 
different but related compounds. The mobile phase was a mixture of ACN/aqueous buffer 9/1, 
containing 10 mM NH4AcO with buffer pH 5,0 or 8,0 adjusted with acetic acid or ammonium 
hydroxide. In another experiment, the pHa was adjusted to 5,0, which meant that a much bigger amount 
of acetic acid had to be added to the mobile phase.  
The detection of analytes was carried out using different wavelengths, e.g. 215, 248, 280 and 360 nm 
and the highest absorbing wavelength was taken into account for data analysis. The retention factors 
and the number of plates per meter of column were juxtaposed in Table 30. As it was described in 
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literature, the pH influenced acidic HILIC compounds, thus exhibiting reduced retention. Whereas the 
same trend was observed for basic compounds, but was less obvious. The ln(k) values were calculated 
and a correlation plot was made for each of the three HILIC columns, for two different pH values. 
These plots illustrated the impact of different mobile phase pH on separation selectivity, in respect to 
the selectivity determined by the stationary phase [59]. Afterwards the selectivity coefficients s2 were 
calculated. A correlation plot illustrated the change in selectivity and/or retention caused by an 
alteration of a chromatographic parameter e.g. the pH (Figure 51).  
 
 
 
 
Figure 51: Illustration of the possible influence of mobile phase pH on analyte retention and selectivity applying a 
zwitterionic HILIC column. A) a retention behaviour and a selectivity is obtained for analyte 1,2 and 3. B) the retention 
of analyte 1,2 and 3 was changed by the change of mobile phase pH. A change in elution strength could also cause a 
altered retention C) the selectivity of analyte 1, 2 and 3 was changed by the mobile phase pH. 
 
 
Firstly, the two mobile phases with pH 5,0 and 8,0 were compared for each of the tested columns. For 
CSP 3 a high degree of correlation of 0,98 was achieved. Correlation was expressed as the square of the 
correlation coefficient R2. The selectivity coefficient s2 was 0,019. Both examined mobile phases were 
compared and exhibited a pH depended linear relationship for the set of investigated analytes, regarding 
the retention. Obviously, the modification of the mobile phase pH did not led to a changed selectivity 
for CSP 3 and for this reason a pH alteration will not be useful to solve a specific separation problem 
(Figure 51).  
 
CSP 4 showed a mixed picture concerning the selectivity correlation investigation.  
R2 was  0,46  and  s2 was 0,539, without any outlier eliminations (Figure 53). Compounds, which 
disturbed a linear correlation were the alkaloids, theobromine and theophylline as well as the basic 
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analytes, phenylephrine and thiamine. The basic compounds exhibited a higher retention, if the mobile 
phase with pH 5 was maintained and their selectivity could be significantly altered by a pH adjustment. 
For CSP 5 a similar behaviour could be achieved as for CSP 4 (Figure 54). The R2 was 0,86 and s2 was 
0,144. If theobromine was excluded as an outlier, the correlation was raised to 0,96 with a selectivity 
coefficient of 0,040. It could be stated that theobromine was stronger influenced by changing the ionic 
strength  of  the  mobile  phase  and  this  could  be  a  hint  for  the  selectivity  enhancement  in  course  of  a  
suitable separation of theobromine and theophylline [81].  
 
 
Figure 52: Correlation plot of two mobile phases with different adjusted pH value for a test set of typical HILIC 
compounds, and evaluation of the selectivity coefficient. The column was CSP 3. 
 
 
Figure 53: Correlation plot of two mobile phases with different adjusted pH value for a test set of typical HILIC 
compounds, and evaluation of the selectivity coefficient. The column was CSP 4. Theophylline, theobromine, thiamine 
and phenylephrine were possibly outliers and were eliminated.  
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Figure 54: Correlation plot of two mobile phases with different adjusted pH value for a test set of typical HILIC 
compounds, and evaluation of the selectivity coefficient. The column was CSP 5 and for the plot the outliers were not 
eliminated.  
 
Secondly, the more acidic mobile phase with pHa 5,0 was compared to the mobile phase with pH 8,0. 
For  the  CSP  3,  the  s2 value was 0,137 (Figure 55) and R2 was 0,86. These values meant a reduced 
correlation of the retention regarding the influence of pH. The acids, ibuprofen, flurbiprofene and 4-
OH-phenyl acetic acid were eliminated as outliers. These acidic compounds were not retained with the 
applied pH. It could be stated that a higher pH value would allow the consideration to place these 
compounds into the selectivity plot.  
For the CSP 4, the selectivity plot is shown in Figure 56. Here, the selectivity coefficient was 
calculated, as 0,361 and R2 was 0,64, theophylline was cancelled as outlier. If outliers were dismissed 
more  restrictly,  e.g.  4-OH-phenyl  acetic  acid  and  theobromine,  the  R2 and  s2 values were 0,89 and 
0,112, respectively. In contrast to CSP 3, the alkaloids were typical outliers and interrupted the linearity 
of the plot. The basic compounds did not give a clear trend, as mentioned in the literature [59]. 
Retention of every compound was decreased when increasing the pH of mobile phase. This trend was 
observed to be quite linear for the set of investigated analytes. This behaviour was not observed for the 
other two investigated columns, CSP 3 and 5.  
For the third HILIC column, CSP 5, a selectivity coefficient of 0,142 and a R2 of 0,85 were achieved 
(Figure 57). Ibuprofen, flurbiprofen and 4-hydoxy-phenyl acetic acid were dismissed, due to a lack of 
retention when applying the mobile phase at pHa 5,0. For all other investigated analytes it could be 
stated that the retention showed a correlation for pH 5,0 to 8,0, where the retention was enhanced with 
increasing the pH value of the mobile phase. The generally low retention was strongly depended on the 
adjusted  apparent  pH.  For  that  reason  a  well  fitted  selectivity  plot  could  not  be  created.  If  the  most  
influenced substances, the acidic compounds were cancelled, a plot could be produced, which showed 
the influence of the ionic strength of the mobile phase on the retention. 
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Figure 55: Selectivity plot of CSP 3, for two different pH values. Ibuprofen, flurbiprofene and 4-OH-phenyl acetic acid 
were eliminated, because they showed minimal retention.  
 
 
Figure 56: Selectivity plot of CSP 4, for two different pH values. Theophylline was eliminated as outlier.  
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Figure 57: Selectivity plot of CSP 5, for two different pH values. Ibuprofen, flurbiprofen and 4-OH-phenyl acetic acid 
were eliminated, because they showed minimized retention. 
 
Generally, with the use of a test set, containing acidic, basic, zwitterionic and polar analytes, it could be 
outlined that the three groups of analytes, with different chemical behaviour, showed retention on all 
three columns. The nucleosides, desoxynucleosides and the nucleobases, such as phenylephredine and 
thiamine had highest retention on the CSP 3, if the mobile phase with pH 5,0 was applied. The 
separations provided good column efficiencies, except thiamine which underlay peak broadening. 
Therefore it could be stated that CSP 3 would hit the prospects for separations of basic compounds at 
the best. Especially 4-OH-phenyl acetic acid and cytidine showed high retention on CSP 4.  
In general, the mobile phase composition with pHa 5,0 and 8,0 exhibited a worse separation 
performance than the “middle” pH of 5,0 for acidic compounds.  
For acids it could be said that the retention was frequently the highest with pH 5,0, using CSP 3 for 4-
OH-phenyl-acetic acid and CSP 5 for flurbiprofene and ibuprofen.  
Zwitterionic compounds, such as nicotinic acid, alpha-methyl-tryptophane and tryptophane were highly 
retained on CSP 3 and CSP 5, and had their highest retention with mobile phase of pH 5,0.  
 
The peak efficiencies were noticeably less satisfying with CSP 3 than with the two other columns. 
Zwitterionic analytes yielded the best retention behaviour with quiet good efficiency with the CSP 5 
(Table 30). In general, CSP 5 provided the best performance in this study, especially at the middle pH 
of 5,0. However, with this mobile phase the highest peak efficiencies, expressed as number of 
theoretical plates were achieved. The combination of CSP 5 with mobile phase of pH 5,0 was 
remarkable for acidic compounds and good selectivity could be reached.  
The alkaloids, theobromine and theophylline were not strongly retained on all three columns using any 
of the applied mobile phase compositions and therefore they were the most challenging compounds in 
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this study.  
Concerning the peak shape, which was also influenced by the number of plates, it should be clarified 
that the zwitterionic compounds, such as tryptophane and alpha-methyl-tryptophane showed the 
broadest peaks with a significant tailing. This was truly based on their zwitterionic character and was 
also observed in reversed phase separations. Thiamine also exhibited low efficiencies on this type of 
sulfobetaine-HILIC columns (Table 30).  
 
The chromatographic parameters for the investigated set of HILIC compounds were also investigated 
using a commercially available ZIC-HILIC column, sulfobetaine type Nucleodur® 100-3 (Table 31). 
The mobile phase was ACN/aqueous buffer, containing 10 mM NH4AcO with pH 5,0 and method 7 was 
applied. In direct comparison with the data for the sulfobetaine columns (Table 30), some aspects 
should be mentioned. CSP 5 had frequently the highest efficiency. Actually, flurbiprofene and 
ibuprofene had highest retention on this column and lowest on the Nucleodur®. On CSP 4, 4-OH-phenyl 
acetic acid, flurbiprofene and ibuprofene were highly retained. CSP 3 showed high retention for 
adenine, adenosine, deoxyadenosine and phenylephrine, but did not exhibit the proper efficiency for 
these compounds compared to the other sulfobetaine columns. The Nucleodur® column gave the best  
retention for cytidine, thiamine, tryptophane, alpha-methyl-tryptophane and nicotinic acid, but 
efficiency was in most cases better on one of the sulfobetaine columns. On the other hand the 
Nucleodur® column had the worst separation performance for adenine, adenosine, deoxyadenosine, 
flurbiprofene and ibuprofene.  
 
Figure 58 provided an overlay of chromatograms of single injections of HILIC compounds using 
method 7 and CSP 5. Theophyllin and theobromine eluted firstly, then the acidic compounds, 4-OH-
ühenyl acetic acid, flurbiprofene and ibuprofene as well as nicotinic acid eluted. The zwitterionic 
tryptophane exhibited a high peak broadening because of its amphoteric nature.  
 
Keeping these results in mind, it should be stated that the synthesized sulfobetaine-type quinine-based 
columns were capable for separations in the HILIC mode. 
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Figure 58: Overlay of the chromatogram of single injections of HILIC compounds using CSP 5 and method 7.  
 
4.7.3 Examination of the retention mechanism of sulfobetaine-type quinine-based 
stationary phases 
Representative for the three synthesized columns, CSP 3, was used for the investigation of the retention 
mechanism of sulfobetaine-type HILIC columns. Alpha-methyl-tryptophane, 4-hydroxy-acetic acid and 
deoxyadenosine were chosen as analytes for the investigation. The observed retention behaviour was 
exemplified using different mixtures of mobile phase, namely ACN/aqueous buffer 10 mM NH4AcO 
pH 5,0, where the water content was increased from 10 to 90 % (v/v) (Figure 59). The buffer 
concentration was kept constant. Retention plots were generated, where the logarithm of the retention 
factor (log k) was plotted against the phase ratio of water. As illustrated, the retention plot showed a 
typically U-shape for all three tested substances. This indicated that a mixed retention mode was 
responsible for the observed elution dependency. Hydrophobic and hydrophilic retention increments 
accounted for the analyte retention [60].  
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Figure 59: Investigation of the retention mechanism of QN-SB-V2, concerning three representative HILIC compounds 
and a mobile phase mixture of ACN/aqueous buffer, with varying content of H2O from 10 to 90 % (v/v). A trendline 
was added for alpha-tryptophane to illustrate the typically U-shape for a mixed-mode retention behaviour.  
 
4.7.3.1 Comparison of the retention mechanism of sulfobetaine- and tert-butyl carbamate modified 
type quinine-based selectors 
Figure 60 illustrated the results of a comparison test. The same analytes and mobile phases were used, 
as for investigations of the retention mechanism of the sulfobetaine-type columns (CSP 3-5), but now 
CSP 2 was applied. The tert-butyl carbamate modified quinidine selector might exhibit a different 
retention mechanism compared to the sulfobetaine-type HILIC columns, although their quinidine 
moiety showed to a high degree of structural analogy. An oblated U-shape was observed in Figure 60 
for deoxyadenosine and alpha-methyl-tryptophane. The retention behaviour 4-OH-phenyl acid did not 
follow this trend. This acidic compound was excluded, because it underwent a different retention 
mechanism on a WAX-type column. The subsequent change in buffer concentration during a series of 
injections would strongly influence the protonation of the acidic analyte as well as the opposite charged 
moiety of the quinidine. The zwitterionic alpha-methyl tryptophane seemed to be uninfluenced by the 
change of buffer concentration, as observed for deoxyadenosine. The latter two compounds exhibited a 
mixed mode retention mechanism on CSP 2. In direct comparison with Figure 59, the magnitude of the 
U-shape was lowered.  
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Figure 60: Evaluation of the retention mechanism of a tert-butyl-carbamate-quinine-based CSP with a mobile phase 
mixture of ACN/aqueous buffer. The content of buffer ranged from 5 to 95 % (v/v). Analytes were alpha-methyl-
tryptophane, 4-OH-phenyl acetic acid and deoxyadenosine. 
 
It  was  found  that  the  reversed  phase  increment  of  CSP  3  and  the  tert-butyl modified quinine column 
was similar (Figure 61). This was confirmed, when the structure of the selectors was taken into 
consideration. The hydrophobic retention was caused by the linkage group or by an interaction site of 
the selector, like the quinoline ring. Both selectors had the similar reversed phase behavior, because of 
their structural analogy. Observing the typical HILIC mode with polar organic solvent and minor 
aqueous content, a difference in retention was observed. Surprisingly, the tert-butyl-carbamate-modified 
quinine CSP exhibited also HILIC character (Table 33). The sulfobetaine column showed a higher 
hydrophilic retention increment. It could be claimed, that the sulfobetaine-type columns exhibited 
stronger HILIC character than CSP 2. It should be mentioned that the selector loading was not equal, 
which would have some impact on the magnitude of the retention increments.  
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Figure 61: Comparison of the investigated retention mechanism of sulfobetaine-type, CSP 3 and tert-butyl carbamate 
modified quinine-based columns for deoxyadenosine and alpha-methyl-tryptophane. Mobile phase mixture of 
ACN/aqueous buffer was applied. The content of buffer was kept constant, but the amount of added water ranged from 
5 to 95 % (v/v).  
 
4.7.3.2 Comparison of the retention mechanism of sulfobetaine-type quinine-based with a 
commercial available zwitterionic sulfobetaine-type HILIC column 
A typical zwitterionic HILIC column was tested with the same mobile phase and analytes as mentioned 
above (Figure 62). Deoxyadenosine was not retained if a water content of 50 % was exceeded, but for 
alpha-methyl-tryptophane and 4-OH-phenyl acetic acid a typical U-shape was observed in the retention 
plot. In direct comparison of Figure 59 and Figure 62, it could be seen that the Nucelodur® column 
exhibited a much stronger HILIC character. The U-shape of the log(k) vs.  ĳ H2O plot for the 
Nucleodur® column was steep in the HILIC phase mode and less strong pronounced in the reversed 
phase mode. It was found that the tested sulfobetaine column, CSP 3 exhibited a moderate HILIC 
character, compared to a commercial zwitterionic HILIC column (Table 32).  
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Figure 62: Investigation of the retention mechanism of a commercial HILIC phase. Nucleodur® 100-3 HILIC, from 
Macherey-Nagel AG, a sulfobetaine-type HILIC column. Mobile phase mixture of ACN/aqueous buffer was applied. 
The content of buffer ranged from 5 to 95 % (v/v). Analytes were alpha-methyl-tryptophane, 4-OH-phenyl acetic acid 
and deoxyadenosine. Deoxyadenosine eluted with the void volume if an aqueous content of 50 % was exceeded.  
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5 CONCLUSION AND OUTLOOK 
The derivatization of amino acids with 6-aminoquinolyl-succinimidyl carbamate (AQC) was 
successfully introduced and optimized for all twenty proteinogenic amino acids and an extended range 
of non-proteinogenic amino acids as well as for alanine and phenylalanine peptides. The 
enantioseparation on tert-butyl carbamate modified quinine/quinidine based CSPs (QN/QD-AX) was 
successfully investigated. All proteinogenic amino acids were separated with a resolution >1,5, except 
for aspartic acid, which could not be separated on QN-AX and on QD-AX only a partial separation was 
achieved. As reported, biacidic analytes with two acidic interaction sites yielded worse separation 
results on the QN/QD-AX columns compared to mono acidic congeners [53]. In contrast, glutamic acid 
was well resolved, which might be a hint for the influence of the amino acid side chain on the chiral 
interaction mechanism and the reversal of the elution order. Other acidic amino acids were also 
resolved, but with somewhat higher retention times. The separation conditions, concentration, pH and 
ratio of buffer composition had to be well optimized, especially for acidic compounds. The separation 
of 4-hydroxyproline stereoisomers was successfully implemented. The threonine stereoisomers, with 
homologues of homoserine were not fully separated, the first eluting enantiomers of threonine and 
homoserine coeluted on both columns. The two coeluting compounds showed a lack of overall 
interaction with the selector and eluted very early. It was worthy to mention that the four stereoisomers 
of DL-threonine and DL-allo-threonine, respectively, could be enantioseparated. The four isoleucine 
stereoisomers were not fully separated. The first eluting stereoisomers coeluted and the later eluting 
ones were only partial resolved. The lack of selectivity was surely based on the small difference 
provided by the amino acid side chain. It was thought that the difference of the Gibbs free energy of the 
coeluting stereoisomers was too small to induce enantioseparation. The low energy amount of 
hydrophobic interactions confirmed this hypothesis. For hydrophobic interactions, the stereochemistry 
was of marginal importance. In addition, these hydrophobic interaction increments take to a different 
degree part in the chiral interaction mechanism. For 4-hydroxypoline and threonine isomers, the 
difference in configuration and comformation of each stereoisomer was remarkably high and besides 
that the interaction increments of their side chains were not hydrophobic in character.  
 
The alanine peptide separations provided insight into the chiral recognition mechanism. The here 
presented results broadened the knowledge gathered during earlier alanine peptide investigations [43]. 
In comparison the investigated protection groups and AQC, the latter mentioned tag positioned itself in 
term of introduced enantioselectivity behind the DNB-derivatives, but before the bulk of the other 
applied protection groups [53]. With growing peptide chain length, the alanine peptides showed a loss 
of retention as well as in enantioselectivity and resolution. Diverse finding were adopted for 
phenylalanine peptides. The retention time increased with growing chain length and hence, the 
enantioselectivity was comparable for each of the peptides in the sequence up to the pentamer. The 
resolution was less reduced up to the tetrapeptide and surprisingly, a drop in resolution could be denoted 
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for the pentamer. The trend was not further investigated for higher peptides, because of strongly 
reduced solubility of longer phenylalanine peptides. 
 
The use of fluoresceine isothiocyanate (FITC) for amino acid derivatization was successfully adopted. 
All twenty proteinogenic amino acid were derivatized and enantioseparation was compared to the 
performance of AQC derivatives. Generally, the enantioselectivity was for all observed derivatives 
marginally reduced, yet comparable. This can be explained by the use of different mobile phases, during 
the analysis. Comparison of the obtained resolution values gave a mixed picture. It was found that 
satisfactory  resolution  was  accessible  with  one  or  the  other  of  these  two  fluorescence  labels,  for  all  
proteinogenic amino acids, besides aspartic acid. The achieved enantioseparation of FITC-labeled 
amino acids provided further evidence for the supreme chiral discrimination abilities of quinine-based 
CSPs. The fact that aspartic acid was not separated, neither with AQC or with FITC, was an obstacle 
and could be caused by the competing interaction of the two carboxylic groups. Empirically, Asp-
derivatives were not separated, whereas glutamic acid was separated with moderate performance. 
The achieved selectivity of enantioseparation of secondary and beta-amino acids, derivatized with AQC 
is worthy to mention. It is known that secondary amino acids like proline and hydroxyproline were only 
resolvable with a limited range of protection groups, whereas primary amino acids allowed the use of a 
broader range of N-derivatization reagents [53]. Especially the AQC reagent seemed to be a quiet good 
option for the enantioseparation of proline and proline analogues. Additionally, beta-amino acid showed 
shorter retention, but in contrast, better alpha and resolution values were obtained compared to their 
alpha counterpart. The urea type derivative of amino acids uses AQC as a reagent open up a new site for 
amide type hydrogen bonding compared to amide type protecting groups, which clearly causes 
differences.  
 
The sulfobetaine-type quinine-based CSPs were found to lack in enantiodiscrimination. First, the 
combination of two strong ion-exchange groups in one selector molecule will overload the selector. As 
one charged group acts as a counterion for the oppositely charged ion-exchange site, and vice versa, the 
charged interaction sites are shielding each other. Furthermore, both modification positions, the 
quinuclidine and the quinoline nitrogen atom, seem to provide no alternative for modification of the 
quinine selector in order to alter or increase the enantiodiscrimination potential. Nevertheless, it was 
investigated that in some special cases some enantioselectivity was exhibited. In detail, the sulfobetaine 
type quinine based CSP (CSP 3) and the quinoline sulfobetaine type tert-butyl carbamate modified 
quinine based CSP (CSP 5) exhibited some enantiodiscrimination ability to the 3,5-dinitrophenyl 
derivatives  of  aspartic  acid,  leucine  and  cysteine  as  well  as  for  the  AQC  derivatives  of  cysteine  and  
cystine.  
In addition these sulfobetaine columns were investigated using a hydrophilic interaction liquid 
chromatographic separation system. Generally, all classes of typical HILIC compounds with polar 
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character were retained to a certain degree on at least one of the sulfobetaine-type columns. They 
showed good selectivity and efficiency, especially for zwitterionic and charged compounds. Alkaloids, 
such as theobromine and theophylline, gave the lowest selectivity followed by the nucleosides and 
nucleobases. The best HILIC performance was reached with CSP 3. The hydroxyl group at position C9 
was not modified, which provided a more polar character of the selector compared to tert-butyl 
carbamate modified quinine selector. Additionally, the higher selector loading of CSP 3 enhanced the 
polarity of the stationary phase. The highest efficiency was achieved with CSP 5. The enantioselectivity 
was also found to be not totally distinct in the HILIC mode. Alpha-methyl-tryptophane, phenylephrine, 
ibuprofene and DNB-aspartic acid were in some cases partially resolved.  
The mode of retention was investigated and it was found that all three sulfobetaine modified quinine-
based columns exhibited a mixed retention mode, containing hydrophobic as well as hydrophilic 
retention increments. In comparison with the tert-butyl carbamate modified quinine-based CSPs, the 
HILIC behaviour was moderately higher for the sulfobetaine columns. A further outlook for the 
investigation of the behaviour of sulfobetaine-type quinine-based HILIC columns is given to access 
better retention behaviour and selectivity. The selector loading, which will have an influence on the 
overall polarity of the stationary phase, should be increased. The alkylation of both nitrogen atoms 
provides another possibility to alter the polarity of the selector. However in the HILIC mode the 
enantioselectivity was widely diminished. 
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7.1 Tables 
 
Table 10: Proteinogenic amino acids derivatized with AQC and column QN-AX (CSP1) was used. Method 1 was 
applied for the enantioseparations. 
Analytes to t1 t2 k1 k2 alpha Rs N1 N2 e.o. 
Gly 1.40 5.65 5.65 3.04 3.04 1.00 0 2709 2709 n.a. 
Ala 1.40 4.20 5.11 2.00 2.65 1.33 2.50 2354 2906 D 
Val 1.40 3.40 6.42 1.43 3.59 2.51 7.93 2493 2755 D 
Leu 1.40 3.56 5.10 1.54 2.64 1.71 4.45 2231 2809 D 
Ile 1.40 3.33 6.34 1.38 3.53 2.56 7.91 2322 2814 D 
Met 1.40 5.10 7.18 2.64 4.13 1.56 4.32 2402 2781 D 
Pro 1.40 4.24 5.22 2.03 2.73 1.35 2.75 2677 2852 L 
Ser 1.40 5.04 7.81 2.60 4.58 1.76 5.50 2348 2773 D 
Thr 1.40 4.08 8.68 1.91 5.20 2.72 9.28 2376 2810 D 
Lys 1.40 4.96 6.99 2.54 3.99 1.57 3.80 1779 2221 D 
Asp 1.40 31.14 31.40 21.24 21.43 1.01 1.00 1716 2197 L 
Asn 1.40 5.46 11.73 2.90 7.38 2.54 8.87 2147 2493 D 
Glu 1.40 14.73 18.55 9.52 12.25 1.29 2.66 2026 2279 D 
Gln 1.40 4.73 5.44 2.38 2.89 1.21 1.71 2131 2635 D 
Arg 1.40 2.04 2.38 0.46 0.70 1.53 1.37 997 1679 D 
Phe 1.40 4.99 7.89 2.56 4.64 1.81 5.73 2493 2716 D 
His 1.40 2.60 3.33 0.86 1.38 1.61 2.63 1526 2071 D 
Tyr 1.40 5.72 10.10 3.09 6.21 2.01 6.74 2302 2429 D 
Trp 1.40 7.00 14.60 4.00 9.43 2.36 8.81 2410 2578 D 
Cysteine 1.40 6.48 11.58 3.63 7.27 2.00 5.79 1796 2094 D 
n.a. not applicable 
       
 
 
Table 11: Cystine derivatized with AQC, column was a QN-AX- low coverage (type CSP 1). Method 1 was applied for 
the enantioseparations. 
Analytes to t1 t2 t3 
k1 
k2 
k3 
Į 2/1 
Į 3/2 
Į 3/1 
Rs 1/2 
Rs 2/3 
Rs 1/3 
N1 
N2 
N3 
e.o. 
DL-Cystine 1.52 19.00 34.08 50.20 
11.5 1.86 5.73 1757 DD-DL-LL 
21.42 1.45 3.68 1561 Ratio peak area 
31.03 2.70 8.82 1432 1:2:1 
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Table 12: Proteinogenic amino acids derivatized with AQC, column was QD-AX (CSP 2). Method 1 was applied for the 
enantioseparations. 
Analytes to t1 t2 k1 k2 alpha Rs N1 N2 e.o. 
Gly 1.45 5.15 5.15 2.55 2.64 1.04 0 3137 5137 n.a. 
Ala 1.45 3.70 4.84 1.55 2.42 1.56 4.63 5059 4705 L 
Val 1.45 3.06 5.29 1.11 2.74 2.47 9.22 4927 4701 L 
Leu 1.45 3.20 4.62 1.21 2.26 1.88 6.29 4900 4678 L 
Ile 1.45 3.02 5.32 1.08 2.76 2.55 9.44 4826 4636 L 
Met 1.45 4.60 6.85 2.17 3.86 1.78 6.71 4746 4600 L 
Pro 1.45 4.28 6.10 1.95 3.32 1.70 6.04 4910 4660 D 
Ser 1.45 4.48 6.29 2.09 3.46 1.65 5.63 4651 4446 L 
Thr 1.45 3.79 6.29 1.61 3.46 2.14 8.35 4701 4443 L 
Lys 1.45 4.75 6.19 2.28 3.39 1.49 4.44 3626 3444 L 
Arg 1.45 2.00 2.28 0.38 0.59 1.56 1.24 753 2835 L 
Asp 1.45 21.64 28.30 13.92 19.18 1.38 4.09 3793 3759 D 
Asn 1.45 4.84 7.20 2.34 4.11 1.76 6.29 4134 4135 L 
Glu 1.45 13.09 13.94 8.03 8.92 1.11 0.94 3602 3476 L 
Gln 1.45 3.97 4.83 1.74 2.41 1.39 3.17 4338 4091 L 
Arg 1.45 2.00 2.28 0.38 0.59 1.56 1.24 753 2835 L 
Phe 1.45 4.70 7.36 2.24 4.22 1.88 7.38 4573 4443 L 
His 1.45 2.55 3.08 0.76 1.16 1.53 1.83 2142 1187 L 
Tyr 1.45 5.21 7.87 2.59 4.59 1.77 6.43 4170 3904 L 
Trp 1.45 7.09 10.60 3.89 6.54 1.68 6.25 4117 3887 L 
Cysteine 1.45 5.70 9.95 2.93 6.07 2.07 7.41 3385 2750 L 
n.a. not applicable       
 
 
Table 13: Separation data for the investigation of a set of proteinogenic amino acids, derivatized with AQC and 
separated on QD-AX using a hydro-polar mobile phase. Method 2 was applied for the enantioseparations. 
Analytes to t1 t2 k1 k2 alpha Rs N1 N2 e.o. 
Val 1.5 9.30 23.90 5.20 14.93 2.87 14.47 4481 4453 L 
Ile 1.5 9.89 27.45 5.59 17.30 3.09 15.7 4440 4483 L 
Met 1.5 14.33 25.79 8.55 16.19 1.89 10.05 5036 4934 L 
Pro 1.5 11.39 20.70 6.59 12.80 1.94 9.96 4674 4768 D 
Ser 1.5 10.45 15.78 5.97 9.52 1.60 7.16 4965 5000 L 
Phe 1.5 17.43 17.43 10.62 10.62 1.00 \ 4781 4781 n.a. 
His 1.5 2.86 3.60 0.91 1.40 1.54 2.95 2622 2696 L 
Tyr 1.5 15.95 15.95 9.63 9.63 1.00 \ 4355 4355 n.a. 
Trp 1.5 29.56 29.56 18.71 18.71 1.00 \ 4418 4418 n.a. 
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Table 14: Retention times of AQC-amino acid derivatives for the applied reversed phase system for optimization of 
derivatization procedure and further investigations. RP column Phenomenox Gemini 150x3,0 3µm. 
Analytes Retention time [min] Analytes Retention time [min]  
Asp 15.3 Met 31,1  
Ser 18,0 Ile 33.4  
Gln  18,9 Leu 33.8  
Asn  19,0 Lys 33.9  
Glu 20.7 Phe 35.2  
Gly 21.9 alpha-Aminobuthyric acid 27.8  
NH3 Peak 22.6 Norvaline 30.9  
His 22.8 Cysteine-acetamide 24.6  
Thr 24.1 Cysteine-4-vinylpyridine 31.5  
Arg 24.3 4-trans-L-Hydroxyproline 13.2  
Ala 25 4-cis-L-Hydroxyproline 24.5  
Pro 26.4 System peaks:    
Cysteine 27.3 AMQ 11.8  
Cystine 29.7 DAD  41.2; 42.1   
Tyr 29.7 FLD 33.4; 34.4; 40.8; 40.9; 41.3; 43.8; 
Val 30.3    
 
 
Table 15: Separation data for non-proteinogenic amino acids, stereoisomers, phosphoaminoacids and phenylalanine 
analoga. The column was a QN-AX (CSP 1). Method 1 was applied for the enantioseparations. 
Analytes to t1 t2 k1 k2 alpha Rs N1 N2 e.o. 
trans-4-D or trans-4-L-
Hydroxypro (2R, 4S and 
2S, 4R) 
1.50 4.37 5.78 1.91 2.85 1.49 2.34 3401 3678 D 
cis-4-D or cis-4-L-
Hydroxypro (2R, 4R allo 
and 2S, 4S) 
1.50 5.20 6.30 2.47 3.20 1.30 1.59 3812 3886 D 
trans-4-D or trans-4-L-
Hydroxypro (2R, 4S and 
2S, 4R)* 
3.76 11.10 15.00 1.95 2.99 1.53 3.95 7526 7787 D 
cis-4-D or cis-4-L-
Hydroxypro (2R, 4R allo 
and 2S, 4S)* 
3.76 13.30 16.20 2.54 3.31 1.30 4.41 7914 8232 D 
beta-DL-Phe 1.50 2.42 5.20 0.61 2.47 4.02 9.41 2397 2838 D 
Gly-DL-Phe 1.50 3.54 4.59 1.36 2.06 1.51 2.26 2579 2613 L 
Gly-DL-Pro ** 5.90 20.90 27.25 2.54 3.62 1.42 2.05 707 1281 L 
DL-Phe-Gly 1.50 4.79 6.53 2.19 3.35 1.53 4.44 3210 3509 L 
DL-Isoser 1.50 5.57 7.98 2.71 4.32 1.59 3.36 1324 1515 n.a. 
DL-Homoser 1.50 3.96 5.53 1.64 2.69 1.64 4.97 3250 3626 L 
DL-Thr 1.50 3.99 7.26 1.66 3.84 2.31 8.89 3513 3898 L 
DL-allo-Thr 1.50 4.30 6.64 1.87 3.43 1.84 6.58 3639 3957 L 
3,4-Dihydroxy-DL- 1.50 4.39 6.49 1.93 3.33 1.73 4.16 1881 1831 L 
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phenylalanine 
p-Fluro-DL-Phe 1.50 4.85 7.36 2.23 3.91 1.75 6.41 3712 4007 n.a. 
p-Chloro-DL-Phe 1.50 5.47 9.04 2.65 5.03 1.90 7.69 3719 4048 L 
p-beta-Chloro-DL-Phe 1.50 4.29 8.93 1.86 4.95 2.66 10.81 3502 3946 n.a. 
p-Bromo-DL-Phe 1.50 5.95 9.89 2.97 5.59 1.89 7.78 3819 4015 n.a. 
ZH555 ( Į-Amino-3-
hydroxy-3-phenyl-ethyl-
phosphon) 
1.50 7.36 27.93 3.91 17.62 4.51 6.36 775 425 n.a. 
FW460 (Į -Amino-
propyl-phosphon) 1.50 5.60 21.80 2.73 13.53 4.95 9.12 1029 936 n.a. 
FW 133 (Į -Amino-1-
cycohexyl-methyl-
phosphon) 
1.50 5.54 5.54 2.69 2.69 1.00 0 1979 1979 n.a. 
DL-Phospholeu 1.50 5.29 19.08 2.53 11.72 4.64 11.8 1692 1827 D 
DL-Methioninsulfone 1.50 6.30 8.20 3.20 4.47 1.40 4.09 3826 3901 L 
DL-Homocysteic acid 1.50 34.10 45.99 21.73 29.66 1.36 4.56 3750 3797 L 
DL-Cys-S-acetamide 1.50 5.09 7.20 2.39 3.80 1.59 5.25 3532 3852 L 
DL-Cys-S-AcOH 1.50 38.04 52.66 24.36 34.11 1.40 4.9 3645 3753 L 
DL-Achsa carbonic acid 1.50 2.84 6.06 0.89 3.04 3.40 10.62 2654 3958 SS 
DL-Achsa-sulfonic acid 1.50 5.27 9.77 2.51 5.51 2.19 9.62 3972 4249 SS 
NVal 1.45 3.33 4.87 1.30 2.44 1.88 6.41 4882 4602 L 
AABA (alpha -amino -
butanoic acid) 1.45 3.39 4.92 1.34 2.48 1.85 6.48 4970 4933 L 
DL-allo-Isoleu 1.50 2.07 3.73 0.38 1.49 3.91 7.13 2097 2730 L 
Dichlorprop 1.50 3.55 4.33 1.37 1.89 1.38 3.48 4628 4519 n.a. 
DL-Pipecolinic acid 
(Homoproline) 1.50 7.35 7.35 3.90 3.90 1.00 0 3896 3896 / 
DL-Nipecotinic acid (ȕ-
Homoproline) 1.50 1.85 2.18 0.23 0.45 1.94 1.72 1891 1536 n.a. 
Gly-DL-Pro*a 3.57 25.6 31.9 6.17 7.94 1.29 1.53 2816 416 D 
Gly-Gly-DL-Proa 1.43 7.2 7.6 4.03 4.31 1.07 0.54 958 2077 D 
Gly-Gly-DL-Pro*a 3.57 18.6 19.9 4.21 4.57 1.09 0.68 1200 2785 D 
n.a. not applicable 
        
Back pressure ca. 60 bar 
        
* Flow 0.4 ml/min  
** Flow 0.25 ml/min          
a Mobile phase: MeOH/H20 80/20, 20 mM NH4AcO pHa= 6,00     
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Table 16: Separation data for non-proteinogenic amino acids, stereoisomers, phosphoaminoacids and phenylalanine 
analoga. The column was a QD-AX (CSP 2). Method 1 was applied for the enantioseparations. 
Analytes to t1 t2 k1 k2 alpha Rs N1 N2 e.o. 
trans-4-D or trans-4-L- 
Hydroxyproline 
 (2R, 4S and 2S, 4R) 
1.50 4.37 5.78 1.91 2.85 1.49 2.34 3401 3678 D 
cis-4-D or cis-4-L- 
Hydroxyproline 
 (2R, 4R allo and 2S,4S) 
1.50 5.20 6.30 2.47 3.20 1.30 1.59 3812 3886 D 
trans-4-D or trans-4-L- 
Hydroxyproline 
 (2R 4S and 2S, 4R)* 
3.76 11.10 15.00 1.95 2.99 1.53 3.95 7526 7787 D 
cis-4-D or cis-4-L- 
Hydroxyproline 
(2R, 4R allo and 2S 4S)* 
3.76 13.30 16.20 2.54 3.31 1.30 4.41 7914 8232 D 
beta-DL-Phe 1.50 2.42 5.20 0.61 2.47 4.02 9.41 2397 2838 D 
Gly-DL-Phe 1.50 3.54 4.59 1.36 2.06 1.51 2.26 2579 2613 L 
Gly-DL-Pro ** 5.90 20.90 27.25 2.54 3.62 1.42 2.05 707 1281 L 
DL-Phe-Gly 1.50 4.79 6.53 2.19 3.35 1.53 4.44 3210 3509 L 
DL-Isoser 1.50 5.57 7.98 2.71 4.32 1.59 3.36 1324 1515 n.a. 
DL-Homoser 1.50 3.96 5.53 1.64 2.69 1.64 4.97 3250 3626 L 
DL-Thr 1.50 3.99 7.26 1.66 3.84 2.31 8.89 3513 3898 L 
DL-allo-Thr 1.50 4.30 6.64 1.87 3.43 1.84 6.58 3639 3957 L 
3,4-Dihydroxy-DL-
phenylalanine 1.50 4.39 6.49 1.93 3.33 1.73 4.16 1881 1831 L 
p-Fluro-DL-Phe 1.50 4.85 7.36 2.23 3.91 1.75 6.41 3712 4007 n.a. 
p-Chloro-DL-Phe 1.50 5.47 9.04 2.65 5.03 1.90 7.69 3719 4048 L 
p-beta-Chloro-DL-Phe 1.50 4.29 8.93 1.86 4.95 2.66 10.81 3502 3946 n.a. 
p-Bromo-DL-Phe 1.50 5.95 9.89 2.97 5.59 1.89 7.78 3819 4015 n.a. 
ZH555 ( 1-Amino-3-
hydroxy-3-phenyl-ethyl-
phosphon) 
1.50 7.36 27.93 3.91 17.62 4.51 6.36 775 425 n.a. 
FW460 (2-Amino-
propyl-phosphon) 1.50 5.60 21.80 2.73 13.53 4.95 9.12 1029 936 n.a. 
FW 133 (1-Amino-1-
cycohexyl-methyl-
phosphon) 
1.50 5.54 5.54 2.69 2.69 1.00 0 1979 1979 n.a. 
DL-Phospholeu 1.50 5.29 19.08 2.53 11.72 4.64 11.8 1692 1827 D 
DL-Methioninsulfone 1.50 6.30 8.20 3.20 4.47 1.40 4.09 3826 3901 L 
DL-Homocysteic acid 1.50 34.10 45.99 21.73 29.66 1.36 4.56 3750 3797 L 
DL-Cys-S-acetamide 1.50 5.09 7.20 2.39 3.80 1.59 5.25 3532 3852 L 
DL-Cys-S-AcOH 1.50 38.04 52.66 24.36 34.11 1.40 4.90 3645 3753 L 
DL-Achsa-carbonic acid 1.50 2.84 6.06 0.89 3.04 3.40 10.62 2654 3958 SS 
DL-Achsa-sulfonic acid 1.50 5.27 9.77 2.51 5.51 2.19 9.62 3972 4249 SS 
NVal 1.45 3.33 4.87 1.30 2.44 1.88 6.41 4882 4602 L 
AABA (alpha -amino -
butanoic acid) 1.45 3.39 4.92 1.34 2.48 1.85 6.48 4970 4933 L 
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DL-allo-Isoleu 1.50 2.07 3.73 0.38 1.49 3.91 7.13 2097 2730 L 
Dichlorprop 1.50 3.55 4.33 1.37 1.89 1.38 3.48 4628 4519 n.a. 
DL-Pipecolinic acid 
(Homoproline) 1.50 7.35 7.35 3.90 3.90 1.00 0 3896 3896 / 
DL-Nipecotinic acid (ȕ-
Homoproline) 1.50 1.85 2.18 0.23 0.45 1.94 1.72 1891 1536 n.a. 
Gly-DL-Proa 1.5 11.49 14.44 6.66 8.63 1.30 1.17 1084 252 L 
Gly-Gly-DL-Pro*a 
          
Gly-Gly-DL-Proa 1.5 9.78 9.78 5.52 5.52 1.00 0.32 3228 3228 n.a. 
n.a. not applicable 
          
* Flow 0.4 ml/min (better separation) 
** Flow 0.25 ml/min (better separation) 
a Mobile phase: MeOH/H20 80/20, 20 mM NH4AcO pHa= 6,00     
 
 
Table 17: Comparison of separation data of all four stereoisomers of hydroxyproline and isoleucine with three different 
mobile phase compositions a) flow rate 1 ml/min MeOH/H2O 80/20, 20 mM NH4AcO pHa 6,0, b) MeOH/H2O 80/20, 200 
mM NH4AcO pHa 6,0 flow rate 1 ml/min and 0,5 ml/min for c). d) flow rate 1 ml/min MeOH/AcOH/NH4AcO 98/2/0,5 % 
(v/v/w) and flow rate of 0,5 ml/min for e) 
Analytes k1/k2 k3/k4 
Į1/2 
Į2/3 
Į3/4 
Į1/4 
Rs1/2 Rs2/3 Rs3/4 N1/N2 N3/N4 e.o. 
4-Hydroxy 
proline - four 
stereoisomers a 
1.99 3.70 1.39 1.14 4.05 3.85 1.81 4740 4772 D<D-allo<L<L-
allo 2.77 4.21 1.34 2.12 \ \ \ 5090 5342 
4-Hydroxy 
proline - four 
stereoisomers b 
4.79 6.69 1.20 1.11 2.89 2.26 1.65 5580 4743 D<D-allo<L<L-
allo 5.77 7.41 1.16 1.55 \ \ \ 5534 6180 
4-Hydroxy 
proline - four 
stereoisomers c 
1.97 2.99 1.29 1.11 3.92 2.64 1.74 7526 7787 D<D-allo<L<L-
allo 2.55 3.32 1.18 1.69 \ \ \ 7912 8832 
4-Hydroxy 
proline - four 
stereoisomers d 
3.30 5.30 1.27 2.86 1.72 1.17 0.96 3442 1359 D<D-allo<L<L-
allo 4.20 15.16 1.26 4.59 \ \ \ 1342 3886 
4-Hydroxy 
proline - four 
stereoisomers d 
10.15 14.02 1.21 1.09 3.92 1.65 1.74 7525 7824 D<D-allo<L<L-
allo 12.33 15.23 1.14 1.50 \ \ \ 7914 8232 
Isoleucine - four 
stereoisomers d 
1.13 3.50 2.97 \ 12.04 0.85 \ 5748 5706 L=allo-L<D<D-
allo 3.36 \ 1.04 \ \ \ \ 4618 \ 
Isoleucine - four 
stereoisomers e 
2.22 8.37 3.55 \ 14.53 0.84 \ 4524 3611 L=allo-L<D<D-
allo 7.87 \ 1.06 \ \ \ \ 4312 \ 
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Table 18: Chromatographic parameters of the investigations of AQC-tagged alanine peptides, separated on QN-AX 
column. Method 2 was applied for the enantioseparations. 
 
 
Table 19: Chromatographic parameters of the investigations of AQC-tagged alanine dipeptides separated on QN-AX 
column. Method 2 was applied for the enantioseparations. 
Analytes to t1/t2 t3/t4 k1/k2 k3/k4 
Į RR/SS 
Į SR/RS 
Rs 
1/2 
Rs 
2/3 
Rs 
3/4 
N1/N2 N3/N4 e.o. 
DL-Ala-
DL-Ala 1.43 
7.6 12.5 4.31 7.74 0.56 1.89 3.51 1.33 2904 2901 DD<DL<
LL<LD 8.8 13.8 5.15 8.65 1.68 
   
3071 2965 
 
 
 
  
Analytes to t1 t2 k1 k2 alpha Rs N1 N2 e.o. 
DL-Ala 1.43 9.8 13.3 5.85 8.30 1.42 4.33 3205 3236 D 
DD/LL-Ala2 1.43 7.74 12.43 4.41 7.69 1.74 6.21 2722 2850 DD 
LLL/DDD-Ala3 1.43 5.5 6.2 2.85 3.34 1.17 1.65 2722 2719 DDD 
LLL/DDD-Ala3 * 3.57 14.16 16.19 2.97 3.54 1.19 2.42 4568 4486 DDD 
LDL/DLD-Ala3 * 3.57 15.9 16.8 3.45 3.71 1.07 0.9 4228 4434 DLD<LDL 
LLD/DDL-Ala3 * 3.57 16.4 16.4 3.59 3.59 1.00 \ 2329 2329 n.a. 
LDD/DLL-Ala3 * 3.57 15.8 17.3 3.43 3.85 1.12 1.57 4741 4704 LDD<DLL 
LLLL/DDDD-Ala4 * 3.57 5.15 5.8 0.44 0.62 1.41 1.47 2608 2524 DDDD 
LLLD/DDDL-Ala4 * 3.57 13.07 15.5 2.66 3.34 1.26 2.25 4408 4450 DDDL<LLLD 
LLDL/DDLD-Ala4 * 3.57 13.44 14.02 2.76 2.93 1.06 \ 4290 3347 DDLD<LLDL 
LDLL/DLDD-Ala4 * 3.57 13.48 13.48 2.78 2.78 1.00 \ 3594 32594 n.a. 
LDDD/DLLL-Ala4 * 3.57 14.03 14.03 2.93 2.93 1.00 \ 1836 1836 n.a. 
all-L/all-D-Ala5  1.43 4.94 5.49 2.45 2.84 1.16 1.25 2330 2356 DDDDD 
all-L/all-D-Ala 6 1.43 4.7 5.2 2.29 2.64 1.15 1.15 2250 2264 DDDDDD 
Gly-DL-Ala* 3.57 22.27 32.44 5.24 8.09 1.54 6.48 4996 4805 D 
DL-Ala-Gly 1.43 8.6 12.4 5.01 7.67 1.53 4.94 3170 3020 D 
DL-Ala-Gly-DL-Ala 1.43 6.48 6.8 3.53 3.76 1.06 0.61 2210 2403 D 
DL-Ala-Gly-Gly* 3.57 18.07 18.77 4.06 4.26 1.05 0.13 6530 7117 D 
Gly-Gly-DL-Ala* 3.57 17.23 17.42 3.83 3.88 1.01 0.22 5265 7702 D 
Gly 1.43 12.57 12.57 7.79 7.79 1.00 0 3398 3398 n.a. 
Gly-Gly  1.43 10.32 10.32 6.22 6.22 1.00 0 3118 3218 n.a. 
Gly-Gly-Gly  1.43 6.98 6.98 3.88 3.88 1.00 0 2808 2808 n.a. 
n.a. not applicable 
          
*flow rate 0.4 ml/min  
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Table 20: Chromatographic parameters of the investigations of AQC-tagged alanine peptides, separated on QD-AX 
column. Method 2 was applied for the enantioseparations. 
Analytes to t1 t2 k1 k2 alpha Rs N1 N2 e.o. 
DL-Ala 1.5 10.05 14.09 5.70 8.39 1.47 5.92 4993 5022 L 
DD/LL-Ala2 1.5 8.77 13.04 4.85 7.69 1.59 6.24 3970 3141 LL 
DL/LD-Ala2 1.5 10.13 12.33 5.75 7.22 1.25 3.09**   
LD 
LLL/DDD-Ala3 1.5 6.4 7.8 3.27 4.20 1.29 3.04 3941 3452 LLL 
LDL/DLD-Ala3 1.5 7.16 7.65 3.77 4.10 1.09 1.01 4053 3542 LDL 
LLD/DDL-Ala3 1.5 7.79 7.9 4.19 4.27 1.02 0.28 7000 5783 DDL 
LDD/DLL-Ala3 1.5 7.07 8.85 3.71 4.90 1.32 3.59 4002 4226 DLL 
LLLL/DDDD-Ala4 * 1.5 6.08 7.42 3.05 3.95 1.29 3.01 3624 3681 LLLL 
LLLD/DDDL-Ala4 * 3.74 17.17 18.12 3.59 3.84 1.07 1.11 6716 7056 LLLD 
LLDL/DDLD-Ala4 * 3.74 15.67 17.11 3.19 3.57 1.12 1.95 7672 8013 LLDL 
LDLL/DLDD-Ala4 * 3.7 15.65 18.03 3.23 3.87 1.20 3.06 7396 7624 LDLL 
LDDD/DLLL-Ala4 * 3.74 15.61 17.91 3.17 3.79 1.19 2.82 6774 6797 LDDD 
all-L/all-D-Ala5 1.5 5.92 7.23 2.95 3.82 1.30 2.9 3377 3411 LLLLL 
all-L/all-D-Ala6 1.5 5.66 6.92 2.77 3.61 1.30 2.79 3216 3119 LLLLLL 
all-L/all-D-Ala7 1.5 5.66 6.91 2.77 3.61 1.30 2.67 2748 3037 LLLLLLL 
Gly-DL-Ala 1.5 10.96 12.1 6.31 7.07 1.12 1.68 4692 4648 L 
DL-Ala-Gly 1.5 10.06 12.83 5.71 7.55 1.32 4.11 4503 4728 L 
DL-Ala-Gly-DL-Ala 1.5 7.42 8.28 3.95 4.52 1.15 1.81 3683 4550 L 
DL-Ala-Gly-Gly 1.5 8.50 8.50 4.67 4.67 1.00 \ 2695 2695 n.a. 
DL-Ala-Gly-Gly* 3.74 21.47 21.47 4.74 4.74 1.00 \ 3419 3149 n.a. 
Gly-Gly-DL-Ala 1.5 7.94 8.59 4.29 4.73 1.10 1.12 2621 4160 L 
Gly 1.5 13.35 13.35 7.90 7.90 1.00 \ 5208 5208 n.a. 
Gly-Gly  1.5 11.44 11.44 6.63 6.63 1.00 \ 4797 4797 n.a. 
Gly-Gly-Gly  1.5 8.50 8.50 4.67 4.67 1.00 \ 4083 4083 n.a. 
LLL/DDD-Ala3 * 3.74 16.19 19.88 3.33 4.32 1.30 4.7 7656 9269 LLL 
LDL/DLD-Ala3 * 3.74 18.05 19.35 3.83 4.17 1.09 1.47 7993 6579 LDL 
LLD/DDL-Ala3 * 3.74 17.80 22.53 3.76 5.02 1.34 5.04 7655 8141 DLL 
LDD/DLL-Ala3 * 3.74 19.50 19.86 4.21 4.31 1.02 0.42 7486 9529 DDL 
* flow rate 0.4 ml/min         
n.a. not applicable          
 
 
Table 21: Chromatographic parameters of the investigations of AQC-tagged alanine dipeptides, separated on QD-AX 
column. Method 2 was applied for the enantioseparations. 
Analytes to t1/t2 t3/t4 k1/k2 k3/k4 
ĮRR/SS 
Į SR/RS 
Rs 
1/2 
Rs 
2/3 
Rs 
3/4 
N1/N2 N3/N4 e.o. 
DL-Ala-
DL-Ala 1.5 
8.77 12.33 4.85 7.22 1.51 2.37 2.92 0.85 4310 3908 DD<L
D<DL 
<LL 10.14 13.21 5.76 7.81 1.25 
   
4307 4095 
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Table 22: Separation parameters of AQC-tagged phenylalanine peptides. Separation was carried out on a QN-AX CSP. 
Method 3 was applied for the enantioseparations. 
Analytes to t1 t2 k1 k2 alpha Rs N1 N2 e.o. 
DL-Phe 2.80 9.17 14.94 2.28 4.34 1.91 7.01 3520 3381 D 
DD/LL-Phe2 2.80 10.80 17.80 2.86 5.36 1.88 6.73 3141 2962 DD 
DL/LD-Phe2 2.80 10.12 11.70 2.61 3.18 1.22 2.02 3146 3076 DL 
DDD/LLL-Phe3 2.80 10.10 14.26 2.61 4.09 1.57 4.30 2538 2561 DDD 
DLL/LDD-Phe3 2.80 10.51 13.34 2.75 3.76 1.37 3.18 2887 2899 DLL 
DDL/LLD-Phe3 2.80 10.21 10.21 2.65 2.65 1.37 \ 2645 2945 n.a. 
DLD/LDL-Phe3 2.80 9.25 10.19 2.30 2.64 1.15 1.31 2947 2933 DLD 
DDDD/LLLL-Phe4 2.80 11.48 16.90 3.10 5.04 1.62 4.65 2285 2477 DDDD 
DLDD/LDLL-Phe4 2.80 10.90 14.75 2.89 4.27 1.48 3.63 2746 2410 DLDD 
DLLL/LDDD-Phe4 2.80 11.90 15.52 3.25 4.54 1.40 4.16 2399 2575 LDDD 
DDLD/LLDL-Phe4 2.80 10.25 10.25 2.66 2.66 1.00 \ 2575 2575 n.a. 
DDDL/LLLD-Phe4 2.80 10.74 12.94 2.84 3.62 1.28 1.58 2667 788 DDDL 
DDLL/LLDD-Phe4 2.80 11.51 15.72 3.11 4.61 1.48 3.47 2518 2184 LLDD 
DLLD/LDDL-Phe4 2.80 10.20 10.82 2.64 2.86 1.08 0.65 1329 2465 LDDL 
DLDL-LDLD-Phe4 2.80 9.88 10.56 2.53 2.77 1.10 0.40 2067 6606 DLDL 
All-D-all-L-Phe5 2.80 12.70 17.54 3.54 5.26 1.49 2.39 443 2363 DDDDD 
 
 
Table 23: Separation parameters of AQC-tagged phenylalanine dipeptides. Separation was carried out on a QN-AX. 
Method 3 was applied for the enantioseparations. 
Analytes to t1/t2 t3/t4 k1/k2 k3/k4 
Į RR/SS 
Į SR/RS 
Rs 
1/2 
Rs 
2/3 
Rs 
3/4 
N1/N2 N3/N4 
e.o. 
DL-Phe-
DL-Phe 
2.8 10.16 11.66 2.63 3.16 2.03 0.52 1.10 4.88 2753 3054 DL<
DD<
LD<
LL  
10.70 17.74 2.82 5.34 1.12 
   
1887 3053 
 
 
Table 24: Separation parameters of AQC-tagged phenylalanine peptides. Separation was carried out on a QD-AX CSP. 
Method 3 was applied for the enantioseparations. 
Analytes to t1 t2 k1 k2 alpha Rs N1 N2 e.o. 
DL-Phe 3.10 9.46 17.37 2.05 4.60 2.24 10.33 5086 4916 L 
DD/LL-Phe2 3.10 12.66 23.05 7.38 14.26 1.93 9.63 4459 4368 LL 
DL/LD-Phe2 3.10 12.27 12.44 2.96 3.01 1.02 0.26 6735 4911 LD 
DDD/LLL-Phe3 3.10 12.13 21.33 2.91 5.88 2.02 8.79 4222 4020 LLL 
DLL/LDD-Phe3 3.10 12.77 19.91 3.12 5.42 1.74 6.94 4002 4074 DLL 
DDL/LLD-Phe3 3.10 12.66 12.66 3.08 3.08 1.00 \ 3445 3445 n.a. 
DLD/LDL-Phe3 3.10 11.23 12.60 2.62 3.06 1.17 1.87 4294 4142 LDL 
DDDD/LLLL-Phe4 3.10 14.45 27.56 3.66 7.89 2.16 8.95 3236 3336 LLLL 
DLDD/LDLL-Phe4 3.10 4.68 5.09 0.51 0.64 1.26 1.37 4150 4343 LDLL 
DLLL/LDDD-Phe4 3.10 14.08 24.03 8.32 14.91 1.79 7.52 3227 3387 DLLL 
DLDD/LDLL-Phe4 3.10 13.36 21.63 7.85 13.32 1.70 7.22 3677 3780 LDLL 
APPENDIX 
118 
DDLD/LLDL-Phe4 3.10 13.27 14.30 7.79 8.47 1.09 1.17 3952 3837 LLDL 
DDDL/LLLD-Phe4 3.10 15.50 15.75 9.26 9.43 1.02 0.20 5571 5520 LLLD 
DDLL/LLDD-Phe4 3.10 14.33 24.67 8.49 15.34 1.81 8.21 3957 3789 DDLL 
DLLD/LDDL-Phe4 3.10 13.46 14.24 7.91 8.43 1.07 0.89 3949 3914 LDDL 
DLDL-LDLD-Phe4 3.10 12.87 12.87 7.52 7.52 1.00 \ 3464 3464 n.a. 
All-D-all-L-Phe5 3.10 17.10 31.14 4.52 9.05 2.00 2.86 1986 227 LLLLL 
 
 
Table 25: Separation parameters of AQC-tagged phenylalanine dipeptides. Separation was carried out on a QD-AX 
CSP. Method 3 was applied for the enantioseparations. 
Analytes to t1/t2 t3/t4 
k1/ 
k2 
k3/ 
k4 
ĮRR/SS 
Į SR/RS 
Rs 
1/2 
Rs 
2/3 
Rs 
1,2,3/4 
N1/N2 N3/N4 e.o. 
DL-Phe-
DL-Phe 3.1 
12.45 12.45 3.02 3.02 2.09 \ \ 7.77 1624 1624 
DL=LD=
DD<LL 
12.45 22.64 3.02 6.30 1.00 
   
1624 4597 
 
Table 26: Chromatographic parameters for the optimization of the retention for a set of FITC derivatized amino acids. 
Four different mobile phase compositions were applied, the parameters were kept constant such as column temperature 
25°C, flow rate 1 ml/min and detection with DAD 235 nm. 
MeOH/AcOH/NH4formate 98/2/0,5 % (v/v/w) and CSP 6 was applied.  
Analytes to t1 t2 k1 k2 alpha Rs N1 N2 e.o. 
Ala 1.55 7.74 9.79 3.99 5.32 1.33 3.4 3088 3648 \ 
Val 1.55 7.02 12.96 3.53 7.36 2.09 8.8 3676 3427 \ 
Leu 1.55 7.31 10.79 3.72 5.96 1.60 5.66 3334 3600 \ 
Pro 1.55 8.21 9.47 4.30 5.11 1.19 2.02 3168 3863 \ 
Ser 1.55 8.50 12.69 4.48 7.19 1.60 5.96 3602 3667 \ 
Lys 1.55 3.67 4.89 1.37 2.15 1.58 2.85 944 2754 \ 
Asp 1.55 \ \ \ \ \ \ \ \ \ 
Asn 1.55 9.08 18.65 4.86 11.03 2.27 10.17 3659 3395 \ 
His 1.55 4.98 6.68 2.21 3.31 1.50 3.82 2750 2749 \ 
Trp 1.55 13.56 23.00 7.75 13.84 1.79 7.71 3628 3540 \ 
MeOH 100mM FA, 50 mM NH4formate  and CSP 6column was applied.  
Analytes to t1 t2 k1 k2 alpha Rs N1 N2 e.o. 
Ala 1.57 6.67 8.62 3.25 4.49 1.38 4.21 4464 4267 \ 
Val 1.57 5.76 9.98 2.67 5.36 2.01 8.99 4379 3883 \ 
Leu 1.57 5.63 8.22 2.59 4.24 1.64 5.93 4472 3796 \ 
Pro 1.57 7.36 8.47 3.69 4.39 1.19 2.18 4040 3696 \ 
Ser 1.57 7.67 12.20 3.89 6.77 1.74 7.13 3748 4070 \ 
Lys 1.57 3.87 4.26 1.46 1.71 1.17 0.67 2892 392 \ 
Asp 1.57 23.13 32.14 13.73 19.47 1.42 5.04 3632 3679 \ 
Asn 1.57 7.93 16.78 4.05 9.69 2.39 10.8 3629 3716 \ 
His 1.57 4.81 6.60 2.06 3.20 1.55 4.39 3085 3192 \ 
Trp 1.57 11.13 19.27 6.09 11.27 1.85 8.58 42229 4046 \ 
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MeOH/ACN 80/20 100 mM FA, 50 mM NH4 formate and CSP 6was applied.  
Analytes to t1 t2 k1 k2 alpha Rs N1 N2 e.o. 
Ala 1.53 4.84 6.14 2.16 3.01 1.39 4.13 4965 4885 \ 
Val 1.53 4.20 7.24 1.75 3.73 2.14 8.95 4879 4325 \ 
Leu 1.53 4.20 5.99 1.75 2.92 1.67 5.99 4908 4581 \ 
Pro 1.53 5.07 5.65 2.31 2.69 1.16 1.64 4335 4139 \ 
Ser 1.53 5.56 8.29 2.63 4.42 1.68 6.75 4913 4529 \ 
Lys 1.53 2.94 3.67 0.92 1.40 1.52 1..58 415 1805 \ 
Asp 1.53 14.08 18.55 8.20 11.12 1.36 4.27 3678 4121 \ 
Asn 1.53 5.40 10.46 2.53 5.84 2.31 10.59 4885 4196 \ 
His 1.53 3.70 4.90 1.42 2.20 1.55 4.28 3579 3805 \ 
Trp 1.53 6.80 10.79 3.44 6.05 1.76 7.65 4781 4466 \ 
MeOH/ACN 70/30 200 mM FA, 100 mM NH4 formate and QD-AX column was applied.  
Analytes to t1 t2 k1 k2 alpha Rs N1 N2 e.o. 
Ala 1.48 6.02 8.27 3.07 4.59 1.50 5.07 4266 4166 \ 
Val 1.48 4.81 8.39 2.25 4.67 2.08 8.58 4261 3889 \ 
Leu 1.48 4.76 6.93 2.22 3.68 1.66 6.12 4155 3849 \ 
Pro 1.48 6.06 7.10 3.09 3.80 1.23 2.44 3930 3741 \ 
Ser 1.48 7.51 10.80 4.07 6.30 1.55 5.54 3496 4052 \ 
Lys 1.48 3.17 4.44 1.14 2.00 1.75 4.48 2862 2962 \ 
Asp 1.48 22.54 22.54 14.23 14.23 1.00 0 2044 2044 \ 
Asn 1.48 7.10 10.29 3.80 5.95 1.57 5.59 3806 3648 \ 
His 1.48 4.66 6.19 2.15 3.18 1.48 4.03 3234 3209 \ 
Trp 1.48 8.82 12.46 4.96 7.42 1.50 5.27 3828 3791 \ 
 
 
Table 27: Chromatographic parameters of FITC derivatized amino acids. Separation was carried out with a QN-AX 
column and method 6 was applied. 
Analytes to t1 t2 k1 k2 alpha Rs N1 N2 e.o. 
Gly 1.4 18.06 18.06 11.90 11.90 1.00 \ 2918 2918 n.a. 
Ala 1.4 11.92 15.77 7.51 10.26 1.37 3.6 2631 2746 D 
Val 1.4 8.67 16.60 5.19 10.86 2.09 8.28 2786 2792 D 
Leu 1.4 8.42 12.55 5.01 7.96 1.59 4.9 2651 2523 D 
Pro 1.4 11.22 12.54 7.01 7.96 1.13 1.38 2439 2562 L 
Ser 1.4 15.88 25.87 10.34 17.48 1.69 6.42 2801 2952 D 
Lys 1.4 4.89 4.97 2.49 2.55 1.02 0.87 1842 1923 D 
Asp 1.4 29.58 29.58 20.13 20.13 1.00 \ 2080 2080 n.a. 
Asn 1.4 13.34 28.90 8.53 19.64 2.30 9.04 2540 2361 D 
His 1.4 6.29 8.56 3.49 5.11 1.46 3.69 2240 2315 D 
Trp 1.4 16.79 28.90 10.99 19.64 1.79 6.65 2541 2683 D 
Tyr 1.4 16.20 26.20 10.57 17.71 1.68 5.89 2564 2452 D 
Ile 1.4 8.19 15.30 4.85 9.93 2.05 8.01 2714 2859 D 
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Met 1.4 14.65 21.65 9.46 14.46 1.53 5.02 2761 2812 D 
Thr 1.4 11.60 27.57 7.29 18.69 2.57 10.38 2380 2711 D 
Arg 1.4 4.60 5.78 2.29 3.13 1.37 2.47 1881 1926 D 
Glu 1.4 30.88 43.85 21.06 30.32 1.44 4.24 2348 2443 D 
Gln 1.4 13.50 16.50 8.64 10.79 1.25 2.56 2632 2627 D 
Phe 1.4 14.25 21.88 9.18 14.63 1.59 5.51 2725 2741 D 
DL-allo-Thr 1.4 16.57 26.11 10.84 17.65 1.63 5.88 2776 2777 D 
DL-Cysteine 1.4 13.89 18.47 8.92 12.19 1.37 7.78 1574 2683 D 
n.a. not applicable         
 
 
Table 28: Chromatographic parameters of FITC derivatized amino acids. Separation was carried out with a QD-AX 
column and method 6 was applied.  
Analytes to t1 t2 k1 k2 alpha Rs N1 N2 e.o. 
Gly 1.4 10.71 10.71 6.65 6.65 1.00 \ 4291 4291 n.a. 
Ala 1.4 7.10 9.96 4.07 6.11 1.50 5.42 4233 4168 L 
Val 1.4 5.44 9.81 2.89 6.01 2.08 9.08 4181 3942 L 
Leu 1.4 5.27 8.07 2.76 4.76 1.72 6.61 3944 4011 L 
Pro 1.4 7.36 8.75 4.26 5.25 1.23 2.66 3957 3693 D 
Ser 1.4 8.92 13.04 5.37 8.31 1.55 5.62 3218 3886 L 
Lys 1.4 3.21 4.75 1.29 2.39 1.85 4.85 2605 3298 D 
Asp 1.4 19.57 22.89 12.98 15.35 1.18 2.35 3610 3637 L 
Asn 1.4 8.52 12.20 5.09 7.71 1.52 5.3 3412 3684 L 
His 1.4 4.99 6.71 2.56 3.79 1.48 4.14 3026 3335 L 
Trp 1.4 11.14 16.16 6.96 10.54 1.52 5.67 3964 3733 L 
Tyr 1.4 9.70 15.45 5.93 10.04 1.69 6.34 2536 3533 L 
Ile 1.4 5.25 9.27 2.75 5.62 2.04 8.58 3920 3830 L 
Met 1.4 8.68 13.82 5.20 8.87 1.71 7.15 3890 3964 L 
Thr 1.4 6.99 12.28 3.99 7.77 1.95 8.68 4108 3945 L 
Arg 1.4 4.01 4.84 1.86 2.46 1.32 1.78 1557 1335 L 
Gln 1.4 8.01 9.69 4.72 5.92 1.25 2.94 4038 3752 L 
Glu 1.4 14.65 17.92 9.46 11.80 1.25 3.01 3705 3565 L 
Phe 1.4 8.97 14.40 5.41 9.29 1.72 7.58 4233 4107 L 
DL-allo-Thr 1.4 8.93 13.52 5.38 8.66 1.61 6.25 3406 3971 L 
DL-Cysteine 1.4 8.04 9.3 4.74 5.64 1.19 1.21 523 2997 L 
n.a. not applicable         
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Table 29: Excerpt of the investigation for chiral discrimination potential of the synthesized sulfobetaine-modified 
quinine-based stationary phases. Results just for the analytes, for which an enantioseparation or partial resolution 
could be achieved, were shown. Determination of the elution order was not performed. 
QN-SB-V2 
Analytes to t1 t2 k1 k2 alpha Rs N1 N2 e.o. 
DNB-Asp a 1.46 13.74 14.30 8.41 9.17 1.09 0.51 1674 1735 \ 
AQC-DL-Lys d 1.47 5.00 5.38 2.40 2.66 1.11 0.65 1471 1141 \ 
AQC-DL-Tyr d 1.47 3.02 3.27 1.05 1.22 1.16 0.64 1005 1023 \ 
AQC-DL-Cys d 1.47 9.03 10.20 5.14 5.94 1.15 0.95 1208 938 \ 
AQC-DL-Trp d 1.47 4.50 4.84 2.06 2.29 1.11 0.62 1717 1144 \ 
AQC-DL-Tyr b  1.47 3.53 3.76 1.40 1.56 1.11 0.61 1598 1446 \ 
DNB-Leu c 1.47 1.95 2.01 0.33 0.39 1.18 0.42 2254 3330 \ 
           
tBuCQN-SB-V2 
AQC-DL-Cys b 1.47 1.54 1.79 0.05 0.22 4.57 0.59 292 233 \ 
           
tBuCQN-SB-V3 
AQC-DL-Cysteine e 1.60 20.00 20.70 11.50 11.94 1.04 0.39 2003 2222 \ 
AQC-DL-Cystine d 1.60 15.80 16.00 8.88 9.00 1.01 0.25 2560 2652 \ 
DNB-DL-Leu  d 1.60 2.10 2.20 0.31 0.38 1.20 0.38 5462 5556 \ 
DL-DNB-Leu e  1.60 2.48 2.57 0.55 0.61 1.10 0.45 4555 4956 \ 
AQC-DL-Cystine b 1.60 39.77 43.61 23.86 26.26 1.10 0.74 1582 1586 \ 
DNB-Leu b  1.60 13.20 13.90 7.25 7.69 1.06 0.45 2568 2544 \ 
AQC-DL-Thr b 1.60 14.90 23.60 8.31 13.75 1.65 0.85 3524 3222 \ 
DNB-DL-Leu f 1.60 4.96 5.25 2.10 2.28 1.09 0.94 4685 4068 \ 
DNB-Glu a 1.60 6.60 6.76 3.13 3.23 1.03 0.42 8150 3420 \ 
Ac-Phe a 1.60 4.04 4.28 1.53 1.68 1.10 0.91 4106 3769 \ 
DNB-Ile a 1.60 4.07 4.23 1.54 1.64 1.06 0.60 3643 2835 \ 
           a ACN/H2O 9/1, 10mM NH4AcO pH 5.0         b MeOH 20mM AcOH 
     c ACN/H2O 9/1 10mM NH4AcO pH 8.1      d MeOH/AcOH/NH4AcO 98/2/0.5 % (v/v/w)      e MeOH/AcOH/NH4AcO 99/1/0.25 (v/v/w)      
 f MeOH/H2O 20 mM NH4AcO pH 6.0 with AcOH      
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Table 30: Comparison of the retention factors and the theoretical plate numbers per meter of column for the three tested sulfobetaine-type columns. Two different pH values in the 
mobile phase were applied, composition was ACN/H2O 9/1, 10 mM NH4AcO, pH was adjusted to pH=8,0 or 5,0 in the aqueous buffer or the apparent pH was adjusted to 5,0, with 
acetic acid or ammonia hydroxid. Other parameter according method 7. 
 
CSP 3 QN-SB-V2 CSP 4 tBuCQN-SB-V2 CSP 5 tBuCQN-SB-V3 
 
pHa 5.0 pH 5.0 pH 8.0 pHa 5.0 pH 5.0 pH .0 pHa 5.0 pH 5.0 pH 8.0 
Analytes k 
N 
[m-1] 
k 
N 
[m-1] 
k 
N 
[m-1] 
k 
N 
[m-1] 
k 
N 
[m-1] 
k 
N 
[m-1] 
k 
N 
[m-1] 
k 
N 
[m-1] 
k 
N 
[m-1] 
Adenine 3.13 20587 4.47 17347 2.27 15513 2.34 28660 4.30 20800 1.01 30313 2.67 33333 3.40 33707 1.07 5007 
Adenosine 2.97 26133 4.27 24513 1.92 24700 2.07 30287 4.20 27093 0.71 34660 2.41 36500 2.93 36207 0.81 1553 
Deoxyadenosi
ne 2.63 22580 3.66 23267 1.51 24073 1.98 12393 3.51 27447 0.59 28240 2.25 28707 2.71 24980 0.72 5160 
Cytidine 3.77 30073 5.79 25367 2.86 24860 2.44 28287 6.26 26500 1.18 35053 2.68 36500 3.61 38580 1.20 2433 
Ibuprofene 1.55 23227 2.47 12213 0.89 22493 1.78 27820 2.59 18773 0.54 33533 1.7 30140 2.99 9167 0.96 18560 
Flurbiprofen 1.61 25973 3.20 27207 1.32 26687 1.63 28380 3.33 29027 0.75 35593 1.84 19947 3.61 41073 1.37 6093 
4-OH-Phenyl 
acetic acid 1.92 20260 5.84 25600 3.56 24587 1.78 26740 12.00 19440 1.56 43813 1.92 32140 5.06 46227 2.34 14320 
Theophylline 2.28 24867 2.65 25373 0.84 21053 1.86 28240 3.60 24033 0.36 31327 1.88 23973 2.11 32667 0.35 10153 
Theobromine 2.28 23080 2.72 22653 0.85 20620 1.91 30047 2.60 24893 2.01 27867 1.95 25667 1.97 25087 0.15 1060 
Phenylephrine 3.98 29993 7.32 17193 3.95 21113 3.64 41367 6.49 11967 2.97 30267 3.15 32480 5.50 30960 2.62 27080 
Nicotinic acid 2.69 23653 6.70 21867 3.51 21900 2.20 34580 6.60 25600 1.52 38800 2.93 39613 5.81 48667 2.69 13853 
Thiamine 4.63 7767 12.26 8000 7.08 8380 4.06 19587 9.09 15767 4.14 18627 4.02 13953 8.37 23820 3.94 13713 
Į-Methyl-
tryptophane 4.47 15460 9.39 10647 5.40 14187 2.99 15020 9.27 11320 2.20 31200 3.52 27107 6.67 5040 3.07 8340 
Tryptophane 4.85 19567 10.37 14733 6.10 17813 3.16 5820 10.10 17593 2.63 14240 4.18 21180 7.45 10707 2.04 7053 
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Table 31: Chromatographic separation data for a set of HILIC representative compounds were presented. Mobile 
phase was a mixture of ACN/H2O 90/10, 10 mM NH4AcO, where the pH of the buffer was adjusted to 5.0 with acetic 
acid. Data were investigated by Georg Schuster.  
Nucleosid® - Zwitterionic HILIC column 
Analytes k N [m-1] 
Adenine 1.98 12419 
Adenosine 2.45 12633 
Deoxyadenosine 1.66 11958 
Cytidine 7.43 13553 
Ibuprofene 0.56 9136 
Flurbiprofen 0.73 9667 
4-OH-Phenyl acetic acid 6.9 13661 
Theophylline 0.42 9120 
Theobromine 0.44 9153 
Phenylephrine 6.5 13304 
Nicotinic acid 7.58 13496 
Thiamine 14.98 11242 
Į-Methyl-tryptophane 10.79 11999 
Tryptophane 13.37 11198 
 
 
Table 32: Evaluation data of the investigation of retention mode for a commercial zwitterionic HILIC column, EC 
150/4,6 mm Nucleodur® 100-3. Three analytes were compared. Mobile phase was a mixture of ACN/H20 with 10 mM 
NH4AcO pH 5,0, where the ratio of ACN/buffer was altered in a range of 5-95 % H20. 
NUCLEOSID® - Zwitterionic HILIC column 
 Retention factor k log(k) 
ĳ H2O Į-Methyl- 
tryptophane 
4-OH-phe-
AcOH 
Deoxyadenosine Į-Methyl-
tryptophane 
4-OH-phe-
AcOH 
Deoxyadenosine 
0.05 18.44 16.53 2.63 1.27 1.22 0.42 
0.10 10.22 5.17 1.48 1.01 0.71 0.17 
0.14 3.41 2.24 0.97 0.53 0.35 -0.01 
0.23 1.13 0.77 0.50 0.05 -0.11 -0.30 
0.32 0.57 0.34 0.23 -0.24 -0.47 -0.64 
0.41 0.32 0.14 0.13 -0.50 -0.87 -0.90 
0.50 0.19 0.04 0.04 -0.71 -1.37 -1.37 
0.59 0.13 0.00 0.00 -0.88 \ \ 
0.68 0.12 -0.02 0.00 -0.93 \ \ 
0.77 0.12 0.02 0.00 -0.91 -1.76 \ 
0.86 0.21 0.08 0.00 -0.68 -1.12 \ 
0.91 0.23 0.07 0.00 -0.63 -1.15 \ 
0.95 0.32 0.11 0.00 -0.50 -0.96 \ 
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Table 33: Comparison of data for the evaluation of retention mode for two columns, QN-SB-V2 and tBuCQD. Three representative analytes were chosen. The mobile phase was a 
mixture of ACN/H20 with 10 mM NH4AcO pH 5,0, where the ratio of ACN/buffer was altered in a range of 5-95 % H20. 
 
QN-SB-V2                   tBuCQD 
 
k log(k) k log(k) 
ĳ H2O 
?-Methyl- 
tryptopha
ne 
4-OH-
phe-
AcOH 
Deoxya
denosin
e 
?-Methyl-
tryptopha
ne 
 4-OH-
phenyl 
acetic acid 
Deoxyade
nosine 
ĳ 
H2O 
?-Methyl- 
tryptopha
ne 
4-OH-phe-
AcOH 
Deoxya
denosin
e 
?-Methyl- 
tryptopha
ne 
4-OH-
phe-
AcOH 
Deoxyaden
osine 
0.95 \ \ \ \ \ \ 0.95 4.72 17.00 3.35 0.67 1.23 0.53 
0.91 3.33 2.99 3.57 0.52 0.48 0.55 0.91 3.72 15.00 2.40 0.57 1.18 0.38 
0.86 2.62 2.47 2.47 0.42 0.39 0.39 0.86 2.94 \ 1.83 0.47 \ 0.26 
0.77 1.82 1.80 1.55 0.26 0.26 0.19 0.77 1.92 \ 1.13 0.28 \ 0.05 
0.68 1.45 1.34 1.25 0.16 0.13 0.10 0.68 1.40 24.00 0.96 0.15 1.38 -0.02 
0.59 1.30 1.20 1.10 0.11 0.08 0.04 0.59 1.15 22.00 0.99 0.06 1.34 0.00 
0.50 1.27 1.16 1.14 0.10 0.06 0.06 0.50 1.05 13.30 0.86 0.02 1.12 -0.07 
0.41 1.36 1.22 1.23 0.13 0.09 0.09 0.41 1.05 10.50 0.87 0.02 1.02 -0.06 
0.32 1.59 1.39 1.40 0.20 0.14 0.15 0.32 1.15 8.66 0.94 0.06 0.94 -0.03 
0.23 2.16 1.81 1.74 0.33 0.26 0.24 0.23 1.83 7.57 1.06 0.26 0.88 0.03 
0.14 3.60 2.87 2.41 0.56 0.46 0.38 0.14 2.20 7.40 1.29 0.34 0.87 0.11 
0.10 5.72 4.12 3.10 0.76 0.61 0.49 0.10 4.07 9.62 1.53 0.61 0.98 0.18 
0.05 \ \ \ \ \ \ 0.05 \ 6.50 2.02 
 
0.81 0.31 
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7.2 Summary 
The enantioselective separation of fluorescent labelled amino acids and peptides was investigated. A set 
of amino acids, all proteinogenic, many non-proteinogenic and dipeptides of biological, pharmaceutical 
or chemical interest were selected for the investigation. tert-Butyl carbamate-modified 
quinine/quinidine based chiral stationary phases (CSPs) were used for enantioseparations. Most of the 
analytes were N-terminal labelled with 6-aminoquinolyl-succinimidyl carbamate (AQC), a common 
fluorescent tag for quantitative amino acid analysis. As an easy derivatization procedure allowing 
sensitive quantification, AQC was often used in chiral separation studies. A comparison with 
fluoresceine-isothiocyanate (FITC) was conducted in the present study, concerning their 
chromatographic performance on an anion-exchanger-type CSP. FITC was found to yield equal chiral 
separation potential compared to AQC. Besides the proteinogenic amino acids, the separation of AQC-
tagged stereoisomers of 4-hydroxyproline, threonine and isoleucine, of dipeptides like 
phenyalaninoylglycine and glycoylphenylalanine or prolinoylglycine and glycoylproline was 
investigated. Further, the separation performance of the AQC reagent was explored using a set of 
alanine peptides. All-D/all-L peptides up to the hexamer were separated. The investigation of the 
influence on chiral recognition of one or two non-chiral linkers in di- and tripeptides, namely glycine 
subunits, either N- or C-terminal located was also part of this study. Enantiomerically pure 
phenylalanine peptides up to pentamers were also separated. These very lipophilic compounds were 
known to exhibit an unfavourable character related to chiral separations. The separation of 
stereoisomers of tri- and tetrapeptides of the before mentioned alanine and phenylalanine peptides was 
also investigated. The performance of the tert-butyl carbamate modified quinine/quinidine based CSPs 
was explored, as well as the influence of the stereochemistry on the N- or C-terminus of peptides on 
chiral recognition.  
 
The second part of the master thesis was the synthesis and application of sulfobetaine-type quinine-
based chiral stationary phases. A set of native or derivatized amino acids was analyzed with different 
types of mobile phase. It was found that the alkylation of the nitrogen atoms, either on the quinuclidine 
or the quinoline ring, had led to strongly reduced or even diminished chiral discrimination behaviour of 
the quinine selector. The sulfobetaine-type columns were also investigated concerning their 
applicability in the hydrophilic interaction liquid chromatography (HILIC) mode. A set of typical 
HILIC compounds, polar and/or charged substances were separated using mobile phases with different 
compositions and adjusted pH values. The retention mechanism of the columns was found to be a mixed 
mode, containing hydrophobic and hydrophilic retention increments. The study also showed that the 
tert-butyl carbamate quinine-based CSPs has also a hydrophilic retention increment. It was shown that 
the synthesized sulfobetaine columns can be used as HILIC columns for the separation of highly polar 
substances. 
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The present master thesis showed the applicability of a fluorescent tag, based on a carbamate linkage 
group, for the enantioselective separation of amino acids and related compounds on a quinine-based 
anion exchange-type chiral stationary phase.  
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7.3 Zusammenfassung 
Im Zuge der Masterarbeit wurde die Enantiomerentrennung von Aminosäuren (AS) unter Verwendung 
von auf Chinin/Chinidin-basierenden chiralen stationären Phasen untersucht. Die AS wurden N-
terminal funktionalisiert, um auf einer Anionenaustauschersäule retardiert zu werden. Dafür wurde ein 
weit verbreiteter Fluoreszenztag, 6-Aminoquinolin succinimid carbamate (AQC), verwendet. 
Demgegenüber wurde ein weiteres Label, Fluoresceinisothiocyanat (FITC), eingesetzt und die 
Ergebnisse bezüglich ihrer chromatographischen Leistung, wie Enantioselektivität, Auflösung und 
Retentionsverhalten, verglichen. AQC wurde über eine Harnstoffgruppe und FITC über eine 
Thioharnstoffgruppe an ein primäres oder sekundäres Amin des Analyten gebunden. Diese Arten von 
chemischen Brückengruppen wurde bislang noch nicht in Kombination mit Chinin/Chinidin 
basierenden chiralen stationären Phasen zur enantioselektiven Trennung untersucht. Die verwendeten 
Substanzen, Aminosäuren, sind mit Ausnahme von Glycin von Natur aus chiral, und kommen beinahe 
ausschließlich in der (S)- bzw. L-Form vor. Die Spanne von Analyten umfasste die proteinogenen AS, 
sowie eine Reihe von nicht proteinogenen AS, wie Aminophosphonsäuren, Phenylalaninderivaten- bzw 
deren Analoga, Sulfon,- als auch Phosphonsäuren, Dipeptide, Phenylalanine- und Alaninpeptide. Die 
chirale Trennung wurde über Hochleistungsflüssigchromatographie (HPLC) durchgeführt. Der chirale 
Selektor, Chinin/Chinidine, wurde an der C9 Position mit einer tert-Butylcarbamatgruppe versehen. 
Diese Modifikation führte zu einer sehr hohen Enantioselektivität gegenüber chiralen Molekülen. 
Betreffend der Wahl eines N-terminalen AS-tags kann das AQC Reagenz als sehr brauchbar eingestuft 
werden. Mit Ausnahme von Asparagrinsäure, wurden alle proteinogenen AS aufgetrennt. Spezielle 
Trennungsprobleme, wie die Separation von Stereoisomeren, wurden untersucht. So konnten alle vier 
Stereoisomere des 4-Hydroxyprolins basislinien rein getrennt werden. Die Threonin Stereoisomere, 
Threonine, allo-Threonin und Homoserin, wurden aufgelöst, mit der Ausnahme von den ersten beiden 
eluierenden Enantiomeren, welche kaum retardiert wurden und als eine Analytbande eluierten. Isoleucin 
Stereoisomere wurden dagegen viel schlechter aufgelöst. Dies kann darauf zurück geführt werden, dass 
das zweite Stereozentrum in der hydrophoben Seitenkette lokalisiert ist. Die hydrophoben 
Wechselwirkungen mit dem chiralen Selektor haben aber keinen Anteil an der chiralen Erkennung. 
Dem zugrunde liegend kann erklärt werden wieso für Isoleucin keine Basislinientrennung 
bewerkstelligt werden konnte. Schwer zu trennende Dipeptide wie Glycylprolin und 
Glycylphenylalanine konnten basislinienrein aufgelöst werden. Die Untersuchung von Alaninpeptiden 
sollte weiteren Aufschluss über die Leistungskraft der AS-label geben und auch über den chiralen 
Erkennungmechanismus weitere Erkenntnisse liefern. Die erzielten Ergebnisse ergänzen frühere 
Untersuchungen zu Alaninpeptiden und vervollständigen das erarbeitete Konzept der chiralen 
Erkennung von Peptiden mit mehreren Stereozentren. Die Abhängigkeit der Enantiomerentrennungen 
bezüglich des Abstandes der Schutzgruppe zu dem chiralen Zentrum wurden untersucht, ebenso der 
Einfuss einer achiralen Brücke, wie der eines Glycinrestes in solch einem Peptid. Die Auftrennung der 
ZUSAMMENFASSUNG 
128 
 
Phenylalaninpeptide war ein weiterer Leistungstest für das angewandte Label. Aufgrund von 
durchgehend erzielten Basislinientrennungen, mit Ausnahme einiger Stereoisomer der Tri- und 
Tetrapeptiden, konnte dieser Derivatisierungsreagenz große Komplementariät zu dem tert-butyl-
carbamate Chinineselektor zugesprochen werden. Generell stellt die AQC Gruppe, aufgrund von guten 
Trennleistungen, eine Erweiterung der möglichen N-terminalen Schutzgruppen dar. FITC konnte 
ebenfalls alle proteinogenen Aminoäuren derivatisieren und die Enantiomere wurden mit ähnlicher 
Trennleistung wie für die AQC-Derivate aufgetrennt. Die Enantioselekitivität war durschnittlich etwas 
geringer als bei AQC. Aufgrund von der weitaus kostengünstigeren Verfügbarkeit von FITC, war auch 
diese fluoreszenz aktive Gruppe sehr attraktiv. 
 
Ein weiterer wesentlicher Bestandteil dieser Masterarbeit war die Synthese und Charakterisierung von 
auf Chinin basierenden Sulfobetain modifizierten chiralen Selektoren. Drei chirale stationäre Phasen 
dieses Typus wurden mittels einer Alkylierung unter Verwendung eines Propylsultons hergestellt.  
Die Alkylierung am Quinucelodinring des nativen Chinins führte zum Selektor der Säule CSP 3. Die 
gleiche Modifikation wurde an einem tert-butyl carbamate modifizierten Chininanalogon durchgeführt 
und führte zu CSP 4. Die Alkylierung am Quinolinring des tert-butyl carbamate Analogons ergab 
CSP 5. Die Säulen wurden auf ihre Fähigkeit zur Enantiomerentrennung getested. Es wurde festgestellt, 
das die Modifikation an einem der beiden enthaltenen Stickstoffatome unter Einführung einer 
Sulfonsäuregruppe die Fähigkeit zur Enantiodiskriminierung stark verringert, beziehungsweise völlig 
auslöscht. Nur für einige Analyte konnte eine Antrennung der Enantiomere erzielt werden. 
Grundsätzlich kann der Ort der Modifkation, als auch die eingeführte Gruppe dafür verantwortlich 
gemacht werden. Die Sulfonsäuregruppe und das quaternäre Amin stellen intramolekulare Gegenionen 
dar und ihre Ladungen können sich gegenseitig abdecken.  
Die Säulen wurden daraufhin auf ihre Anwendbarkeit in den hydrophilen Interaktionsmodus (HILIC) 
untersucht. Generell wurden dem Selektormolekül zwei Ladungen zugefügt, wodurch die Polarität des 
Gesamtmoleküls wesentlich gesteigert wurde. In Bezug auf die Anwendung als HILIC Säulen konnte 
ermittelt werden, dass eine grundsätzliche Retention von polaren und geladenen Analyten, Nukleoside, 
Nukleotide, Alkaloide, Säuren, Basen und amphotere Verbindungen, stattfindet. Die Selektivität 
bezüglich Nukleosiden und Nukleotiden war begrenzt, wogegen geladene und zwitterionische 
Verbindugen mit hoher Selektivität als auch Effizienz getrennt wurden.  
Die Modifikation an den Stickstoffatomen des Chinins, unter Einführung einer zweiten starken 
Ionenaustauschgruppe, führte zu einer Verminderung des chiralen Erkennungssystems. Diese 
Modifizerung des Chinins war daher nicht zielführend um die chirale Erkennung zu verändern oder zu 
verstärken. Als HILIC Säulen konnten die Sulfobetainphasen Verwendung finden. Eine höhere 
Selektorbeladung, sowie die Einführung einer zweite Alkylierung mit einem Akylsulfon, oder einer 
anderen, mehr HILIC taugliche Gruppe am C9-Atom des Chinins könnte zu mehr Effizienz der 
Auftrennung von HILIC Verbindungen führen. Die Retention von Analyten auf CSP 3 wurde durch 
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hydrophobe als auch hydrophile Inkremente hervorgerufen. Es wurde auch hydrophiles 
Retentionsinkrement des tert-butyl carbamat Chininselektors festgestellt, das zu moderaten Retentionen 
von hydrophilen Substanzen im HILIC Modus führte.  
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